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Abstract
The seven transmembrane-spanning G Protein-coupled Receptor (GPCR) super family is the
largest family of cell-surface receptors, comprising greater than 650 members. GPCRs
represent the primary targets of most therapeutic drugs. Desensitization, endocytosis and
recycling are major mechanisms of receptor regulation and intracellular trafficking of GPCRs
is linked to the Rab family of small G proteins. In the present study, we examined whether
multiple Rab GTPase regulate receptor trafficking through endosomal cellular compartments
as a consequence of their direct association with GPCRs. We find that Rab4, Rab7 and
Rab11 all bind to the last 10 amino acid residues of the angiotensin II Type 1 (AT1R)
carboxyl-terminal tail. We show that the Rab GTPases compete with one another for receptor
binding and that Rab4 effectively displaces Rab11 from the receptor. In contrast, Rab11
overexpression does not prevent Rab4 binding to the AT1R. Overexpression of wild-type
Rab4, but not Rab11, facilitates AT1R dephosphorylation, and a constitutively active Rab4Q67L mutant reduces AT1R desensitization and promotes AT1R resensitization. We also
find that Rab8, a RabGTPase involved in the regulation of secretory/recycling vesicles,
modulation of the actin cytoskeleton and cell polarity, interacts with the carboxyl-terminal
tail of metabotropic glutamate receptor 1 (mGluR1a) and attenuates mGluR1a signalling and
endocytosis in a protein kinase C-dependent manner. Finally, we have examined several
previously uncharacterised but naturally occurring mutaions in mGluR1a that have been
associated with cancer that may alter mGluR1a signalling. We find that mutations found
within the ligand binding domain of mGluR1a result in both decreased cell surface
expression and basal inositol 1,4,5, trisphosphate formation and bias mGluR1a signalling via
the ERK1/2 pathway. Additional mGluR1a mutations localized to the mGluR1a glutamate
iii

binding site, intracellular regulatory domains and Homer binding site also result in changes
in mGluR1a subcellular localization, signalling and cell morphology. Taken together, these
results indicate that GPCR signalling is significantly modulated by the association of
intracellular regulatory proteins that can be influenced by receptor structure.
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CHAPTER 1
INTRODUCTION

1

1.1.

THE G PROTEIN-COUPLED RECEPTOR SUPERFAMILY
The seven transmembrane-spanning G Protein-Coupled Receptor (GPCR)

superfamily is the largest family of cell-surface receptors that is comprised of more than
650 receptor proteins. Based on structure-function and crystallographic structure of
rhodopsin and, more recently the β2-adrenergic receptor (β2AR), GPCRs are
characterised by extracellular amino-terminal regions, followed by seven transmembranespanning domains separated by three extracellular and three intracellular loop domains
and finally an intracellular carboxyl-terminal tail (Palczewski et al., 2000; Cherezov et
al., 2007; Rasmussen et al., 2011; Tebben and Schnur, 2011). GPCRs are categorized into
six classes based on sequence homology, ligand activation and G protein coupling: the
largest class A or rhodopsin-like receptors; class B, secretin-like, many of which are
regulated by peptide hormones from the glucagon hormone family and class C, the
metabotropic glutamate receptors characterized by the large venus fly trap like amino
terminus ligand binding pocket; Class D the Gαi-associated pheromone receptors; Class E
the D. discoïdeum - specific cAMP receptors; and finally the Frizzled/Smoothened
family, activated by Wnt ligands (Bockaert and Pin, 1999; Foord et al., 2005; Fredriksson
et al., 2003; Kolakowski, 1994; Sharman et al., 2011; Bockaert and Pin, 1999).
1.2.

RECEPTOR SIGNALLING

1.2.1. G Protein-Dependent Signal Transduction Paradigm
GPCRs couple to and activate cognate heterotrimeric guanine-nucleotide binding
(G) proteins, which in turn transduce the GPCR signal through coupling to downstream
effector molecules (Neer, 1995). Heterotrimeric G proteins are comprised of α, β and γ
2

subunits, which associate with the plasma membrane in a variety of ways, including lipid
modification and association with membrane-bound proteins (Casey, 1994). Also called
molecular switch proteins, the α subunit of the G protein cycles between the inactive
guanosine 5’-diphosphate (GDP) bound state and becomes activated when GDP is
exchanged for guanosine 5’-triphosphate (GTP) (Neer, 1995). In addition to the G
protein’s endogenous GTP hydrolysis activity, several proteins assist the G protein
through this cycle including: 1) guanine nucleotide exchange proteins (GEFs), which
facilitate the exchange of GDP for GTP, and 2) GTPase activating proteins (GAPs),
which enhance GTP hydrolysis and regulators of G protein signalling (RGS) (Siderovski,
2005). The classical GPCR signalling paradigm begins with ligand activation of the
GPCR, which induces a conformational change in the receptor, such that it can associate
with its cognate heterotrimeric G protein and act as a GEF by exchanging GDP for GTP
on the α subunit, thereby activating it. Once activated, the heterotrimeric G protein
dissociates into the functional α and the βγ subunits to target downstream effector
molecules.
There are four classes of α subunits (Neer, 1995; Gilman, 1987). Gαs activates
membrane-bound adenylyl cyclase (AC) stimulating the formation of the second
messenger molecule cyclic adenosine 5’ monophosphate (cAMP) and the activation of
cAMP-dependent protein kinase-A (PKA). Conversely, Gαi inhibits AC, decreasing
cAMP generation and decreasing PKA activity. Gαq/11 proteins activate phospholipase C
(PLC), which in turn hydrolyzes the membrane phospholipid, phosphatidylinositol 4,5bisphosphate (PtdIns (4,5)P2, or PIP2), into inositol trisphosphate (IP3) and
diacylglycerol (DAG). IP3 then activates endoplasmic reticulum localized IP-gated
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calcium channels, releasing intracellular calcium stores, which triggers protein kinase C
(PKC) translocation to the plasma membrane, where it is co-activated by DAG. Finally,
Gα12/13 activates Rho and other small G proteins leading to the rearrangement of the actin
cytoskeleton (Suzuki et al., 2009). The activation of these second messenger-dependent
kinases triggers a phosphorylation cascade of membrane associated, intracellular and
nuclear signalling scaffolding proteins and transcription factors leading to immediate and
long term functional changes in the cell.
1.2.2. G Protein-Independent and Non-Classical Signal Transduction
In addition to these classical heterotrimeric G protein signalling pathways, Gαq/11coupled receptor-mediated activation of PKC also triggers the phosphorylation of Raf-1,
thus activating mitogen activated kinases (MAPK) and extracellular signal-related
kinases (ERK) (Luttrell, 2002). ERK activation by GPCRs is also mediated by adaptor
molecules such as β-arrestin, transactivation of receptor tyrosine kinases and ion
channels, downstream activation of intracellular tyrosine and serine/threonine kinases
such as Src and Pyk2 and Gβγ-mediated mechanisms (Luttrell, 2002; van Biesen et al.,
1995).

For example, Pyk2 uncouples metabotropic glutamate receptor G protein

signalling, but facilitates ERK1/2 activation (Nicodemo et al., 2010). Meanwhile,
endothelin-1-induced ERK activation and is predominantly regulated by EGFR
transactivation (Kodama et al., 2003). Activated MAP kinases then regulate the
phosphorylation and activation of transcription factors related to cell growth.

4

1.2.3. Agonists and Functional Agonism
Ligands are characterized via their affinity for cognate receptors, and their
efficacy of signalling and functional responses. Therefore, ligands can be classified as
full agonists (eliciting maximal possible receptor response), partial agonists (submaximal response), neutral antagonists (occupies ligand binding region of receptor, yet
elicits no signalling response, positive or negative), or inverse agonists (reduced ligandindependent, basal receptor activity) (Kenakin, 2002). Traditionally, ligand functionality
was considered to be constant at a given receptor, eliciting the same response regardless
of receptor location, and differences in receptor response were considered to be due to
differentially expressed signal transduction machinery. For example, several GPCRs,
including the vasopressin and angiotensin II receptors have been shown to couple to
multiple G proteins generating divergent signal transduction pathways (Gudermann et al.,
1996). Additionally, although β-arrestin was traditionally thought only to participate in
receptor desensitization and endocytosis, it is now clear that this adaptor molecule can
facilitate signal transduction through multiple pathways including MAPK, Src and PI3K
(Rajagopal et al., 2010).
However, emerging evidence suggests that ligands can induce unique, ligandspecific receptor conformations resulting in differential activation of signal transduction
pathways. Additionally, ligands with the same intrinsic activity can display different
relative potency to divergent signalling pathways activated by the same receptor. This
phenomenon, sometimes termed functional selectivity or biased agonism has been
reviewed by Kenakin and Miller, 2010, Rajagopal et al., 2010 and Kenakin, 2011.
Ligand-induced functional selectivity has been well-characterized for dopamine and
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serotonin receptors. Activation of the 5-HT2C receptor by agonists such as quipazine
preferentially activates PLC while other agonists including LSD activate PLA2 (Berg et
al., 1998).
One way biased agonists may function is by stabilizing a receptor conformation
favourable for association with different downstream molecules. For example, the βAR
inverse agonist carvedilol triggers Gαs-independent, β-arrestin-dependent EGFR
activation leading to downstream ERK phosphorylation while β2AR activation by
cyclopentylbutanephrine biases the receptor toward β-arrestin-dependent MAPK
activation relative to isoproterenol (Azzi et al., 2003; Noma et al., 2007; Drake et al.,
2008).
Multiple amino acid residues in various GPCRs have been shown to play a role in
functional selectivity. For example, μ-opioid receptor stimulation by different agonists
results in site-specific patterns of serine (ser) and threonine (thr) phosphorylation in the
second intracellular loop of the receptor, resulting in differential receptor endocytosis
patterns and targeting the receptor toward either PKCε or ERK signal transduction
pathways (Doll et al., 2011; Zheng et al., 2011). Mutation of histidine 393 in the sixth
transmembrane domain of the dopamine D2L receptor abolishes the functional selectivity
exhibited by the wild type receptor whereas ligand modification at the site of histidine
393 interaction biases the signalling towards ERK1/2 phosphorylation (Tschammer et al.,
2011).
1.2.4. Receptor Desensitization
Ligand activation of GPCRs also results in a cascade of events ultimately leading
to decreased receptor signalling. This process, termed desensitization, is crucial to
6

prevent aberrant or chronic receptor over-stimulation. There are multiple mechanisms of
receptor desensitization ranging from immediate G protein uncoupling to degradation of
the receptors and transcriptional down-regulation (Ferguson, 2001).
1.2.4.1.

Receptor Phosphorylation
Phosphorylation is the most rapid desensitization response to receptor activation,

occurring within seconds to minutes after receptor activation. GPCR phosphorylation
occurs mainly at Ser and Thr residues within the carboxyl-terminal tail and third
intracellular loop (Ferguson and Caron, 1998; Kohout and Lefkowitz, 2003; Krupnick
and Benovic, 1998; Pierce et al., 2002). The addition of large, negatively charged
phosphates to the intracellular loops and C-tail of receptors desensitizes receptor
signalling by interfering with G protein-coupling, as well as facilitating recruitment of
adaptor proteins for internalization. Receptor phosphorylation can be carried out both
homologously and heterologously by second messenger-dependent protein kinases (PKA
and PKC) or homologously by G protein-coupled receptor kinases (GRKs) (Figure 1.1.).
Phosphorylation by either type of kinase can lead to decreased receptor signalling.
However, GRK phosphorylation results in desensitization via recruitment of the adaptor
molecules called β-arrestins (Benovic et al., 1987; Lohse et al., 1990b; Pippig et al.,
1993). β-arrestins associate exclusively with ligand-activated and GRK-phosphorylated
GPCRs and functions in two ways to desensitize the receptor: first, β-arrestin physically
uncouples the receptor from the G protein and secondly they recruit the endocytic
machinery required to facilitate the endocytosis of the receptor.
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Figure 1.1. Schematic diagram illustrating the agonist-induced desensitization of
GPCRs via phosphorylation. Agonist binding triggers second messenger generation,
leading to activation of second messenger-dependent kinases (PKA and PKC). Receptor
activation also allows for the recruitment of G protein-coupled receptor kinases (GRK),
which associate with and phosphorylate exclusively agonist-activated receptors
(homologous desensitization). In addition to homologously phosphorylating agonistactivated receptors, second messenger-dependent protein kinases can also phosphorylate
non-activated receptors (heterologous desensitization).
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1.2.2.4.

Second-Messenger-Dependent Protein Kinase
GPCR-stimulated second messenger generation of molecules such as cAMP and

ca2+ leads to the activation of second messenger dependent kinases, which in turn
phosphorylate downstream target proteins. Second messenger dependent kinases PKC
and PKA function to transfer the high energy γ phosphate from adenosine 5’ triphosphate
(ATP) to target serine and threonine residues contained within specific consensus sites of
proteins (Taylor et al., 1988). Protein phosphorylation cascades generate short and long
term changes in cell signalling and function, however, these kinases can also feedback
phosphorylate GPCRs within their intracellular loops and carboxyl terminal tails (Smith,
1998; Eason et al., 1995; Bouvier et al., 1988). However, so long as the necessary
consensus sequence is present on the target GPCR, second messenger dependent kinases
do not discriminate upon receptor activation state or, indeed receptor type. This process is
termed heterologous desensitization (Hausdorff et al., 1989; Lohse et al., 1990a).
1.2.4.2.

G Protein-Coupled Receptor Kinases
The GRK family of protein kinases contain a central catalytic domain flanked by

a carboxyl terminal membrane targeting domain and an amino terminal RGS-like domain
hypothesised to be responsible for substrate recognition (Pitcher et al., 1998; Stoffel et
al., 1997). The seven GRK family members are sub-classified into three groups based on
sequence homology and functional similarity (Figure 1.2). The groups are: 1) visual
GRKs, GRK1 (rhodopsin kinase) and GRK7, (Shichi and Somers, 1978; Weiss et al.,
1998), 2) GRK2 (β adrenergic receptor kinase 1, βARK1) and GRK3 (β adrenergic
receptor kinase 2, βARK2) (Benovic et al., 1986; Benovic et al., 1991) and 3) GRK4,
GRK5 and GRK6 (Benovic and Gomez, 1993; Kunapuli and Benovic, 1993; Premont et
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al., 1994; Sallese et al., 1994). The plasma membrane targeting of the different GRK
groups is mediated by mechanisms involving their carboxyl-terminal domains. GRK1
and GRK7 are farnesylated at CAAX motifs in their carboxyl termini while GRK2 and
GRK3 contain a carboxyl-terminal βγ-subunit binding pleckstrin homology domain
(Pitcher et al., 1998). The GRK5 carboxyl-terminal domain contains a stretch of 46 basic
amino acids that allow plasma membrane phospholipid interactions and finally, GRK4
and GRK6 are palmitoylated at cysteine residues (Premont et al., 1996; Shaw, 1996;
Stoffel et al., 1994; Stoffel et al., 1998).
1.2.4.3.

Arrestin
GRK phosphorylation is usually not sufficient for GPCR desensitization and

requires the association of arrestin molecules to agonist-activated, GRK-phosphorylated
GPCRs. There are four arrestin family members categorized into two groups; 1) visual
and cone arrestin are expressed exclusively in the retina while 2) β-arrestin-1 (arrestin 2)
and β-arrestin-2 (arrestin 3) are ubiquitously expressed, though they show enhanced
localization in neuronal tissues (Ferguson, 2001; Krupnick and Benovic, 1998;
Lefkowitz, 1993). Arrestins associate preferentially with agonist-activated, GRKphosphorylated GPCRs, as opposed to unphosphorylated or second messenger-dependent
kinase phosphorylated receptors (Lohse et al., 1990b; Lohse et al., 1992). β-arrestin is an
important player in clathrin-mediated GPCR internalization. Once β-arrestin associates
with agonist-activated and GRK-phosphorylated GPCRs, it recruits AP2 and clathrin,
initiating receptor endocytosis (Ferguson et al., 1996; Goodman et al., 1996; Laporte et al
1999). The role of β-arrestin in GPCR desensitization and endocytosis is discussed in
detail in section 1.3.2.1.
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Figure 1.2. Schematic representation of the GRK family structure. The aminoterminus contains the conserved regulator of G protein signalling (RGS) homology
domain (RH) while the divergent carboxyl-terminal domains participate in GRK plasma
membrane targeting. GRK1 and 7 are farnesylated within the CAAX motifs, GRK4 and 6
are palmitoylated and GRK5 contains a 46 basic amino acid stretch that allows
association with membrane phospholipids. Finally, GRK2 and 3 contain Gβγ binding
motifs similar to pleckstrin homology domains. Figure adapted from Ferguson, 2001.
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1.2.4.4.

Phosphorylation-Independent Desensitization
Phosphorylation of intracellular residues of agonist activated receptors is the most

widely studied and best understood form of receptor desensitization. However, it is now
appreciated that phosphorylation-independent mechanisms of receptor desensitization
also exist. Phosphorylation-independent desensitization has been shown for the
endothelin A and B receptors, as well as the follicle-stimulating hormone receptor,
histamine H2 receptor, m3 muscarinic acetylcholine and metabotropic glutamate receptor
1a (mGluR1a) (Dhami et al., 2002; Ferguson, 2007; Fernandez et al., 2011; Reiter et al.,
2001; Shibasaki et al., 1999; Willets et al., 2004).
GRK catalytically inactive mutants are sufficient for desensitization of 5HT1B
and parathyroid hormone receptors. While GRK2 does phosphorylate agonist activated
mGluR1a, physical association between GRK2, Gαq/11 and mGluR1a is sufficient for
this receptor’s desensitization in a phosphorylation independent manner, partially though
the GRK2 RGS homology (RH) domain (Dhami et al., 2002; Flannery and Spurney,
2001; Lembo et al., 1999). Other proteins have been implicated in phosphorylationindependent GPCR desensitization. For example, the huntingtin-binding and Rab8
effector molecule optineurin has been shown to associate with group I mGluRs to
physically uncouple the receptor from G protein (Anborgh et al., 2005).
1.2.4.5.

GPCR Down-Regulation

In addition to the immediate phosphorylation by GRKs and second messengerdependent kinases and clathrin-mediated internalization of activated receptors, other
down-regulation mechanisms are employed to decrease the total cellular compliment of
receptors in response to prolonged or repeated agonist stimulation. Receptor down12

regulation is achieved via proteosomal and lysosomal GPCR degradation, modulation of
receptor gene transcription, RNA stability and translation (Tsao and von Zastrow, 2000;
Bouvier et al., 1989).
1.2.4.6.

GPCR Proteolytic Degradation
Two specific compartments contribute to the proteolytic degradation of GPCRs,

the proteosome and lysosome (Hislop et al., 2011; Clague and Urbe, 2010). Proper cell
signalling requires selective trafficking of membrane proteins to lysosomes for
degradation. A major mechanism of lysosomal targeting involves protein ubiquitination
on lysine residues and sorting via the endosomal sorting complex required for transport
(ESCRT) machinery (Katzmann et al., 2001). Proteosomal degradation of cytosolic
proteins is signalled by polyubiquitination whereas multiple monoubiquitination or
polyubiquitination signals membrane proteins for lysosomal sorting and degradation.
Ubiquitinylated proteins are not recycled back to the plasma membrane, but instead are
sorted into intraluminal vesicles in endosomes, forming multivesicular bodies. When
these MVBs fuse with lysosomes, lipases degrade the ILV membrane as well as the
transmembrane proteins (Marchese et al., 2008; Katzmann et al., 2002). Mu-opioid
(MOR) and β2AR both undergo agonist-dependent ubiquitination and receptor
degradation and β2AR mutation of Lys residues internalizes normally, but does not
downregulate in response to prolonged agonist exposure (Hislop et al., 2011; Xiao and
Shenoy, 2011). However, several GPCRs including delta-opioid (DOR) have been shown
to target to lysosomes independent of ubiquitination (Tanowitz and Von Zastrow, 2002).
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1.2.4.7.

Transcriptional Downregulation
Total cell receptor loss involves not only degradation of existing receptor

proteins, but also alterations in receptor transcription and translation. Interestingly, GPCR
activation of second messenger dependent signalling may function as positive or negative
feedback regulators of GPCR gene and protein expression. For example, cAMP
activation induces PKA-mediated β2AR phosphorylation and also decreases the level of
β2AR mRNA, ultimately decreasing receptor population while serotonin treatment of C6
glioma cells leads to a PKC-dependent decrease in 5HT2A receptor mRNA levels (Anji
et al., 2001; Bouvier et al., 1989). Other GPCRs, including AT1R, dopamine D1 and
thyroid-stimulating hormone receptors also show agonist-induced decreases in receptor
mRNA (Collins et al., 1992).
1.3.

GPCR TRAFFICKING
Intracellular trafficking is a crucial mechanism to ensure proper targeting and

function of receptor signalling and deregulated trafficking has been shown to play a role
in multiple disorders and pathologies. This section will highlight the major steps in
receptor intracellular trafficking as it relates to function and signalling.
1.3.1. ER/Golgi to Plasma membrane
As transmembrane proteins, GPCRs are synthesized and processed in the
endoplasmic reticulum (ER). Folding and post-translational modifications such as
glycosylation and ubiquitination, oligomerization take place in this compartment as well
as association with accessory proteins (Braakman and Bulleid, 2011). Accumulating
evidence suggests that receptor dimerization is necessary for correct plasma membrane
targeting for some GPCRs and there are reports of dimerization mutations in hormone14

activated GPCRs that result in ER retention. One example of this is heterodimerization
of GABAB receptor subunits, which masks an ER retention sequence in the C-terminus of
GABAB and allows the dimer to reach the plasma membrane (Margeta-Mitrovic et al.,
2000). It is becoming clear that proper receptor targeting and function is dependent on
dimer formation. For example, the GABAB receptor requires both GABAB1 and GABAB2
subunits in order to reach the plasma membrane as well as activate G proteins (Duthey et
al., 2002; Pin et al., 2004). Dimerization is also essential for receptor-G protein coupling.
GABAB1 requires co-expression with GABAB2 in order to couple functionally to the Gprotein signalling cascade (Galvez et al., 2001; Margeta-Mitrovic et al., 2000). This is not
just due to plasma membrane localization as a mutant form of GABAB1 that lacks its ER
retention signal and can reach the cell surface on its own still requires GABAB2 for
functional activity (Margeta-Mitrovic et al., 2000).

Additionally, heterodimerization

between the α1D- and α1B-adrenoceptors, was shown to be necessary for the proper cellsurface expression of the α1DAR subtype (Hague et al., 2006).
1.3.2. Receptor Internalization
The internalization and intracellular trafficking of GPCRs is a highly regulated
process that, in addition to contributing to GPCR desensitization, is also required for
receptor dephosphorylation and resensitization (Ferguson, 2001). GPCRs may internalize
in either a constitutive manner or in response to agonist activation: once the receptor is
desensitized at the cell surface, it must then be internalized into the cell where it is
sequestered or targeted for resensitization or degradation (Figure 1.3) (Ferguson, 2001).
There are multiple means of receptor internalization employed by the cell including lipid
rafts, caveolin, pinocytosis and the most common, clathrin-mediated endocytosis.
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Figure 1.3. Clathrin-mediated endocytosis and intracellular trafficking of agonistactivated receptors. Ligand-activated receptors are phosphorylated on intracellular
residues by G protein-coupled receptor kinases (GRKs) and bound by the adaptor protein,
β-arrestin (βarr). β-arrestin then recruits the clathrin adaptor protein, AP2 as well as
clathrin, which assembles to form clathrin-coated pits. The GTPase dynamin severs the
pit from the membrane, forming a clathrin coated vesicle. Once internalized, clathrin
uncoats from the vesicle, during which arrestin may or may not also dissociate from the
receptor. The vesicle is then trafficked to early endosomes, where the acidic pH
facilitates agonist dissociation from the receptor and phosphates are removed by G
protein-coupled receptor phosphatases (GRP). Internalized receptors may be sequestered
in early endosomes, trafficked to the lysosome and degraded or recycled back to the
plasma membrane as a fully functional receptor.
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1.3.2.1.

Clathrin-mediated Endocytosis
Clathrin is a triskelion membrane coat protein that when assembled, forms a

polyhedron lattice, which surrounds membrane and encourages invagination and clathrincoated pit formation (Hinrichsen et al., 2006; Kirchhausen and Harrison, 1981). Clathrin
coated vesicles transport molecules from the plasma membrane, endosomes and transGolgi network. Several adaptor molecules, including adaptor protein-2 (AP-2), epsin and
β-arrestin recruit clathrin and other accessory proteins to the site of invagination and
facilitate clathrin assembly (Wolfe and Trejo, 2007). β-arrestin is an important player in
clathrin-mediated GPCR internalization. Once β-arrestin associates with agonist-activated
and GRK-phosphorylated GPCRs, it recruits AP2 and clathrin, initiating receptor
endocytosis (Ferguson et al., 1996; Goodman et al., 1996; Laporte et al 1999). Once the
clathrin coated pit is formed, the GTPase dynamin severs the pit from the membrane, thus
forming a clathrin-coated vesicle (Ungewickell and Hinrichsen, 2007; Praefcke and
McMahon, 2004).
1.3.3. Early Endosomal Sorting and Trafficking
Once the coated vesicle is internalized, clathrin disassembles and uncoates the
vesicle (McMahon and Boucrot, 2011). Internalized receptor is trafficked to the early
endosome where it can be sorted for retention, recycling or degradation. A key
determinant of receptor fate occurs in the process of uncoating, when β-arrestin may or
may not also dissociate from the internalized receptor (Oakley et al., 2000). Class A
receptors, such as the β2 adrenergic receptor and α1b adrenergic receptor contain few
phosphorylation sites and therefore form a transient association with β-arrestin 1 and 2.
However, class B receptors, including AT1 and V2 vasopressin receptors contain multiple
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phosphorylation sites and form high affinity, prolonged association with arrestins
(Anborgh et al., 2000; Oakley et al., 2000; Zhang et al., 1996). The presence of clusters
of phosphorylated Ser and Thr residues in some GPCRs may stabilize the interaction with
arrestins (Oakley et al., 2000). β-arrestin dissociation is assumed to allow access for
protein phosphatases to cleave phosphates from the receptor, which in turn allows the
receptor to recycle and resensitize at the cell surface, but there is no direct experimental
evidence to support this assumption (Lefkowitz, 1998). However, if β-arrestins cannot
dissociate, phosphatases are unlikely to access the phosphorylated receptor and
dephosphorylate and resensitize the receptor (Ferguson and Caron, 1998; Ferguson et al.,
1998; Ferguson, 2001; Ferguson, 2007).
1.3.3.1.

Recycling Endosomes

Recycling and resensitization of internalized receptors to the plasma membrane
represents a much more efficient way to re-initialize signal transduction than novel
receptor synthesis. GPCR sorting into the recycling pathway can either occur via a
default trafficking mechanism or through a regulated process. Studies of nutrient
receptors supported the idea that receptor recycling occurs via a default “bulk” membrane
flow from endosomes to the plasma membrane (Gruenberg, 2001; Gruenberg and
Stenmark, 2004; Maxfield and McGraw, 2004; Mayor et al., 1993). However, this model
does not allow for the dependency of GPCR recycling on specific protein interactions
(Anborgh et al., 2000; Cao et al., 1999; Dale et al., 2004; Seachrist et al., 2000). Many
GPCRs, including β2AR, μ-opioid and endothelin receptors contain specific plasma
membrane sorting sequences, necessary for endocytic delivery back to the cell surface
(Cao et al., 1999; Paasche et al., 2005; Tanowitz and von Zastrow, 2003). Many GPCR
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recycling sequences, including those found on the β1AR and β2AR encode motifs
recognized by a variety of postsynaptic density 95/disc large/zonula occludens-1 (PDZ)containing proteins. Other protein trafficking molecules, such as Rab small G proteins
(discussed in detail below) also differentially regulate receptor recycling.
1.3.3.2.

Lysosomes

Lysosomes are acidic intracellular membrane-bound organelles distinguished
from endosomes by their lack of mannose-6-phosphate receptor (Luzio et al., 2007).
Lysosomes contain lysosomal-associated proteins, lysosomal integral membrane proteins
I and II, lysosomal acid phosphatase and acid hydrolases, which function optimally at
acidic pH. As mentioned above, a major mechanism for endosome-lysosome trafficking
involves the ESCRT machinery targeting ubiquitinated GPCRs to the lysosome. For
example, lysines in the third intracellular loop (Lys-263 and Lys-270) and in the carboxyl
tail (Lys-348, Lys-372, and Lys-375) of the β2AR are involved in ubiquitination and
lysosomal degradation (Xiao and Shenoy, 2011). There are, however, multiple other
mechanisms of lysosomal targeting, including GPCR-associated sorting proteins (GASP)
and sorting nexin-1 (Gaborik and Hunyady, 2004; Tanowitz and von Zastrow, 2002).
Additionally, lysosomal targeting may involve Rab5 and/or Rab7 as discussed in detail in
later sections (Seachrist and Ferguson, 2003).
1.3.4. Role of the Receptor Carboxyl-Terminal Tail in Trafficking
While it is well known that the C-tails of GPCRs mediate receptor desensitization
through phosphorylation of serine and threonine residues and the association with βarrestin, there is also much evidence to support the importance of GPCR C-tails in the
coordination of receptor intracellular trafficking. Chimeric receptor constructs
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demonstrate specific residues that determine the fate of different receptors. For example,
chimeric receptors in which the C-tails of β2AR and AT1R were exchanged demonstrated
that the C-tail of β2AR does not form a stable association with β-arrestin, which may
account for this receptor’s rapid and efficient recycling (Anborgh et al., 2000).
Meanwhile, although wild type AT1R is neither dephosphorylated nor recycled, a
chimeric AT1R containing the β2AR C-tail does dissociate from β-arrestin and promotes
partial receptor recovery.
Many proteins involved in protein scaffolding and/or transport associate with
GPCR C-tails. Molecules such as PDZ-containing proteins associate with GPCRs via
protein modular domains commonly found in the carboxyl-terminal tail to mediate
protein targeting (Cao et al., 1999; Magalhaes et al., 2011; Romero et al., 2011; Xia et al.,
2003). The Homer family of proteins contain Enabled/VASP Homology-1 (EVH-1)
domains that associate with a proline-rich region in the C-tails of mGluR1/5 and α1DAR
(Roche et al., 1999). Homer proteins regulate the targeting of mGluRs to different
subcellular compartments, mediate their insertion into the plasma membrane and
facilitate receptor activation (Ango et al., 2002; Ciruela et al., 1999; Coutinho et al.,
2001; Roche et al., 1999; Tadokoro et al., 1999).
Other protein trafficking molecules have also been shown to associate with the
C-tail of GPCRs to mediate receptor localization. For example, Rab5a has been shown to
interact with the AT1AR carboxyl-terminal tail and retain the receptor in Rab5a-positive
early endosomes (Seachrist et al., 2002; Dale et al., 2004).

Rab11 binding to the

thromboxane A2 receptor is mediated by residues 335-345 that are localized within the
central region of the thromboxane A2 receptor carboxyl-terminal tail and Rab11 binding
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to the β2AR involves a bipartite binding motif, with arginine 333 and lysine 348
representing the essential amino acid residues mediating Rab11 binding to the receptor
(Hamelin et al., 2005; Parent et al., 2009).
1.4.

EFFECTS OF INTRACELLULAR TRAFFICKING ON GPCR
SIGNALLING
Agonist-activation of signal transduction cascades through GPCRs comprises

both G protein-dependent and -independent signalling resulting in parallel signalling
cascades and complex signalling networks. Because cells express hundreds of different
receptors, a mechanism to organize signal cascades must be put in place. One major
mechanism of spatiotemporal signal organization includes protein intracellular trafficking
(Jean-Alphonse and Hanyaloglu, 2011). In addition to rapid and effective signal
desensitization, the endocytosis and intracellular trafficking of GPCRs can spatially and
temporally determine G protein-dependent and independent signalling pathways.
Receptors such as the β2AR, which recycle quickly and efficiently also resensitize to
persistent or repeated agonist activation whereas receptors such as AT1R, which are
retained in early endosomes remain desensitized much longer (Anborgh et al., 2000;
Oakley et al., 2000). However, chronic GPCR stimulation may cause altered GPCR
trafficking away from the recycling to the degradative pathway leading to receptor
downregulation (Hislop et al., 2011; Xiao and Shenoy, 2011). Conversely, GPCR
recycling has been shown to actually change the signalling of the receptor. For example,
β2AR endocytosis and recycling switches the receptor’s traditional coupling with Gαs to
Gαi (Wang et al., 2007).
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Membrane trafficking of GPCRs provides novel compartments for G protein
signalling. GPCR signalling via heterotrimeric G proteins is traditionally associated with
the plasma membrane. However, recent studies indicate that GPCRs may also associate
with and signal through their cognate G proteins at intracellular sites. Membrane
permeable agonists also suggest that GPCRs such as the V2 vasopressin receptor and
estrogen receptor GPR30 signal from the ER/Golgi (Revankar et al., 2005; Robben et al.,
2009). Meanwhile, the β2AR has been shown to be pre-associated with its heterotrimeric
G proteins as well as adenylyl cyclase II in the ER (Dupre et al., 2006; Dupre et al.,
2007).
Few GPCRs have been shown to co-localize with their G proteins at the
endosomes and display persistent, internalization-dependent G protein signalling. In S.
cerevisiae, the Gα protein translocates to the endosome where it stimulates PI3K, while
in mammalian cells, lysophosphtidic acid treatment causes Gβγ to associate with Rab11a,
PI3K and PKT at the endosome (Garcia-Regalado et al., 2008; Slessareva and Dohlman,
2006; Slessareva et al., 2006). FRET-based measurement of the cAMP sensitive EPAC
molecule showed that parathyroid hormone receptor (PTHR) and thyroid-stimulating
hormone receptor (TSHR) internalization is required for sustained Gαs signalling from
the endosomal compartment (Calebiro et al., 2010a; Calebiro et al., 2010b; Calebiro et
al., 2009; Jalnik and Moolenaar, 2010).
It is also well established that GPCRs can mediate non-G protein signalling
pathways from endosomes, mainly via GPCR/β-arrestin complexes, that scaffolds
association with MAPK molecules and tyrosine kinases (DeWire et al., 2007). This was
first reported in studies inhibiting receptor internalization when overexpression of either
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dominant negative β-arrestin or dynamin prohibited β2AR-induced ERK activation
(Daaka et al., 1998; Lin et al., 1998; Luttrell et al., 1997). It was later shown that βarrestin couples β2AR to Src in order to mediate ERK1/2 phosphorylation (Luttrell et al.,
1999). Similarly, phosphorylation of protease-activated receptor-2 (PAR-2) is not
required for β-arrestin recruitment and internalization, but a phosphorylation-deficient
PAR-2 mutant is unable to facilitate β-arrestin-dependent MAPK activation (DeFea et al.,
2000). Meanwhile, PAR-2 can increase PI3K activity through a Gαq/calcium-dependent
pathway involving PYK2 and Src, while inhibiting PI3K activity through a β-arrestindependent mechanism (Wang and DeFea, 2006). It has been proposed that β-arrestin
facilitates ERK activation by recruiting and scaffolding members of the MAPK pathways
to internalizing vesicles or endosomes (DeWire et al., 2007; Luttrell et al., 2001; DeFea
et al., 2000). Moreover, anchoring activated ERK to endosomes may prevent ERK
translocation to the nucleus, thus encouraging cytoplasmic ERK signalling (Figure 1.4).
This suggests an important spatial role, as well as temporal control, for GPCR membrane
trafficking.
Less well understood are the direct and indirect roles of GPCR signal
transduction on regulation of trafficking machinery, though it has been proposed that
receptors participate in modulation of their own intracellular trafficking (Seachrist et al.,
2002; Yudowski et al., 2009). AT1AR activation causes GTP binding of Rab5a, while
PKA activation by β2AR regulates Rab4, but not Rab11 recycling pathways and β2AR
also modulates the Rab8 geranyl-geranylation, altering the ability of Rab8 to associate
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Figure 1.4. GPCR-mediated activation of ERK1/2 signalling. A) Agonist-activation of
receptors leads to downstream activation of protein kinase-C (PKC), which can activate
Raf, initiating the MAP kinase cascade. Phosphorylated and activated ERK then
translocates to the nucleus where it regulates gene transcription through phosphorylation
of transcription factors. B) β-Arrestin associates with agonist-activated, GRKphosphorylated receptors and acts as a scaffold, recruiting tyrosine kinases such as Src, as
well as components of the MAP kinase cascade. β-arrestin-mediated scaffolding retains
activated ERK in the cytosol where it phosphorylates target proteins.
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with membranes, and thus its activity. Additionally, p38 MAPK activation stimulates the
formation of Rab5-guanine dissociation inhibitor (GDI) complexes, thereby increasing
endocytosis (Lachance et al., 2011).
1.5.

ANGIOTENSIN II TYPE 1 RECEPTOR
The Angiotensin II receptor family includes angiotensin II type 1 (AT1R), the

focus of this thesis, and type 2 (AT2R) receptors. The AT1R mediates the cardiovascular
effects of the AngII peptide hormone including vasoconstriction, angiogenesis,
atherosclerosis, glomerulosclerosis and cardiac cell growth and hypertrophy. AT2
receptors, on the other hand are expressed in the fetus, injured tissue, adult brain and
affect vascular tone and growth oppositely to AT1 receptors (de Gasparo et al., 2000).
1.5.1. AT1R Signalling
The AT1R is coupled through Gαq/11 to the activation of phospholipase Cβ
resulting in the formation of diacylglycerol and inositol 1,4,5 trisphosphate leading to the
release of intracellular calcium stores and the activation of PKC (de Gasparo et al., 2000).
AT1R also couples to Gαo/i in some tissues leading to inactivation of adenylyl cyclase and
decreased production of cyclic AMP and can also couple to the pertussis insensitive
Gα12/13, which mediate AngII-induced L-channel activation (de Gasparo et al., 2000).
AT1R can also mediate G protein-independent signalling mechanisms, such as mitogen
activated protein kinases (MAPK), JAK/STAT kinases, tyrosine kinase activation (Pyk2,
Src) and transactivation of growth factor receptors. Multiple amino acid residues
involved in G protein-coupling and phosphorylation have been isolated (Figure 1.5).
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Figure 1.5. Snake model identifying amino acid residues of the Angiotensin II Type
Receptor. Amino acid residues in the extracellular loop regions are involved in binding
the ligand AngII, while residues in the eighth helix are required for G protein-coupling.
Multiple serine and threonine residues in the carboxyl-terminal tail have been shown to
be phosphorylated and are required for desensitization.
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1.5.2. AT1R Desensitization, Endocytosis and Intracellular Trafficking
Agonist-activation of the AT1R also results in the attenuation of receptor
signalling as the consequence of receptor phosphorylation by G protein-coupled receptor
kinases (GRKs) and PKC. Agonist activation and GRK-mediated phosphorylation of the
AT1R facilitates the recruitment of the cytosolic adaptor protein, β-arrestin, which
functions to sterically uncouple the AT1R from the heterotrimeric G protein and targets
the AT1R for clathrin-mediated endocytosis (Freedman et al., 1995; Ferguson et al., 1995;
Ferguson et al., 1996; Opperman et al., 1996; Krupnick and Benovic, 1998; Ferguson,
2001; Ferguson, 2007). Once internalized, GPCRs may be either sequestered in early
endosomes, dephosphorylated and recycled back to the plasma membrane or targeted to
lysosomes for degradation (Ferguson, 2001; Gáborik and Hunyady, 2004; Seachrist and
Ferguson, 2003). In the case of the AT1R, the receptor is internalized as a complex with
β-arrestin and is retained in the early endosomal compartment and is not readily
dephosphorylated and recycled (Anborgh et al., 2000).
1.6.

THE METABOTROPIC GLUTAMATE RECEPTOR FAMILY
Glutamate is a major excitatory neurotransmitter whose actions are mediated

though two types of receptors: ionotropic and metabotropic glutamate receptors (Figure
1.6). Ionotropic glutamate receptors are ligand-gated cation channels subdivided into Nmethyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) and Kainite receptors based in agonist preference. Metabotropic glutamate
receptors (mGluR) are G protein-coupled receptors, which play an important role in
processes of synaptic plasticity, such as learning and memory, neuronal development, and
neurodegeneration. mGluRs are categorized into three classes based on sequence
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homology and G protein coupling (Niswinder and Conn, 2010). Group I mGluRs,
including mGluR1a, the focus of this thesis, and mGluR5 are primarily located
perisynaptically on the postsynaptic cell (Niswiender and Conn, 2010). The prototypic
mGluR1 has five splice variants (mGluR1a-e), which differ primarily in the length of the
carboxyl terminus (Conn and Pin, 1997). There are no alterations in G protein-coupling
between these variants as this is mediated by residues within the second and third
intracellular loops as well as the membrane proximal region of the c-tail (Figure 1.7).
Group II and III receptors are localized to both presynaptic and postsynaptic terminals
and are negatively coupled to adenylyl cyclase and inhibit action of L-, N- and P/Q-type
VDCC, thus activating hyperpolarizing potassium currents. Activation of these receptors
leads to presynaptic inhibition of the release of neurotransmitters, including glutamate
(Conn and Pin, 1997).
1.6.1. Group I mGluR Signalling
Group I mGluRs are coupled through Gαq to activate PLC production of IP3 and
DAG generation leading to intracellular calcium release and PKC activation. These
receptors can also functionally activate a number of G protein-independent signal
transduction pathways including tyrosine kinases, mitogen activated kinases, ion
channels and other phospholipases. The tyrosine kinase Pyk2 uncouples mGluR Gprotein signalling, but facilitates extracellular signal-regulated kinases (ERK) 1/2
activation (Dhami and Ferguson, 2006; Kim et al., 2008; Niswender and Conn, 2010;
Ribeiro et al., 2010). ERK phosphorylates transcription factors such as cAMP response
element-binding protein (CREB) and Elk-1, facilitating immediate early gene expression
(Nicodemo et al., 2010). Via G proteins, mGluRs activate K+, Ca2+ and nonselective
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Figure 1.6. Schematic depiction of the glutamatergic synapse. Depolarization of the
presynaptic cell results in the membrane translocation of secretory vesicles, which release
glutamate into the synaptic cleft. Presynaptic Group I mGluRs (mGluR1/5) enhance
glutamate secretion while presynaptic Group II and III mGluRs inhibit secretion.
Glutamate diffuses through the synaptic cleft to activate numerous postsynaptic
glutamate receptors, ultimately resulting in increased calcium release in the postsynaptic
cell. Ionotropic glutamate receptor channels, including AMPA, NMDA and Kainate-type
channels are located in the postsynaptic density while metabotropic glutamate receptors
are predominately found perisynaptically.
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Figure 1.7. Snake model depicting amino acid residues of the metabotropic
glutamate receptor 1 (mGluR1). The mGluRs possess a large bi-lobed extracellular
amino-terminal, which folds to form the characteristic “venus fly trap” domain involved
in agonist binding. This agonist-binding domain is linked via a Cysteine-rich region to
the heptahelical transmembrane domains, linked by the intracellular loop domains
collectively responsible for G protein activation. Ligand binding to a receptor dimer
stabilises a closed conformation of the lobes, triggering intracellular signal transduction
by stabilising the two receptors in an active conformation. The carboxyl-terminal tail
contains numerous serine and threonine residues, which may be phosphorylated by
second messenger-dependent kinases as well as G protein-coupled receptor kinases. The
C-tail is also involved in the regulation of receptor function through interaction with
intracellular proteins including the Homer family and calmodulin. Figure adapted from
Dhami and Ferguson, 2006.
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cation channels have been shown to mediate long-term potentiation, as well as long-term
depression in neurons, involving mGluR1/5 activation or inhibition (respectively) of
AMPAR- or NMDAR-mediated transmission (Mao et al., 2008). mGluR activation of
phospholipase A2 (PLA2) can occur via PKC or ERK (Rozenjurt, 2007; Stella et al.,
1994). PLA2 hydrolyses glycerophospholipids generating arachidonic acid, which can
then be converted into pro-inflammatory eicosanoids. Phospholipase D (PLD) is
activated in both PKC-dependent and independent manners PLD activation by mGluRs in
astrocytes is dependent on PKC and small G proteins of the ARF family (Anwyl, 1999).
1.6.2. mGluR1 Desensitization, Endocytosis and Intracellular Trafficking
Desensitization and endocytosis of mGluRs abandons the GPCR paradigm as
mGluR1 undergoes constitutive, as well as agonist-induced endocytosis and mGluR1
desensitization includes phosphorylation-dependent and -independent mechanisms
(Ferguson, 2007; Dhami and Ferguson, 2006; Bhattacharya et al., 2004; Dhami et al.,
2005, Dhami et al., 2004; Dhami et al., 2002). Phosphorylation-independent mGluR
desensitization involves the GRK2 RGS homology domain associating with both the
receptor second intracellular loop and the alpha subunit of the heterotrimeric G protein
(Bhattacharya et al., 2004; Dale et al., 2000; Dhami and Ferguson, 2006; Ferguson,
2001b; Ferguson, 2007). Phosphorylation-dependent mGluR desensitization occurs via
receptor phosphorylation by second messenger-dependent kinases (PKC and CamKII)
(Dale et al., 2000; Dhami et al., 2002; Dhami et al., 2004). To date, many proteins have
been implicated in the desensitization of the mGluRs including GRK2, second messenger
dependent kinases, scaffolding and trafficking molecules, such as, the huntingtininteracting protein optineurin (Anborgh et al., 2005; Mundell et al., 2004; Mundell et al.,
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2003; Schoepp and Johnson, 1988). The endocytosis of mGluR1 is equally complex,
with differing partners contributing to constitutive versus agonist-induced internalization
and even different endocytic machinery depending on the agonist (Dhami and Ferguson,
2006). PKC activation is important for glutamate-induced mGluR1a internalization while
mGluR1 constitutive internalization can be mediated by scaffolding RalA along with
phospholipase D2 (PLD2) at the receptor (Bhattacharya et al., 2004a).
1.7.

SMALL G PROTEINS
The small, monomeric GTP-binding superfamily contains more than 100

members with molecular masses ranging from 20 to 30 kDa, classified into five
subfamilies based on structural similarity: Ras, Rho, Ran Arf and Rab family GTPases
(Figure 1.8) (Bhattacharya et al., 2004b; Mundell et al., 2003; Exton, 1998). Small G
proteins play essential roles in signal transduction, growth regulation, cell motility and
intracellular trafficking among other cellular processes. Ras family members (Ras, Rap
and Ral) typically regulate cell signalling events that lead to alterations in gene
transcription while the Rho family also regulates the actin cytoskeleton (Takai et al.,
2001; Wettschureck and Offermanns, 2005; Sah et al., 2000). Ran members regulate
microtubule organization and protein transport between the nucleus and cytoplasm (Bos,
1998). The Rab and Arf families control the formation, fusion, and movement of
vesicular traffic between different membrane compartments (Bos, 1998).
As guanine nucleotide binding proteins, members of this superfamily cycle
between the guanosine triphosphate (GTP) bound “active” state and the guanosine
diphosphate (GDP) bound “inactive state” and possess intrinsic GTP hydrolysis activity
(Lundquist, 2006; Zerial and McBride, 2001). In addition to their inherent GTPase
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Figure 1.8. The Ras superfamily of small G proteins. G proteins (also called GTPases)
cycle between the guanosine triphosphate (GTP)-bound active form and the guanosine
diphosphate (GDP)-bound inactive forms. In addition to the inherent hydrolyzing activity
of G proteins, GTP hydrolysis is assisted by GTPase accelerating proteins (GAP) while
the exchange of GDP for GTP is facilitated by guanine exchange factors (GEF). A large
class of G protein GEFs include GPCRs themselves. The superfamily of Ras small G
proteins are categorized into five subfamilies, including Ras, Raf, Rho, Arf, Rab and Ran.
While the Ras subfamily participates mainly in signal transduction events, Arf, Rab and
Ran family members facilitate intracellular membrane transport and Rho members
associate with the cytoskeleton.
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activity, many members of this family associate with accessory proteins including
GTPase activating (GAP) proteins, which accelerate GTP hydrolysis, as well as guanine
exchange factors (GEF), which facilitate the exchange of GDP for GTP (Bos, 1998;
Takai et al., 2001).
1.7.1. Overview of the Rab Family of Small GTPases
Ras-like in Brain (Rab) are the largest group of small Ras-like G proteins
comprising 11 members in yeast and over 60 in mammals (Ross, 2008; Rossman et al.,
2005). Rab family members regulate all aspects of intracellular membrane trafficking
from vesicular targeting, docking and fusion events. They participate in the transport of
nascent proteins from the trans-Golgi network (TGN), the exocytosis and endocytosis of
proteins, endocytic sorting and lysosomal degradation of membrane bound proteins
(Seachrist and Ferguson, 2003; Zerial and McBride, 2001; Stenmark, 2009). Rabs
reversibly associate with membranes via hydrophobic geranylgeranyl groups attached to
two C-terminal Cysteine residues. Rab escort proteins (REPs) capture newly synthesized
Rabs and present them to geranylgeranyl transferase before targeting them to the
appropriate membrane. GDP dissociation inhibitors (GDIs) recognize Rab-GDP and
prevent GDP release, while simultaneously chaperoning geranylgeranylated Rabs in the
cytosol and mediating their delivery to membranes or recycling them back to the cytosol.
GDI displacement factors (GDFs) recognize specific Rab-GDI complexes and promote
GDI release, thereby facilitating the association of Rabs with relevant membrane domains
(Hutagalung and Novick, 2011; Pfeffer and Aivazian, 2004).
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1.7.1.1.

Intracellular Localization of Rab Proteins
A unique and useful characteristic of Rabs is their tendency to occupy distinct

and predicable membrane microdomains (Figure 1.9) (Hutagalung and Novick, 2011;
Stenmark, 2009; Zerial and McBride, 2001). Rab1 and Rab2 are localized to the
endoplasmic reticulum and pre-Golgi area and mediate ER-Golgi trafficking. Rab 6, 33
and 40 are found at the Golgi and mediate intra-Golgi trafficking while Rab8 mediates
constitutive biosynthetic trafficking from the trans-Golgi network to the cell surface and
has also been implicated in Rab11 mediated recycling (Wang and Wu, 2012; Knodler et
al., 2010). Rab32 controls mitochondrial fission while Rab13 assembles epithelial cell
tight junctions. Autophagosome formation is regulated by Rabs 33 and 24 (Chua et al.,
2011; Marzescot and Zarhaoui, 2005; Alto et al., 2002).

Rab3, 26, 27 and 37 regulate

exocytic events and Rab27 mediates the translocation of melanosomes to the cell
periphery (Fukuda, 2008; Strom et al., 2002). Rab5 is localized to the plasma membrane,
early endosomes and phagosomes, where it participates in clathrin-mediated endocytosis
of plasma membrane proteins (Seachrist and Ferguson, 2003). Rab21 is implicated in
integrin endocytosis (Pellinen et al., 2006). Rab4 is localized to early endosomes and
recycling endosomes and is responsible for “fast” recycling of plasma membrane proteins
while Rab11, which is located in the perinuclear region and Rab35 mediates “slow”
recycling of plasma membrane proteins (Chua et al., 2010; Seachrist and Ferguson,
2003). Rab7 and Rab9 are located in late endosomes and lysosomes and traffic proteins
for degradation (Zerial and McBride, 2001). This thesis focuses on the management of
GPCRs by Rabs involved in the endocytic pathway including Rab4, Rab5, Rab7, Rab8
and Rab11 and will henceforth focus on these Rab family members (Figure 1.9).
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Figure 1.9. Rab Family members coordinate all aspects of endocytic trafficking.
Rab5 participates in clathrin-mediated endocytosis and early endosomal trafficking of
endocytic vesicles while Rab7 mediates the late endosomal and lysosomal trafficking of
proteins for degradation. Rab4 mediates the “fast” recycling route, directly from early
endosomes to plasma membrane while Rab11 mediates the “slow” perinuclear recycling
route. Rab8 participates in the plasma membrane targeting of nascent proteins and may
coordinate with Rab11 for recycling.
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1.7.1.2.

Structure of Rab Proteins
Like other members of the Ras superfamily of small G proteins, Rabs contain

the GTPase fold and COOH-terminal to the fold is the hyper-variable region as well as
the CAAX boxes containing two cysteines, which are posttranslationally modified with
the addition of a geranylgeranyl group, allowing the Rab to associate with membranes
(Ng and Tang, 2008; Stenmark, 2009; Zerial and McBride, 2001). The switch I and II
regions of Rabs are the area of nucleotide binding, and both switch regions make contact
with the γ phosphate of GTP. Effector molecules likely associate with the heterogeneous
switch domains along with the α3/β5 loop (a loop that connects α helix 3 with β sheet 5)
that lies adjacent to the switch II domain. Rab GTPases are differentiated from other
members of the Ras superfamily by a Rab-specific amino acid sequence F1-F5. Rab
GTPases are evolutionarily well conserved with 55-75% identity between orthologs from
yeast and mammals (Hutagalung and Novick, 2011; Pfeffer and Aivazian, 2004).
1.7.1.3.

Rab Interacting-Proteins
Rabs mediate targeting, docking and fusion of their cognate vesicles via

association with effector molecules and Rab interacting proteins (Zerial and McBride,
2001). Membrane tethering complexes often contain GEFs for Rabs that serve to recruit
them. For example, the Rab5 effector Rabaptin 5 is complexed with the Rab5 GEF
Rabex5, which amplifies Rab5 activation in microdomains of endosomal membranes
while Rab5 association with effectors Rabenosyn 5 and Early Endosomal Antigen 1
(EEA1) recruit members of the SNARE complex to coordinate tethering, docking and
fusion (Hutagalung and Novick, 2011).
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1.7.1.4.

Mechanisms of Rab Action
GTP bound Rabs can activate sorting adaptors to sort a receptor into budding

vesicles and via recruitment of PI kinases and phosphatases can alter PI composition and
trigger uncoating. Rabs can also mediate vesicle transport along actin filaments or
microtubules by recruiting motor adaptors or binding directly to motors. For example, the
plus-end-directed, actin-based motor protein myosin Vb facilitates protein trafficking in
Rab11a-specific recycling vesicles (Hutagalung and Novick, 2011; Pfeffer and Aivazian,
2004; Stenmark, 2009; Zerial and McBride, 2001). Rabs mediate vesicle tethering by
recruiting tethering factors that interact with SNARES or their regulators. Finally,
following membrane fusion, the Rab hydrolyzes GTP, thus associating with GDP and
therefore targeted by a GDI back to the donor membrane and then to a GDF.
Rab activity can be manipulated by specific functional mutations. These
mutations are design based on well-characterized amino acid substitutions in the p21ras
GTPase. Dominant negative and constitutively active Rab mutations are very useful
tools, which are frequently utilized to study the effect of Rab function in regulation of
membrane trafficking.
Dominant negative Rab mutations are created by substituting an amino acid in the
N-terminal (equivalent to p21ras S17N) or C-terminal (equivalent to p21ras N116I) of the
Rab nucleotide binding domain (Millman et al., 2008; Volpicelli et al., 2002). This forces
the Rab to be constitutively associated with a guanine nucleotide exchange factor, thus
preventing Rab activation and rendering the Rab defective in guanine nucleotide binding.
Constitutively active Rab mutations are created by substituting an amino acid in
the GTPase region, equivalent to the p21ras Q61L mutant, which exhibits reduced
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GTPase activity (Stenmark et al., 1994). Thus, the Rab does not hydrolyse GTP to GDP
and its activity is effectively non-regulated.
1.7.2. Rabs and Receptor Intracellular Trafficking
An explosion of Rab-mediated GPCR trafficking studies in recent years has
expanded our understanding of the different members of this family of small G proteins
affects the intracellular targeting of GPCRs.
1.7.2.1.

Rab4
Rab4 is involved in the transport of protein from early endosomes to the plasma

membrane via a direct, “fast” recycling route directly from early endosomes (Table 1.1.).
Rab4 is involved in the recycling of the AT1R, somatostatin receptor 3, corticotropin
releasing factor 1α receptor and β2 adrenergic receptor among others (Esseltine et al.,
2011; Yudowski et al., 2009; Holmes et al., 2006; Odley et al., 2004; Seachrist et al.,
2000).

Although the AT1R is not known to be efficiently recycled, fluorescence

resonance energy transfer (FRET) microscopy shows that during the early recycling
stage, internalized AT1Rs are associated with Rab4 in the cytoplasm whereas during the
mid-recycling stage, AT1Rs are associated with both Rab4 and Rab11 in the perinuclear
compartments (Esseltine et al., 2011; Hunyady et al., 2002; Seachrist et al., 2000).
Internalized CRF1α receptor transits from Rab5-positive early endosomes to Rab4positive recycling endosomes and CRF1α receptor resensitization is blocked by the
overexpression of wild-type Rab5 and Rab4 GTPases (Holmes et al., 2006). Meanwhile,
the apelin-13 internalized receptor is rapidly recycled to the cell surface through a Rab4dependent mechanism, while dominant negative Rab4 causes the receptor to be trafficked
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Table 1.1. Rab4-mediated GPCR trafficking and signalling
Receptor
Somatostatin 3
Angiotensin II type 1
Corticotropin releasing
factor 1 alpha
Oxytocin receptor
Mu-opioid receptor
Apelin
Thyrotropin releasing
factor
Glucagon
CXC chemokine 2
Prostaglandin D2
Neurokinin
Beta 2 adrenergic
Beta 1 adrenergic

Proposed Function in Receptor Trafficking and Signalling
Rapid SSTR3 trafficking
Facilitates AT1R dephosphorylation, thereby decreasing desensitization and
increasing resensitization
Rab4 overexpression blocked CRF1αR resensitization
Recycling of phosphorylated MOR
Rab4 rapidly recycled apelin-13 receptor while Rab4DN caused receptor
trafficking to lysosomes
Localized with both phosphorylated and dephosphorylated TRH
Facilitates actin- and arrestin-dependent GR recycling
CA RhoB reroutes CXCR2 from Rab11 to Rab4 recycling
Specifically recycles DP2 receptor, not CRHT2
Rab4 disruption attenuated NK1R resensitization
β2AR activation results in increased Rab4-positive vesicle fusion with PM
Transgenic Rab4DN decreased catecholamines response and caused
abnormal accumulation of β2AR in the sarcoplasm
Transgenic overexpression of Rab4 in the mouse myocardium increased
βAR in the plasma membrane and cAMP production leading to cardiac
hypertrophy
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to lysosomes (Lee et al., 2010). Somatostatin receptor 3 traffics through Rab4-, and
Rab11-containing

endosomes

and

expression

of

the

inactiveRab4/S22N,

and

Rab11/S25N inhibits receptor trafficking (Tower-Gilchrist et al., 2011). Similarly, Rab4
or Rab11 dominant-negative mutants and small interfering RNA both significantly impair
the recycling of the wild-type μ-opioid receptor (Wang et al., 2008).
1.7.2.2.

Rab5

Rab5 is one of the more intensely studied members of the large and diverse family
of Rab GTPases (Table 1.2.). Enriched at the plasma membrane and early endosomes,
Rab5 coordinates the endocytosis of proteins via clathrin-coated vesicles and transport to
early endosomes where proteins may be sorted for retention, recycling or degradation
(Seachrist and Ferguson, 2003). Rab5a has been shown to interact with the AT1AR
carboxyl-terminal tail and retain the receptor in Rab5a-positive early endosomes (Dale et
al., 2004; Seachrist et al., 2002). Co-expression of cannabinoid receptor 2, muscarinic
acetylcholine receptor M4 and human NPY receptors with dominant negative Rab5
results in a significant reduction in receptor internalization (Grimsey et al., 2011; Lecat et
al., 2011; Volpicelli et al., 2001). Conversely, although dominant-negative Rab5-S34N
did inhibit receptor internalization, Rab5 and TRH receptor do not colocalize at the
plasma membrane immediately after TRH addition, but overlap extensively by 15 min
(Jones and Hinkle, 2009). Cysteinyl leukotriene receptor is internalized through a
clathrin- arrestin- and Rab5-dependent pathway and internalized adenosine A (2A)
receptors also co-localize with clathrin and Rab5 (Parhamifar et al., 2009; Mundell et al.,
2000). Both phosphorylated and nonphosphorylated μ-opioid receptor internalize via
Rab5-dependent pathway after agonist stimulation (Wang et al., 2008).
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Table 1.2. Rab5-mediated GPCR trafficking and signalling
Receptor
Cannabinoid 2
angiotensin II type 1
corticotropin releasing
factor
Melanocortin
Cysteinyl leukotriene 1
Dopamine 2
Neurokinin
CXC chemokine 2
Endothelin A
Endothelin B
Oxytocin
mu-opioid
C5a anaphylatoxin
chemotactic
Thyrotropin releasing
Platelet activating
factor
Somatostatin 1
TPbeta

Proposed Function in Receptor Trafficking and Signalling
Rab5DN attenuated CB2 internalization
Rab5a associates with last 10 amino acids and Rab5aDN or truncated
AT1AR prevents AT1AR trafficking into large, hollow cored vesicular
structures. AT1AR activation facilitates Rab5a GTP binding.
Rab5 overexpression blocked CRF1αR resensitization
Clathrin, arrestin-3, and Rab5 mediates internalization of CysLT(1)R
Rab5aCA facilitates while Rab5aDN attenuates β-arrestin-mediated D2R
Endocytosis and ERK1/2 activation
Rab5aDN caused retention of the NK1R in early endosomes
Rab5DN mutant decreases CXCR2 endosomal sequestration

Rab5 facilitates phosphorylated and nonphosphorylated MOR
internalization
Rab5 and phosphorylated TRHR colocalized at 15 min and
dephosphorylated receptor colocalized with Rab4 but not with Rab5.
Rab5DN inhibited receptor internalization.
PAFR activation triggered signal-regulating kinase-1/MAPK kinase-3/p38
MAPK assembly with Rab5a and Rab GDI, thus activating Rab5a
Amino acids 335-344 of the TPbeta C-tail essential for the directing the
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Adenosine (2B)
Neurotensin 1
Beta 2 adrenergic
Ghrelin
Human prostacyclin

receptor from the Rab5-positive vesicles to the perinuclear recycling
endosome
Involved in β arrestin-1 mediated endocytosis of A(2B)AR
Rab5DN impaired β2AR internalization and β2AR-positive vesicles
remained closely associated with plasma membrane. Rab5CA internalized
β2AR to enlarged endosomes

Rab5a associates with C-tail of hIP in agonist-dependent manner and hIP
stimulation triggered Rab5a translocation from cytosolic to membrane
fraction.
Rhodopsin
Dynamin- and Rab5-dependent endocytosis necessary to prevent early
onset of rhabdomere degeneration in Drosophila.
M4 muscarinic
Rab5DN inhibits m4 endocytosis while Rab5CA enhances m4 intracellular
distribution and produces enlarged vacuoles
Neuropeptide Y
Facilitates clathrin-mediated endocytosis of NPY receptor
Metabotropic glutamate Rab5b siRNA prevents DHPG-mediated LTD in neurons. Group I mGluRs
1
are linked to Rab5b synthesis
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1.7.2.3.

Rab7
Rab7 is enriched at late endosomes and lysosomes where it mediates the

trafficking of targeted proteins to the lysosome for degradation (Table 1.3.). CXCR2 type
1 PDZ binding motif truncation increases ligand-mediated receptor degradation and Rab7
dominant negative overexpression prevents CXCR2 from trafficking to lysosomes
(Baugher and Richmond, 2008; Fan et al., 2003). Rab7 also targets the apelin-13 receptor
to lysosomes and Rab7 overexpression can change the fate of AT1AR from Rab5mediated sequestration to Rab7-mediated degradation (Lee et al., 2010; Dale et al.,
2004).
1.7.2.4.

Rab8
Rab8 is localized to Golgi, vesicles and membrane ruffles and is involved in

trafficking of basolateral proteins in polarized epithelial cells, as well as neurite
outgrowth (Table 1.4.) (Ng and Tang, 2008). Rab8 has been shown to regulate ionotropic
glutamate AMPA receptor synaptic delivery and recycling in rat hippocampal spines and
is documented in the polarized transport of rhodopsin in photoreceptor cells (Brown et
al., 2007; Gerges et al., 2004; Moritz et al., 2001; Deretic, 1997). Rab8 has recently been
shown to directly associate with different regions of the α2B- and β2-adrenergic receptors
and a GDP-bound dominant negative Rab8 mutant blocks cell surface expression and
ERK1/2 activation of α2BAR but not β2AR (Dong et al., 2010). Rab8 has also been
implicated in non-clathrin mediated endocytosis and is associated with macropinosomes
generated at ruffling membrane domains (Hattula et al., 2006).
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Table 1.3. Rab7-mediated GPCR trafficking and signalling
Receptor
Apelin
Angiotensin II type 1
GABA(A)
Prostaglandin EP4
C5a anaphylatoxin
CXC chemokine 2
Beta 2 adrenergic
Neurotensin 1

Proposed Function in Receptor Trafficking and Signalling
Rab7 targeted the receptor to lysosomes
Rab7 associates with last 10 amino acids of AT1R and wild-type Rab7 and
Rab7CA increased AT1AR lysosomal targeting and degradation
EP(4), γ-secretase and Rab7 co-localised after agonist stimulation in cells
and also in the brain of wild-type mice but not of EP(4) receptor null mice.
CXCR2 type 1 PDZ binding motif truncation increases ligand-mediated
receptor degradation
PI3K inhibitors reroute β2AR from recycling to degradative pathways
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Table 1.4. Rab8-mediated GPCR trafficking and signalling
Receptor
Alpha 2B adrenergic
Beta 2 adrenergic
CXC chemokine 4
CCR5
Rhodopsin

Proposed Function in Receptor Trafficking and Signalling
DN Rab8 reduced α2BAR plasma membrane expression
β2AR modulates the Rab geranyl-geranylation
DN Rab8 reduced β2AR plasma membrane expression
CXCR4-CCR5 homodimer transport from endoplasmic reticulum to
plasma membrane when CD4 co-receptor is present
Rab8DN caused rapid retinal degeneration in Xenopus
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1.7.2.5.

Rab11
Rab11 is another extensively studied protein transport molecule (Table 1.5.).

Rab11 is localized to early endosomes and the perinuclear regions and is crucial for
recycling and resensitization of many GPCRs and other receptors (Seachrist and
Ferguson, 2003). Like Rab4, Rab11 mediates protein trafficking from endosomes back to
the plasma membrane. However, unlike the direct Rab4 route from early endosomes to
plasma membrane, Rab11 coordinates a “slow” recycling route through the perinuclear
region and Rab11 and has often been shown to coordinate with or be in competition with
Rab4 for recycling (Esseltine et al., 2011; Hunyady et al., 2002). For example, Rab11
mediates the recycling of nonphosphorylated MOR, while Rab4 mediates phosphorylated
μ-opioid receptor recycling (Wang et al., 2008). Dominant negative Rab11 causes
decreased β2AR membrane expression and mediates recycling of constitutively
internalized TPβ receptor (Parent et al., 2009; Hamelin et al., 2005; Theriault et al.,
2004). Rab11 also participates in M4 muscarinic receptor recycling via myosin Vb, a
Rab11a effector (Volpicelli et al., 2002). In addition to recycling, Rab11 has been shown
to mediate other antrograde trafficking pathways and along with Rab6, Rab3 and Rab8,
Rab11 is also linked to post-Golgi trafficking of rhodopsin and coordinates CXCR4CCR5 homodimer transport from endoplasmic reticulum to the plasma membrane (Satoh
et al., 2005; Deretic, 1997).
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Table 1.5. Rab11-mediated GPCR trafficking and signalling
Receptor
Somatostatin 3
Cannabinoid 2
Angiotensin II type 1

Proposed Function in Receptor Trafficking and Signalling
Regulates slow receptor trafficking
Rab11DN impaired receptor return to plasma membrane
Rab11 associates with AT1R C-tail to mediate recycling

Beta 2 adrenergic

β2AR modulates the Rab geranyl-geranylation
endoplasmic reticulum to plasma membrane
PI3K inhibitors reroute β2AR from recycling to degradative pathways
DN Rab11 causes decreased β2AR membrane expression
Actin-dependent recycling of β2AR

Melanocortin 2
Human prostacyclin
CXC chemokine 4
CCR5
Vasopressin
CXC chemokine 2
LPAR

Rab11a increased recycling of hIP, while Rab11DN impaired recycling.
Interaction between hIP and Rab11a via Val299-Gln320 sequence within
the hIP C-tail domain
Gα13 and Rho mediate actin-dependent trafficking of CXCR4 into the
Rab11 compartment
CXCR4-CCR5 homodimer transport from ER to PM
RhoB CA mutant reroutes CXCR2 from Rab11 to Rab4 recycling
LPA promotes Rab11a interaction with Gβγ, activating PI3K and AKT
Recycling of nonphosphorylated MOR

Mu-opioid
Delta-opioid
C5a anaphylatoxin
Glucagon

DN Rab11 abolished the ability of Src blockers to prevent DOR
desensitization
Facilitates actin- and arrestin-dependent GR recycling
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1.7.3. Rabs and Receptor Signalling
1.7.3.1.

Rab4
Previously, it has been shown that the dephosphorylation and resensitization of

the β2AR occurs as the receptor transits between the Rab5-positive early endosome and
the Rab4-positive rapid recycling endosome (Seachrist et al., 2000). Transgenic
overexpression of Rab4 in the mouse myocardium significantly increased the number of
βAR in the plasma membrane and augmented cAMP production at the basal level and in
response to isoproterenol stimulation (Odley et al., 2004). Expression of dominant
negative Rab4 impaired β2AR responsiveness to endogenous and exogenous
catecholamine and Rab4 inhibition prevented resensitization after isoproterenol-induced
in vivo adrenergic desensitization (Filipeanu et al., 2006). Moreover, it has been reported
that phosphorylated µ-opioid receptor is preferentially recycled through Rab4-positive
endosomes (Wang et al., 2008). CRF1α receptor resensitization was blocked by the
overexpression of wild-type Rab5 and Rab4 GTPases and dephosphorylated receptor
colocalized with Rab4 but not with Rab5 (Holmes et al., 2006).
1.7.3.2.

Rab5
As stated above, dephosphorylation and resensitization of the β2AR occurs as the

receptor transits between the Rab5-positive early endosome and the Rab4-positive rapid
recycling endosome and CRF1α receptor resensitization was blocked by the
overexpression of wild-type Rab5 (Holmes et al., 2006; Seachrist et al., 2000). Rab5 has
also been shown to be involved in other aspects of GPCR signalling. Interestingly,
Purvanov et al., 2010 demonstrate an interaction of Drosophila Rab5 and the G protein
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Go, in vitro and in vivo. Purified Rab5 and Go proteins associate with each other and Go
contributes to Rab5 activation and endosome fusion. Serotonin, by cooperating with
mGluRs, regulates synaptic plasticity through a mechanism dependent on p38
MAPK/Rab5-mediated

enhancement

of

AMPA

receptor

internalization

in

a

clathrin/dynamin-dependent manner (Zhong et al., 2008). Further studies established a
functional link between phosphatidic acid-derived DAG and the activation of p38
mitogen-activated protein kinase and the subsequent phosphorylation of the Rab5 effector
EEA1, which has been demonstrated to be required for the induction of MOR
endocytosis (McLaughlin et al., 2008). Additionally, Rab5b plays an important role in
Group I mGluR-mediated neuroprotection and synaptic plasticity. While DHPG
treatment of neurons typically leads to long term depression (LTD) in Rab5b siRNA
treated neurons, DHPG no longer causes LTD. Additionally, group I mGluRs are linked
to Rab5b synthesis (Baskys et al., 2007; Arnett et al., 2004).
1.7.3.3.

Rab8
Rab8 has been shown to coordinate with Rab11 to modulate plasma membrane

targeting of receptors. Like Rab11, Rab8 associates with the actin motor protein myosin
Vb to regulate trafficking (Roland et al., 2007). β2AR also modulates the geranylgeranylation of Rab8, thus facilitating the Rab association with membranes and Rab8
activity (Lachance et al., 2011). Dominant negative or depletion of Rab8 by siRNA
significantly attenuates ERK1/2 activation by α2BAR but not β2AR and inhibits plasma
membrane delivery of α2BAR from the TGN (Parent et al., 2009). Our lab has previously
demonstrated that the Rab8 effector molecule, optineurin associates with and desensitizes
mGluR1 IP3 signalling (Anborgh et al., 2005). Rab8 also coordinates with Rab11 to
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mediate the synaptic delivery of AMPARs during long-term potentiation and constitutive
receptor cycling (Brown et al., 2007; Gerges et al., 2004). After Rab11 targets AMPARcontaining endosomes from the dendritic shaft into spines, Rab8 directs receptor insertion
into the synaptic membrane (Brown et al., 2007).
1.7.3.4.

Rab11
In addition to recycling and resensitizing receptors to the plasma membrane,

Rab11 has been shown in recent years to participate in many other aspects of receptor
signalling. For example, DN Rab11 causes decreased β2AR membrane expression
through decreased receptor recycling, but additionally, β2AR itself also modulates the
geranyl-geranylation of Rab11, thus determining the membrane association state of the
Rab and its activity (Lachance et al., 2011). Rab11 also coordinates with other signalling
and regulatory molecules including heterotrimeric G proteins and other small G proteins.
Gα13 and Rho mediate actin-dependent trafficking of CXCR4 into the Rab11
compartment while a RhoB constitutively active mutant reroutes CXCR2 from Rab11 to
Rab4 recycling pathways (Kumar et al., 2011; Reid et al., 2010; Neel et al., 2007; Fan et
al., 2003). Additionally, LPA promotes Rab11a interaction with Gβγ, causing PI3K
recruitment and AKT phosphorylation (Garcia-Regaldo et al., 2008).
1.8.

HYPOTHESIS AND SPECIFIC OBJECTIVES
In recent years, our lab and others have provided increasingly convincing

evidence that Rab small G proteins comprise a major component of intracellular
trafficking machinery and it is now apparent that GPCR trafficking actively affects signal
transduction. Rabs directly associate with, and actively direct GPCR signalling through
intracellular localization of receptors and signalling molecules. Our research presented
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here further supports the hypothesis that intracellular trafficking of GPCRs can
actively contribute to and alter receptor signal transduction.
The aim of this thesis is to elucidate the role that receptor trafficking plays in
signal transduction by addressing the following three questions:
1.

Do multiple Rab proteins associate with AT1R to alter receptor desensitization
or resensitization?

2. Does Rab8 associate with mGluR1 to modulate its intracellular trafficking and
signalling?
3. What alterations do previously uncharacterized mutations in mGluR1 exhibit in
mGluR1 intracellular localization and signal transduction?
The data presented in chapters 2, 3 and 4 of this thesis summarize my research aimed at
answering important questions regarding the regulation of two prototypic GPCRs.
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CHAPTER 2.
RAB GTPASES BIND AT A COMMON SITE WITHIN THE
ANGIOTENSIN II TYPE I RECEPTOR CARBOXYL-TERMINAL
TAIL: EVIDENCE THAT RAB4 REGULATES RECEPTOR
PHOSPHORYLATION, DESENSITIZATION AND
RESENSITIZATION1

1

A version of this chapter has been published: Esseltine JL, Dale LB and Ferguson SS
(2011) Rab GTPases bind at a common site within the angiotensin II type I receptor
carboxyl-terminal tail: Evidence that Rab4 regulates receptor phosphorylation,
desensitization and resensitization. Mol Pharm 79:175-84.
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1.1.

INTRODUCTION
The angiotensin II type 1 receptor (AT1R) is a member of the G protein-coupled

receptor (GPCR) superfamily, the largest family of integral membrane receptors and
represents an important pharmacological target for drug therapy in hypertension
(Hoffman and Lefkowitz, 1996). The AT1R is coupled through Gαq/11 to the activation of
phospholipase Cβ resulting in the formation of diacylglycerol and inositol 1,4,5
trisphosphate leading to the release of intracellular calcium stores and the activation of
PKC. Agonist activation of the AT1R also results in the attenuation of receptor signalling
as the consequence of receptor phosphorylation by GRKs and PKC. Agonist activation
and GRK-mediated phosphorylation of the AT1R facilitates the recruitment of the
cytosolic adaptor protein, β-arrestin, which functions to sterically uncouple the AT1R
from the heterotrimeric G protein and targets the AT1R for clathrin-mediated endocytosis
(Benovic et al., 1987; Freedman et al., 1995; Ferguson et al., 1995; Ferguson et al., 1996;
Opperman et al., 1996; Krupnick and Benovic, 1998; Ferguson, 2001; Ferguson, 2007).
Once internalized, GPCRs may be either sequestered in early endosomes,
dephosphorylated and recycled back to the plasma membrane or targeted to lysosomes
for degradation (Ferguson, 2001; Gáborik and Hunyady, 2004; Seachrist and Ferguson,
2003). In the case of the AT1R, the receptor is internalized as a complex with β-arrestin
and is retained in the early endosomal compartment and is not readily dephosphorylated
(Anborgh et al., 2000).
The Rab subfamily of small Ras-like GTPases regulate the intracellular
trafficking of proteins between intracellular compartments through their ability to
regulate vesicular targeting, docking and fusion (Seachrist and Ferguson, 2003; Gáborik
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and Hunyady, 2004). Rab protein function is in turn tightly regulated at the level of
protein expression, localization, membrane association, and activation. Different Rab
isoforms regulate different aspects of intracellular trafficking such as internalization
(Rab5), recycling (Rab4 and Rab11) and degradation (Rab7) and different GPCRs are
known to preferentially traffic through certain Rab pathways (Seachrist et al., 2000;
Hunyady et al., 2002; Seachrist et al., 2002; Dale et al., 2004; Hamelin et al., 2005;
Holmes et al., 2006; Wang et al., 2008; Li et al., 2008; Parent et al., 2009). For example,
Rab5a has been shown to interact with the AT1AR carboxyl-terminal tail and retain the
receptor in Rab5a-positive early endosomes. Nevertheless, overexpression of either Rab7
or constitutively active Rab11 can redistribute AT1R into either Rab7-positive late
endosomes or Rab11-positive recycling endosomes, respectively (Seachrist et al., 2000;
Dale et al., 2004). Additionally, although AT1R is not readily dephosphorylated and
efficiently recycled, there is evidence to suggest that the receptor can be recycled via both
slow (Rab11-mediated) and rapid (Rab4-mediated) pathways (Hunyady et al., 2002; Li et
al., 2008). Rab binding to a GPCR is not unique to the AT1R, as Rab11 has been shown
to bind to the β2-adrenergic receptor (β2AR), thromboxane A2 receptor and prostacyclin
receptor (Seachrist et al., 2002; Hamelin et al., 2005; Parent et al., 2009; Reid et al.,
2010). Emerging evidence suggests that Rab interactions with these GPCRs are also
critical for regulating both the trafficking and activity of these receptors. For example,
previous studies with the β2AR have shown that the transit of the receptor from the Rab5positive early endosome to the Rab4-positive recycling endosome is required for the
dephosphorylation of the receptor (Seachrist et al., 2000).
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In the present study, we have investigated whether other Rab GTPases (Rab4,
Rab7 and Rab11) can interact with AT1R carboxyl-terminal tail and compete with Rab5
for binding. We report here that Rab4, Rab5, Rab7 and Rab11 each compete for an
overlapping site in the last 10 amino acid residues of the AT1R carboxyl-terminal tail and
that proline residue 354 and Cysteine residue 355 represent important amino acid
residues involved in Rab protein binding. Moreover, we find that overexpression of
either wild-type or constitutively active Rab4, but not Rab11, promotes AT1R
dephosphorylation.

The overexpression of a constitutively active Rab4 mutant also

results in reduced AT1R desensitization and promotes AT1R resensitization.

Taken

together, our data indicate that multiple Rab GTPases are able to associate with their
cargo and that the activity of the AT1R may be regulated by the interaction of different
Rab GTPases at the carboxyl-terminal Rab binding site.
2.2.

EXPERIMENTAL PROCEDURES

2.2.1. Materials
myo-(3H)Inositol and (32P)orthophosphate were acquired from PerkinElmer Life Sciences
(Waltham, MA). Dowex 1-X8 (formate form) resin 200–400 mesh was purchased from
BioRad (Mississauga, ON). Rabbit anti-GST, -Rab4 (sc-26562), -Rab5a (sc-312) and Rab11 (sc-309) antibodies were purchased from Santa Cruz Biotech (Santa Cruz, CA)
and goat anti-GST as well as ECL Western blotting detection reagents were purchased
from GE Healthcare (Oakville, Ontario, Canada). Horseradish peroxidase-conjugated
anti-rabbit and anti-goat IgG secondary antibody was from BioRad (Mississauga, ON).
QuikChangeTM site-directed mutagenesis kit was from Stratagene (La Jolla, CA). Rabbit
anti-FLAG antibody, M2 anti-FLAG agarose and all other biochemical reagents were
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purchased from Sigma-Aldrich (St. Louis, MO).
2.2.2. DNA Construction
An AT1R mutants lacking the distal 10 amino acids (AT1R-C1) was generated using the
QuikChangeTM Site-directed mutagenesis kit (Stratagene) to introduce a stop codon after
residue 319 in the AT1R carboxyl-terminal tail. Subsequently, primers were designed for
mutagenesis such that amino acid residues within the last 10 amino acid residues of the
AT1R tail were mutated in pairs to alanine residues using the QuikChange Site-directed
mutagenesis kit.
2.2.3. Cell Culture
Human embryonic kidney (HEK) 293 cells were maintained in Eagle's minimal essential
medium supplemented with 10% (v/v) heat inactivated fetal bovine serum (Invitrogen,
Burlington, ON) and 50 µg/ml gentamicin.

Cells seeded in 100 mm dishes were

transfected using a modified calcium phosphate method as described previously
(Ferguson and Caron, 2004). Following transfection (18 h), the cells were incubated with
fresh medium and allowed to recover for 24 hrs for co-immunoprecipitation studies.
Otherwise, they were allowed to recover for 6-8 hrs and re-seeded into 24-well dishes
and then grown an additional 18 hrs prior to experimentation.
2.2.4. Co-Immunoprecipitation
HEK 293 cells were transiently transfected with FLAG-tagged AT1R and either GSTtagged Rab4, Rab4-Q67L, Rab4-S22N, Rab5, Rab7, Rab7-Q67L, Rab7-N125I, Rab11,
Rab11-Q70L or Rab11-S25N. Following transfection, the cells were incubated for 20
minutes in Hepes balanced salt solution (HBSS) at 37°C with or without 100 nM AngII.
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The cells were then placed on ice, washed two times with ice-cold phosphate-buffered
saline (PBS) and lysed with cold-lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1%
Triton X-100) containing protease inhibitors (1 mM AEBSF, 10 μg/ml leupeptin, and 5
μg/ml aprotinin). The lysates were placed on a rocking platform for 15 min at 4°C and
centrifuged at 15000 x g for 15 min at 4°C to pellet insoluble material.

Cleared

supernatant containing 250 µg protein were incubated with 25 µL of FLAG M2-affinity
beads (Sigma) for 1h rotating at 4°C to immunoprecipitate FLAG-AT1R. Following
incubation, the beads were washed twice with lysis buffer and twice with PBS, and
proteins were solubilized in a 3X SDS sample buffer containing 2-mercaptoethanol
(BME).

Samples were separated by SDS-PAGE, transferred to a nitrocellulose

membrane and immuno-blotted to identify co-immunoprecipitated GST-tagged Rab
proteins using a primary polyclonal rabbit or goat anti-GST antibody (1:1000 dilution,
Santa Cruz, GE Healthcare) followed by a horseradish peroxidase-conjugated secondary
anti-rabbit antibody (1:10000, BioRad) or secondary anti-goat (1:2500, BioRad).
Receptor and Rab protein expression was determined by immunoblotting 10 μg of protein
from each cell lysate used for immunoprecipitation.

Proteins were detected using

chemiluminescence with the ECL kit from GE Healthcare.
2.2.5. Whole cell phosphorylation
AT1R phosphorylation was measured as described previously (Anborgh et al., 2000).
HEK 293 cells were transiently transfected with FLAG-AT1R along with either pEGFP
(control), GFP-tagged Rab4, Rab4Q67L, Rab4S22N, Rab5, Rab5-S34N, Rab5-Q79L,
Rab11, Rab11Q70L or Rab11S25N. Seventy-two hours post transfection cells were
rinsed twice and incubated at 37°C for one hour in phosphate-free HBSS (5 mM
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NaHCO3, 20 mM HEPES, 11 mM glucose, 116 mM NaCl, 4.7 mM KCl, 1.2 mM
MgSO4, 2.5 mM CaCl2, pH 7.4). Cells were then incubated at 37°C for one hour in 100
µCi/mL [32P]orthophosphate, and treated for 10 min with and without 100 nM AngII,
rinsed and allowed to recover at 37°C for 0, 20 or 40 min in phosphate-free HBSS. Cells
were placed on ice and lysates were collected in the presence of protease inhibitors (0.1
mM PMSF, 10 μg/ml leupeptin, and 5 μg/ml aprotinin) and phosphatase-inhibitors
(10mM NaF and 10mM Na4P2O7) and incubated with M2 anti-FLAG affinity agarose for
2-3 hours to immunoprecipitate receptor protein. Beads were washed and bound proteins
were solubilized in SDS-PAGE sample buffer. Equal amounts of receptor protein, as
determined by protein measurement and flow cytometry were separated by SDS-PAGE
and receptor phosphorylation was determined via autoradiography at -80°C.
2.2.6. Measurement of inositol phosphate formation
Desensitization of AT1R signalling of inositol phosphate was measured as described
previously (Olivares-Reyes et al., 2001) with some modifications. HEK 293 cells were
transiently transfected with the cDNAs as described. Fourty-eight hours post-transfection
cells were incubated overnight in inositol-free DMEM with 100 µCi/mL myo(3H)Inositol. Cells were washed twice and incubated for one hour in warm HBSS then
preincubated for 3 min at 37°C in either HBSS (lacking LiCl) alone or with 100 nM
AngII (desensitizing stimulus). After a brief acid wash (50 mM glycine, 150 mM NaCl,
pH 3.0), cells were washed twice and were then incubated with either 10 mM LiCl alone
or 10 mM LiCl with 100 nM AngII for 10 min. The resensitization of AT1R-mediated
IP3 formation was assessed in the same fashion except that desensitized cells were
allowed to recover for 30 min prior to the second incubation with either 10 mM LiCl
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alone or 10 mM LiCl with 100 nM AngII for 10 min. Cells were placed on ice and the
reaction was stopped with 500 µL of perchloric acid and was neutralized with 400 µl of
0.72 M KOH, 0.6 M KHCO3. Total cellular (3H)inositol incorporation was determined in
50 µl of cell lysate.

Total inositol phosphate was purified by anion exchange

chromatography using Dowex 1-X8 (formate form) 200-400 mesh anion exchange resin
and (3H)inositol phosphate formation was determined by liquid scintillation using a
Beckman LS 6500 scintillation system.
2.2.7. Statistical Analysis
Densitometric data were normalized first for protein expression and the maximum value
was set to 100, with all other values displayed as percentage thereof. One-way analysis of
variance test (ANOVA) was performed to determine significance, followed by a post-hoc
Tukey multiple comparison test or Bonferroni’s multiple comparisons test to determine
which means were significantly different (p < 0.05) from one another.
2.3.

RESULTS

2.3.1. Rab4, Rab5, Rab7 and Rab11 all interact with the AT1R
Previous research showed direct association between Rab5a and AT1R, as well as
co-localization of the AT1R in Rab7- and Rab11-positive endosomes following Rab
GTPase overexpression (Seachrist et al., 2002; Dale et al., 2004). Thus, we investigated
whether Rab binding to the human AT1R C-tail was either exclusive to Rab5 or was also
observed for Rab4, Rab7 and Rab11. HEK293 cells were transiently transfected with
FLAG-AT1R and either GST-tagged Rab4, Rab5, Rab7 or Rab11. We find that similar to
what we observed previously for Rab5a, each of the GST-Rab4, GST-Rab7 and GST-

85

Rab11 proteins could be co-immunoprecipitated with the FLAG-AT1R from HEK 293
cells (Figure 2.1A and 1B).

We found that in the absence of agonist treatment

significantly more GST-Rab11 and significantly less Rab4 protein could be coimmunoprecipitated with the FLAG-AT1R, when compared to GST-Rab5 (Figure 2.1A
and 1B). Treatment of cells with 100 nM AngII to activate the FLAG-AT1R resulted in a
small and statistically insignificant increase in GST-Rab5 and GST-Rab7 binding to the
receptor, but had no effect on the association of either Rab4 or Rab11 (Figure 2.1A and
1B). We also examined whether endogenous Rab4, Rab5 and Rab11 could be coimmunoprecipitated with the FLAG-AT1R from HEK 293 cells. We found that Rab4
could be co-immunoprecipitated and that agonist stimulation increased Rab4 coimmunoprecipitation with the FLAG-AT1R by 1.6 ± 0.3 fold (P< 0.05) (Figure 2.1C).
However, agonist treatment had no effect upon the co-immunoprecipitation of either
Rab5 or Rab11 with the receptor (Figure 2.1D and 1E).
The rat AT1AR was previously shown to preferentially bind to the GDP-bound
form of Rab5 (Rab5-S34N) and the GDP-bound form of Rab11 interacted specifically
with the thromboxane A2 receptor (Seachrist et al., 2002; Hamelin et al., 2005). We
found that wild-type Rab4, dominant-negative Rab4-S22N, and constitutively active
Rab4-Q67L did not exhibit a preference for binding to the FLAG-AT1R (Figure 2.2A).
In contrast, constitutively active Rab7-Q67L mutant exhibited preferential binding to the
FLAG-AT1R (Figure 2.2B). Unlike what was previously observed for the thromboxane
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Figure 2.1. Rab4, Rab4, Rab7 and Rab11 each co-immunoprecipitate with
AT1R. (A) Representative immunoblot showing the co-immunoprecipitation of
GST-Rab4, GST-Rab5, GST-Rab7 and GST-Rab11 with the FLAG-AT1R from
HEK 293 cells in the absence (-) and presence (+) of 100 nM AngII treatment for
20 min. (B) Densitometric analysis of GST-Rab4, GST-Rab5, GST-Rab7 and
GST-Rab11 co-immunoprecipitated with the FLAG-AT1R from HEK 293 cells in
the absence (-) and presence (+) of 100 nM AngII treatment for 20 min. Data
represents the mean ± SD of 5 independent experiments. Data were normalized
for both individual Rab protein expression levels and normalized to maximum
Rab protein binding to the AT1R in each experiment. *p< 0.05 compared to Rab5
co-immunoprecipitated

with

theAT1R

and

correspondingly

treated.

(C)

Immunoblot demonstrating the co-immunoprecipitation of endogenous Rab4
protein with the FLAG-AT1R from HEK 293 cells in the absence (-) and presence
(+) of 100 nM AngII treatment for 20 min. Rab4 co-immunoprecipitated with
GFP antibody (Con) is used as a control. Data represents the mean ± SD of 4
independent

experiments.

(D)

Immunoblot

demonstrating

the

co-

immunoprecipitation of endogenous Rab5 protein with the FLAG-AT1R from
HEK 293 cells in the absence (-) and presence (+) of 100 nM AngII treatment for
20 min. Rab5 co-immunoprecipitated with GFP antibody (Con) is used as a
control. Data represents the mean ± SD of 4 independent experiments.

(E)

Immunoblot demonstrating the co-immunoprecipitation of endogenous Rab11
protein with the FLAG-AT1R from HEK 293 cells in the absence (-) and presence
(+) of 100 nM AngII treatment for 20 min. Rab11 co-immunoprecipitated with
GFP antibody (Con) is used as a control. Data represents the mean ± SD of 4
independent experiments.
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Figure 2.2. Co-immunoprecipitation of wild-type, dominant negative and
constitutively active Rab4, Rab7 and Rab11 GTPases with the AT1R. (A)
Representative immunoblot and densitometric analysis showing the coimmunoprecipitation of GST-Rab4 (WT), constitutively active GST-Rab4-Q67L
(CA) and dominant-negative GST-Rab4-S22N (DN) with FLAG-AT1R from
HEK 293 cells.

(B) Representative immunoblot and densitometric analysis

showing the co-immunoprecipitation of GST-Rab7 (WT), constitutively active
GST-Rab7-Q67L (CA) and dominant-negative GST-Rab7-N125I (DN) with
FLAG-AT1R from HEK 293 cells. *p< 0.05 compared to wild-type Rab7 coimmunoprecipitated with the AT1R. (C) Representative immunoblot and
densitometric analysis showing the co-immunoprecipitation of GST-Rab11 (WT),
constitutively active GST-Rab11-Q70L (CA) and dominant-negative GST-Rab7S25N (DN) with FLAG-AT1R from HEK 293 cells. *p< 0.05 compared to wildtype Rab11 co-immunoprecipitated with the AT1R. Data represents the mean ±
SD of 3-5 independent experiments. All data were normalized for individual Rab
protein expression levels in each experiment.
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A2 receptor wild-type Rab11 interacted with the FLAG-AT1R, but both constitutively
active Rab11-Q70L and dominant-negative Rab11-S25N mutants did not effectively
interact with FLAG-AT1R (Figure 2.2C). This observation suggests that GTP hydrolysis
is required for Rab11 binding to the AT1R. Taken together, the data indicated that Rab4,
Rab5, Rab7 and Rab11 each bind to the AT1R but that the association of each of the Rab
GTPases was mediated by different activation states of the GTPases.
2.3.2. Identification of the AT1R Rab GTPase binding site
Previously, we demonstrated that the deletion of the last 10 amino acid residues of
the rat AT1AR C-tail (AT1AR-C1) resulted in a loss of AT1AR colocalization with GFPRab5a (Dale et al., 2004). Therefore, we tested whether the deletion of the distal 10
amino acid residues of the human AT1R would result in both the loss of Rab5 binding, as
well as a loss of Rab4, Rab7 and Rab11 binding to a human FLAG-AT1R-C1 construct.
We found that the deletion of the last 10 amino acid residues resulted in a significant
decrease in Rab4, Rab5, Rab7 and Rab11 protein that was co-immunoprecipitated with
the FLAG-AT1R-C1 mutant (Figure 2.3A-D). Therefore, we examined which amino acid
residues localized with the distal AT1R C-tail sequence KKPAPCFEVE were required for
Rab4, Rab5, Rab7 and Rab11 binding to the receptor by performing alanine scanning
mutagenesis of pairs of amino acid residues (Figure 2.3A). We found that Rab4, Rab5,
Rab7 and Rab11 binding to FLAG-AT1R-KK, FLAG-AT1R-PA, FLAG-AT1R-FE and
FLAG-AT1R-VE mutant receptors was unaffected by alanine substitutions at the
corresponding residues (Figure 2.3A-D). In contrast, Rab4, Rab5, and Rab11 were not
co-immunoprecipitated effectively with the FLAG-AT1R-PC alanine substitution mutant
(Figure 2.3A, 2.3B and 2.3D). Although Rab7 binding to the FLAG-AT1R-PC alanine
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Figure 2.3. Identification of the Rab GTPase binding site within the AT1R
carboxyl-terminal tail. (A) Representative immunoblot showing the coimmunoprecipitation of Rab4 with either the wild-type AT1R (WT) or AT1R-C1
(1-349),

AT1R-K350A/K351A

(KK),

AT1R-P352A/A353G

(PA),

AT1R-

P354A/C355A (PC), AT1R-F356A/E357A (FE), and AT1R-V358A/E359A (VE)
mutants from HEK 293 cells. (B) Representative immunoblot showing the coimmunoprecipitation of Rab5 with either the wild-type AT1R (WT) or AT1R
mutants from HEK 293 cells. (C) Representative immunoblot showing the coimmunoprecipitation of Rab7 with either the wild-type AT1R (WT) or AT1R
mutants from HEK 293 cells. (D) Representative immunoblot showing the coimmunoprecipitation of Rab11 with either the wild-type AT1R (WT) or AT1R
mutants from HEK 293 cells. Data represents the mean ± SD of 3-5 independent
experiments. Data were normalized for both individual Rab protein expression
levels and wild-type Rab protein binding to the AT1R in each experiment. *p<
0.05 compared to wild-type Rab co-immunoprecipitated with the AT1R.
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substitution mutant was reduced, binding was not statistically significantly different from
control (Figure 2.3C). None of the alanine substitutions to the AT1R C-tail affected the
coupling of the AT1R to the activation of IP3 formation (Figure 2.4). Taken together, the
data suggested that proline residue 354 and Cysteine residue 355 played an important role
in the binding of the Rab4, Rab5, Rab7 and Rab11 GTPases to the AT1R and that each of
these different Rab GTPases bind to the same site on the receptor.
2.3.3. Rab GTPases compete with each other for association with AT1R
Because Rab4, Rab5, and Rab11 interact with an overlapping site in the AT1R Ctail and the overexpression of constitutively active Rab7 and Rab11 was previously
shown to alter the intracellular trafficking of the receptor (Dale et al., 2004), we
examined whether Rab GTPases compete for binding to the AT1R. We found that the coimmunoprecipitation of GST-Rab5 with the FLAG-AT1R could be antagonized by the
overexpression of increasing amounts of HA-Rab11 protein (Figure 2.5A). Moreover,
despite the fact that GST-Rab4 was apparently a weak FLAG-AT1R-interacting protein,
the

overexpression

of

HA-Rab4

effectively

prevented

GST-Rab11

co-

immunoprecipitation with FLAG-AT1R in an expression-dependent manner (Figure
2.5B). Unexpectedly, increasing expression levels of HA-Rab11 did not result in the
attenuation of GST-Rab4 binding to FLAG-AT1R (Figure 2.5C).
2.3.4. Rab4 but not Rab11 affects the phosphorylation state and desensitization of
AT1R signalling
Because Rab 4, Rab5 and Rab11 GTPases appeared to compete for a common
binding site on the carboxyl-terminal tail of the AT1R, we examined whether the
overexpression of wild-type, dominant-negative and constitutively active Rab4, Rab5 and
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Figure 2.4. Agonist-stimulated AT1R inositol phosphate formation. Shown is agoniststimulated (100 nM AngII, 10 min) inositol phosphate formation mediated by either the
wild-type FLAG-AT1R (WT) or FLAG-AT1R-C1 (1-349), FLAG-AT1R-K350A/K351A
(KK), FLAG-AT1R-P352A/A353G (PA), FLAG-AT1R-P354A/C355A (PC), FLAGAT1R-F356A/E357A (FE), and FLAG-AT1R-V358A/E359A (VE) mutants from HEK
293 cells. Data represents the mean ± SD of 3 independent experiments.
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Figure 2.5. Competition between Rab GTPases for co-immunoprecipitation
with FLAG-AT1R. (A) Representative immunoblots and densitometric analysis
of the co-immunoprecipitation of GST-Rab5 with FLAG-AT1R in the absence or
presence of increasing amounts of HA-Rab11. *p< 0.05 compared GST-Rab5 coimmunoprecipitated with the AT1R in the absence of HA-Rab11. (B)
Representative

immunoblots

and

densitometric

analysis

of

the

co-

immunoprecipitation of GST-Rab11 with FLAG-AT1R in the absence or presence
of increasing amounts of HA-Rab4.

*p< 0.05 compared to GST-Rab11 co-

immunoprecipitated with the AT1R in the absence of HA-Rab4.

(C)

Representative

co-

immunoblots

and

densitometric

analysis

of

the

immunoprecipitation of GST-Rab4 with FLAG-AT1R in the absence or presence
of increasing amounts of HA-Rab11.

*p< 0.05 compared to GST-Rab4 co-

immunoprecipitated with the AT1R in the absence of HA-Rab11. Data represents
the mean ± SD of 3-5 independent experiments. Data were normalized for both
GST-Rab protein expression levels and GST-Rab protein binding to the AT1R in
absence of HA-Rab.
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Rab11 mutants might lead to altered AT1R phosphorylation and dephosphorylation.
Consistent with previous studies (Opperman et al., 1996; Anborgh et al., 2000), agoniststimulation of the AT1R for 10 min effectively promoted the phosphorylation of the
AT1R (Figure 2.6A-C). However, when agonist was washed out for 20 and 40 min, no
dephosphorylation of the AT1R was observed under control conditions (Figure 2.6A-C).
In contrast, the overexpression of either wild-type Rab4 or constitutively active Rab4Q67L significantly reduced the extent of agonist-stimulated AT1R phosphorylation
(Figure 2.6A). Consistent with a role of Rab4 in promoting AT1R dephosphorylation,
overexpression of a dominant-negative Rab4-S22N mutant resulted in a significant
increase in agonist-stimulated AT1R phosphorylation, which was reduced to
phosphorylation levels observed in control cells following agonist washout (Figure 2.6A).
The overexpression of wild-type Rab5 had no effect on either AT1R phosphorylation or
dephosphorylation (Figure 2.6B). However, the overexpression of either constitutively
active Rab5-Q79L or dominant-negative Rab5-S34N appeared to result in a trend
towards increased dephosphorylation of the receptor the results did not reach statistical
significance. The extent of agonist-stimulated AT1R phosphorylation when compared to
control cells was not altered by the overexpression of either wild-type, dominant-negative
Rab11-S25N or constitutively active Rab11-Q67L and none of the Rab11 proteins
resulted in AT1R dephosphorylation following agonist washout (Figure 2.6C).
Given that wild-type Rab4 and constitutively active Rab4-Q67L lead to decreased AT1R
phosphorylation, we examined whether the expression of either wild-type or dominantnegative Rab4, Rab5 and Rab11 would alter the desensitization and resensitization of the
AT1R. To assess AT1R desensitization, cells were pretreated with 100 nM AngII for 3
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Figure 2.6. Whole cell phosphorylation of AT1R in the presence and absence
of wild-type and mutant Rab4 and Rab11. (A) Representative autoradiograph
and densitometric analysis of AT1R phosphorylation in absence (control) and
presence of wild-type Rab4 (WT), constitutively active Rab4-Q67L (CA), and
dominant-negative Rab4-S22N (DN) mutants. HEK 293 cells expressing FLAGAT1R were treated with 100 nM AngII for 10 min, washed and allowed to recover
for 0 (desensitization), 20 (resensitized) and 40 (resensitized) min. Data represents
the mean ± SD of 6 independent experiments. *p< 0.05 compared to
corresponding control. (B) Representative autoradiograph and densitometric
analysis of AT1R phosphorylation in absence (control) and presence of wild-type
Rab5 (WT), constitutively active Rab5-Q79L (CA), and dominant-negative Rab4S34N (DN) mutants.

Data represents the mean ± SD of 4 independent

experiments. *p< 0.05 compared to corresponding control. (C) Representative
autoradiograph and densitometric analysis of AT1R phosphorylation in absence
(control) and presence of wild-type Rab11 (WT), constitutively active Rab11Q70L (CA), and dominant-negative Rab11-S25N (DN) mutants. Data represents
the mean ± SD of 4 independent experiments. *p< 0.05 compared to
corresponding control.
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min in HBSS lacking LiCl (desensitizing stimulus), washed and then treated with and
without AngII for 10 min in HBSS containing LiCl. Receptor resensitization of AT1Rmediated IP3 responses was measured in the same way except that cells were allowed to
recover in the absence of agonist for 30 min prior to being subjected to a second round of
agonist treatment. The pretreatment of control cells (desensitizing stimulus) reduced
AT1R-stimulated IP3 formation to between 41 ± 4% and 48 ± 2% of control (naïve)
response when cells were exposed to a subsequent 10 min exposure to AngII (Figure
2.7A-C). The overexpression of constitutively active Rab4-Q67L significantly reduced
the extent of AT1R desensitization and increased the extent of AT1R resensitization
(Figure 2.7A). The overexpression of the constitutively active Rab5-Q67L mutant did
not alter AT1R desensitization, but facilitated the resensitization response (Figure 2.7B).
None of the other Rab constructs had any effect on AT1R desensitization and
resensitization. Taken together these results indicate that Rab4 binding, but not Rab11
binding, to the AT1R carboxyl-terminal tail alters the phosphorylation status of the AT1R
leading to reduced AT1R desensitization.
2.4.

DISCUSSION
In the present study we have investigated whether multiple Rab GTPases might

associate with the carboxyl-terminal tail of the AT1R tail and influence the activity and
function of the receptor. We find that Rab4, Rab5, Rab7 and Rab11 each exhibit the
capacity to bind to the distal 10 amino acids of the AT1R carboxyl-terminal tail and can
compete with one another for binding. Previously, we demonstrated that the AT1R
preferentially associated with the GDP-bound form of Rab5. We show here that the
AT1R does not distinguish between GDP- and GTP-bound forms of Rab4, binds
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Figure 2.7. Desensitization and resensitization of AT1R-mediated inositol
phosphate formation. (A) HEK 293 cells transfected with FLAG-AT1R with
empty pEBG vector (NT), wild-type Rab4 (WT), constitutively active Rab4Q67L (CA), and dominant-negative Rab4-S22N (DN) mutants. (B) HEK 293
cells transfected with FLAG-AT1R with empty pEBG vector (NT), wild-type
Rab5 (WT), constitutively active Rab5-Q79L (CA), and dominant-negative Rab4S34N (DN) mutants. (C) HEK 293 cells transfected with FLAG-AT1R with
empty pEBG vector (NT), wild-type Rab11 (WT), constitutively active Rab11Q70L (CA), and dominant-negative Rab11-S25N (DN) mutants. Transfected
cells were treated either with or without 100 nM AngII for 3 min in the absence of
LiCl (desensitizing stimulus) and then either washed and subjected to a second
treatment of 100 nM AngII for 10 min in the presence of LiCL (desensitized) or
washed and allowed to recover for 30 min prior to a second treatment of 100 nM
AngII for 10 min in the presence of LiCL (resensitized). Data were normalized
for protein expression and basal IP3 formation and desensitized and resensitized
IP3 responses compared to naive control cells that were not subjected to
desensitizing stimulus. Data are representative of 5 independent experiments. *p<
0.05 compared to corresponding control.
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preferentially to GTP-bound Rab7 and interacts with wild-type Rab11 and does not
associate with either constitutively active or dominant negative Rab11 mutants. We have
also identified two amino acid residues (proline 354 and Cysteine 355) within the Rab
binding domain of the AT1R carboxyl-terminal tail that are essential for the association of
Rab4, Rab5 and Rab11 but not Rab7. The association of different Rab GTPases with the
AT1R carboxyl-terminal tail has different functional outcomes, with Rab5 promoting the
retention of the AT1R in early endosomes (Seachrist et al., 2002), Rab7 facilitating the
trafficking of the AT1R to lysosomes (Dale et al., 2004) and Rab4 promoting the
dephosphorylation and resensitization of the receptor. Taken together, our data indicate
that the association of different Rab GTPases with the carboxyl-terminal tail domain of
the AT1R may regulate different functional outcomes for AT1R signalling in tissues that
may express differing levels of each of the relevant Rab GTPases as the overexpression
of a constitutively active Rab4-Q67L mutant decreases AT1R desensitization, while
facilitating resensitization.
In the current study, we have demonstrated that the domain required for Rab
GTPase interactions with AT1R are identical for Rab4, Rab5, and Rab11. Previously, we
identified that the Rab5 binding domain resides within the distal 10 amino acids of AT1R
carboxyl-terminal tail and that deletion of this motif resulted in altered AT1R trafficking
to lysosomes as opposed to the retention of the receptor in early endosomes (Dale et al.,
2004). We have further defined the critical residues required for Rab GTPase binding to
the AT1R and show that proline 354 and Cysteine 355 are essential for binding Rab4,
Rab5, and Rab11.

Previously, it has been shown that the dephosphorylation and

resensitization of the β2AR occurs as the receptor transits between the Rab5-positive
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early endosome and the Rab4-positive rapid recycling endosome (Seachrist et al., 2000).
Moreover, it has been reported that phosphorylated μ-opioid receptor is preferentially
recycled through Rab4-positive endosomes (Wang et al., 2008). We find here, that the
overexpression of a constitutively active Rab4-Q67L mutant decreases both AT1R
phosphorylation and desensitization, while promoting the resensitization of the receptor.
Thus, these data are consistent with the hypothesis that the Rab4-positive recycling
endosome functions as the compartment in which GPCR dephosphorylation is mediated
by phosphatases.
Several GPCRs have now been reported to associate with Rab GTPases including
the β2AR, thromboxane A2 receptor and prostacyclin receptor (Hamelin et al., 2005;
Parent et al., 2009; Reid et al., 2010). However, the residues that we have identified to be
essential for Rab GTPase binding to the AT1R are not conserved in any of these GPCRs.
Rab11 binding to the thromboxane A2 receptor is mediated by residues 335-345 that are
localized within the central region of the thromboxane A2 receptor carboxyl-terminal tail
and Rab11 binds α-helix 8 at the proximal end of the prostacyclin receptor. In contrast,
Rab11 binding to the β2AR involves a bipartite binding motif, with arginine 333 and
lysine 348 representing the essential amino acid residues mediating Rab11 binding to the
receptor (Parent et al., 2009). Thus, to date there is no clearly defined consensus motif
for Rab GTPase association with GPCRs. However, previous work from our laboratory
using yeast two hybrid screen suggest that the regional of the AT1AR carboxyl-terminal
tail that is proximal to the seventh transmembrane spanning domain of the AT1AR may
also be involved in Rab5 binding (Seachrist et al., 2002). Thus, the fact that we do not
observe complete loss of binding of the Rab GTPases to the carboxyl-terminal tail of the
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receptor suggests that secondary residues within the membrane proximal domain of the
receptor likely also contribute in part to Rab protein binding.
Rab GTPases not only influence the intracellular trafficking and recycling of
GPCRs by directly interacting with these vesicular cargo proteins, but Rab GTPases also
indirectly influence the trafficking of receptors between intracellular compartments as a
consequence of their intrinsic activity. Following their internalization, many GPCRs
have been shown to either recycle to the cell surface via the Rab4-mediated rapid
pathway directly from sorting endosomes or via the Rab11-mediated slow pathway from
perinuclear recycling endosomes.

The recycling of other GPCRs, including the

corticotrophin releasing factor receptor 1, somatostatin-3 receptor, vasopressin V2
receptor,

neurokinin-1

receptor,

chemokine

CXC

receptor-2,

m4

muscarinic

acetylcholine receptor and protease receptor, are also differentially regulated by Rab4 and
Rab11 (Innamorati et al., 2001; Kreuzer et al., 2001; Schmidlin et al., 2001; Signoret et
al., 2001; Fan et al., 2002; Volpicelli et al., 2002; Roosterman et al., 2003; Holmes et al.,
2006). Thus, potential alterations in individual Rab GTPase protein expression may have
profound effects on GPCR activity. This could occur as the consequence of either direct
competition for GPCR binding or by increasing the relative efficiency of the intracellular
trafficking and membrane fusion of vesicular compartments within the cell that is
regulated by the Rab GTPase. Rab GTPase protein expression and activity has been
demonstrated to be regulated by a number of different signals. First, Rab1, Rab4 and
Rab6 protein expression is altered in dilated cardiomyopathy model of heart failure and
overexpression of Rab4 in the heart leads to altered β2AR desensitization and
resensitization (Wu et al., 2001; Odley et al., 2004). Second, parasitic infection of
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cardiomyocytes in vitro with the protozoan Tyranosoma cruzi results in the
downregulation of both Rab7 and Rab11 protein expression (Batista et al., 2006).
Finally, insulin is able to stimulate GTP-loading of Rab11 in cardiomyocytes indicating
the potential of Rab GTPases to serve as substrates for GPCR activated kinases such as
phosphatidylinositol 3-kinase (Schwenk and Eckel, 2007).

Thus, taken together

alterations in Rab GTPase expression and activity have the potential to both directly and
indirectly influence GPCR signalling under both physiological and pathophysiological
conditions suggesting that these proteins may represent targets for the treatment of
cardiovascular-related diseases.
In HEK 293 cells, the AT1R is internalized to and retained in early endosomes,
where it remains phosphorylated and does not recycle to the plasma membrane (Anborgh
et al., 2000; Seachrist et al., 2002; Dale et al., 2004). We find that the overexpression of
different Rab GTPases can specifically alter the intracellular trafficking fate of the AT1R
with Rab7 overexpression favouring the trafficking of the receptor to lysosomes and
Rab4 overexpression favouring the dephosphorylation of the receptor.

In contrast,

although Rab11 effectively interacts with the AT1R, the interaction of the wild-type
Rab11 does not influence the dephosphorylation of the receptor, although it can promote
plasma membrane recycling (Dale et al., 2004). Interestingly, Rab4 is able to effectively
displace Rab11 binding to the AT1R, despite the observation that Rab11 is more
effectively co-immunoprecipitated with the receptor. Therefore, even small differences
in Rab4 expression may lead to profound changes in AT1R activity. However, Rab
binding to the AT1R, if competitive, should be reciprocal and Rab11 protein expressed at
sufficiently high levels should be able to compete for binding. It is possible that in our
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experiments we have not achieved Rab11 expression that can displace Rab4 from the
receptor at complimentary expression levels. Moreover, the overexpression of one Rab
protein may shift the receptor from one cellular compartment to another that is not
available to the competing Rab protein. It is also possible that Rab GTPases selectively
bind to different receptor sites depending upon their activation state, since wild-type
Rab7 does not bind to the receptor as effectively as Rab7-Q70L and wild-type Rab7
binding is not significantly impaired when the AT1R C-tail is truncated. This may
explain why we previously observed that truncation of the AT1R C-tail resulted in the
targeting of the receptor to endosomes (Dale et al., 2004). Nevertheless, depending on
the complement of Rab GTPases expressed in different tissue and cell types, it is likely
that the AT1R will exhibit differences in its functional regulation ranging from prolonged
desensitization associated with impaired dephosphorylation and resensitization to rapid
resensitization associated with receptor dephosphorylation.
To date, few GPCRs, including the AT1R, β2AR, thromboxane A2 receptor and
prostacyclin receptor have been shown to directly associate with members of the Rab
family.

Emerging evidence suggests that these interactions are critical to proper

trafficking and regulation of these receptors. Understanding the role of Rabs in the
regulation of GPCR redistribution into different intracellular compartments will serve to
improve our understanding of the molecular and physiological consequences of GPCR
signalling. It is now evident that multiple small GTP-binding proteins, including Rabs
interact with GPCRs and future studies should reveal whether GPCRs either interact with
or regulate additional components of the intracellular trafficking machinery.
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CHAPTER 3

RAB8 MODULATES METABOTROPIC GLUTAMATE RECEPTOR
SUBTYPE 1 INTRACELLULAR TRAFFICKING AND SIGNALLING
IN A PKC-DEPENDENT MANNER1

1
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3.1.

INTRODUCTION
Glutamate is the primary excitatory neurotransmitter in the brain and its actions

are mediated though two types of receptors: ionotropic glutamate receptors that are
ligand-gated cation channels and metabotropic glutamate receptors (mGluR) that are G
protein-coupled receptors (GPCRs) (Olney, 1994; Dingledine et al., 1999; Pin et al.,
2003). mGluRs play an important role in processes underlying learning and memory,
neuronal development, and neurodegeneration (Nakanishi, 1994; Pin et al., 1994; Pin and
Duvoisin, 1995; Conn and Pin, 1997; Dale et al., 2002). mGluRs are categorized into
three subclasses based on sequence homology and G protein coupling specificity. Group
1 mGluRs include mGluR1 and mGluR5, which are coupled through Gαq to the
activation of phospholipase C, which in turn catalyzes the formation of inositol 1,4,5
trisphosphate and diacylglycerol, which mediate the release of intracellular calcium
stores and the activation of protein kinase C (PKC) (Conn and Pin, 1997; Dhami and
Ferguson, 2006; Niswender and Conn, 2010).
The GPCR desensitization paradigm involves receptor phosphorylation by either
second messenger-dependent protein kinases or G protein-coupled receptor kinases
(GRKs) followed by β-arrestin binding, which functions to uncouple the receptor from
the G protein and targets GPCRs for clathrin-mediated endocytosis (Krupnick and
Benovic, 1998; Ferguson, 2001). However, Group I mGluR desensitization and
endocytosis is mediated by GRK2 in a phosphorylation-independent manner and does not
require β-arrestin (Ferguson, 2001; Dhami et al., 2002; Dhami et al., 2004; Dhami et al.,
2005; Dhami and Ferguson, 2006; Ferguson, 2007; Ribeiro et al., 2011). PKC also
contributes to the regulation of glutamate-induced mGluR1a internalization whereas
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constitutive mGluR1a internalization is mediated by RalA and phospholipase D2
(Mundell et al., 2003; Bhattacharya et al., 2004; Mundell et al., 2004).
Optineurin, a protein we have previously shown to contribute to the attenuation of
mGluR1a signalling, has also been shown to be a Rab8 effector protein (Hattula and
Peränen, 2000; Anborgh et al., 2005). Rab8 is a member of the Rab GTPase family of
small G proteins that are involved in regulating the trafficking, docking and fusion of
vesicles between intracellular membrane compartments (Zerial and McBride 2001;
Seachrist and Ferguson, 2003; Gaborik and Hunyady, 2004). Rab8 is localized to the
Golgi apparatus, intracellular membrane vesicles and membrane ruffles and is involved in
trafficking of basolateral proteins in polarized epithelial cells, neurite outgrowth, delivery
and recycling of the ionotropic glutamate AMPA receptors at synapses and has recently
been shown to directly associate with the α2B- and β2-adrenergic receptors (ARs)
(Deretic, 1997; Gerges et al., 2004; Gerges et al., 2005; Brown et al., 2007; Ng and Tang,
2008; Dong et al., 2010). Since Rab8 has been shown to interact with optineurin, in the
present study we have investigated whether Rab8 contributes to the regulation of
mGluR1a desensitization and endocytosis. We report that Rab8 interacts with mGluR1a
in an agonist-regulated manner to antagonize mGluR1a endocytosis and coordinates the
attenuation of mGluR1a-stimulated IP3 formation and release of Ca2+ from intracellular
stores in PKC-regulated manner.
3.2.

EXPERIMENTAL PROCEDURES

3.2.1. Materials
myo-[3H]-Inositol was acquired from PerkinElmer Life Sciences (Waltham, MA).
Dowex 1-X8 (formate form) resin 200 - 400 mesh was purchased from BioRad
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(Mississauga, ON, Canada). Goat anti-glutathione-S-transferase (GST) antibodies as
well as ECL Western blotting detection reagents were purchased from GE Healthcare
(Oakville, ON, Canada). Horseradish peroxidase-conjugated anti-rabbit and anti-goat IgG
secondary antibody was obtained from BioRad (Mississauga, ON, Canada). Anti-Gαq/11
rabbit polyclonal antibody was purchased from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA, USA). Anti-mGluR1a rabbit polyclonal antibody was obtained from Upstate
(Lake Placid, NY, USA).

Rabbit polyclonal phospho-p44/44 MAP kinase

(Thr202/Tyr402), p44/44 MAP kinase antibodies were obtained from Cell Signalling
Technology (Pickering, ON, Canada). Alexa Fluor 488 donkey anti-mouse IgG, Alexa
Fluor 568 donkey anti-rabbit IgG, Zenon Rabbit Alexa Fluor 555 and Fluo-4 AM ester
calcium indicators were purchased from Invitrogen/Molecular Probes (Burlington, ON,
Canada). Rabbit anti-FLAG antibody, M2 anti-FLAG agarose and all other biochemical
reagents were purchased from Sigma-Aldrich (Oakville, ON, Canada).
3.2.2. Cell Culture
Human embryonic kidney (HEK) 293 cells were maintained in Eagle's minimal
essential medium supplemented with 8% (v/v) heat inactivated fetal bovine serum
(Invitrogen, Burlington, ON) and 50 µg/ml gentamicin. Cells seeded in 100 mm dishes
were transfected using a modified calcium phosphate method as described previously
(Ferguson and Caron, 2004). Following transfection (18 h), the cells were incubated with
fresh medium and allowed to recover for 24 hrs for co-immunoprecipitation studies.
Otherwise, they were allowed to recover for 6-8 hrs and re-seeded into 24-well dishes
and then grown an additional 18 hrs prior to experimentation.
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3.2.3. Primary Hippocampal Neuronal Culture
Hippocampi from embryonic day 18 CD-1 mice were processed, as described
previously (Xie et al., 2000) and maintained in Neurobasal medium supplemented with
B27, glutamax and pen/strep. Neurons were transfected at DIV 7-10 using a modified
calcium phosphate technique and imaged 24 hr later.
3.2.4. Co-Immunoprecipitation
HEK 293 cells were transiently transfected with the cDNAs as described in the
Figure Legends. Following transfection, the cells were incubated for 15 minutes in
HEPES balanced salt solution (HBSS) at 37°C with or without 30 μM quisqualate. The
cells were then placed on ice, washed two times with ice-cold phosphate-buffered saline
(PBS) and lysed with cold-lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1% Triton
X-100) containing protease inhibitors (1 mM AEBSF, 10 μg/ml leupeptin, and 5 μg/ml
aprotinin).

The lysates were placed on a rocking platform for 15 min at 4°C and

centrifuged at 15000 x g for 15 min at 4°C to pellet insoluble material.

Cleared

supernatant containing 250 µg protein was incubated with 25 µL of FLAG M2-affinity
beads for 1h rotating at 4°C to immunoprecipitate FLAG-mGluR1a. Following
incubation, the beads were washed twice with PBS, and proteins were solubilized in a 3X
SDS sample buffer containing 2-mercaptoethanol (BME). Samples were separated by
SDS-PAGE, transferred to a nitrocellulose membrane and immunoblotted to identify coimmunoprecipitated GST-tagged Rab8 protein using a primary goat anti-GST antibody
(1:1000 dilution) followed by a horseradish peroxidase-conjugated secondary anti-goat
(1:2500 dilution). Receptor and Rab8 protein expression was determined by
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immunoblotting 10 μg of protein from each cell lysate used for immunoprecipitation.
Proteins were detected by chemiluminescence.
3.2.5. Biotinylation Assay
HEK 293 cells were transiently transfected with the cDNAs as described in the
Figure Legends. For cell surface biotinylation 48 hours post transfection cells were
incubated in 37ºC HBSS for 1 hour and then treated vehicle or 30 μM quisqualate. Cells
were then placed on ice, washed in ice-cold HBSS and cell surface proteins labelled with
1.5 mg/ml biotin for 1 hour and biotin was subsequently quenched with 100 mM glycine
for 30 min. For internalization experiments, cells were labelled with biotin on ice,
quenched and then cells were treated with vehicle or 30 μM quisqualate for the times
indicated in the Figure Legends to induce mGluR1a internalization. Cell surface biotin
was stripped from the cells using 150 mM MesNa. The cells were then placed on ice,
washed two times with ice-cold phosphate-buffered saline (PBS) and lysed with coldlysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1% Triton X-100) containing protease
inhibitors (1 mM AEBSF, 10 μg/ml leupeptin, and 5 μg/ml aprotinin). The lysates were
placed on a rocking platform for 15 min at 4°C and centrifuged at 15000 x g for 15 min at
4°C to pellet insoluble material. Cleared supernatant containing 250 µg protein was
incubated with 35 µL of neutravidin-affinity beads for 1h rotating at 4°C to
immunoprecipitate biotin-labeled proteins. Following incubation, the beads were washed
twice with PBS, and proteins were solubilized in a 3X SDS sample buffer containing
BME. Samples were separated by SDS-PAGE, transferred to a nitrocellulose membrane
and immunoblotted to identify biotinylated mGluR1a proteins using a primary rabbit anti
mGluR1a antibody (1:1000 dilution) followed by a horseradish peroxidase-conjugated
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secondary anti-rabbit (1:10000 dilution). Receptor and Rab8 protein expression was
determined by immunoblotting 10 μg of protein from each cell lysate used for
biotinylation. Proteins were detected by chemiluminescence.
3.2.6. Inositol Phosphate Formation
HEK 293 cells were transiently transfected with the cDNAs as described in the
Figure Legends. 48 hours post-transfection cells were incubated overnight in inositoland glutamate-free DMEM with 100 µCi/mL myo-[3H]-inositol. For PKC inhibition
experiments, cells were washed twice and incubated for one hour in 37ºC HBSS then
preincubated for 10 min at 37°C with either DMSO (control) alone or with 1 μM
bisindolymaleimide I or 5 μM chelerythrine chloride. For all other experiments cells were
incubated for one hour in 37ºC HBSS and were then incubated with 10 mM LiCl alone
for 10 min followed by 30 μM quisqualate treatment for 30 min. Cells were placed on
ice and the reaction was stopped with 500 µL of perchloric acid and neutralized with 400
µl of 0.72 M KOH, 0.6 M KHCO3.
determined in 50 µl of cell lysate.

Total cellular [3H]-inositol incorporation was
Total inositol phosphate was purified by anion

exchange chromatography using Dowex 1-X8 (formate form) 200 - 400 mesh anion
exchange resin and [3H]-inositol phosphate formation was determined by liquid
scintillation using a Beckman LS 6500 scintillation system.
3.2.7. ERK Activation
HEK 293 cells were transiently transfected with FLAG-mGluR1 and pEGFP
(control) or GFP-Rab8. 48 hours post-transfection cells were serum starved overnight in
glutamate-free DMEM and stimulated for 0, 1, 5 or 15 min with 30 μM quisqualate. Cells
were lysed and proteins were solubilized in a 3X SDS sample buffer containing BME.
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Samples were separated by SDS-PAGE, transferred to a nitrocellulose membrane and
immunoblotted to identify phosphorylated and total extracellular regulated kinase
(ERK1/2) antibody (1:1000 dilution) followed by a horseradish peroxidase-conjugated
secondary anti-Rabbit antibody (1:10,000 dilution). Receptor and Rab8 protein
expression was determined by immunoblotting 10 μg of protein from each cell lysate.
Proteins were detected by chemiluminescence.
3.2.8. Confocal Microscopy
Confocal microscopy was performed using a Zeiss LSM510 META laser
scanning confocal microscope equipped with a Zeiss 63X, 1.4 numerical aperture, oil
immersion lens (North York, ON, Canada). HEK293 cells expressing GFP-Rab8 and
FLAG-mGluR1a were serum starved for 1 hr at 37°C in HBSS (116 mM NaCl, 20 mM
HEPES, 11 mM glucose, 5 mM NaHCO3, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4,
1.2 mM KH2PO4, pH 7.4). HEK293 cells were prelabelled with Alexa Fluor 568conjugated anti-FLAG polyclonal rabbit antibody. Cells were then treated with 30 μM
quisqualate and live cells imaged over a 30 min time period at 37°C. Primary mouse
hippocampal neurons were transiently transfected with FLAG-mGluR1a, fixed with
periodate lysine paraformaldehyde and permeabilized with 0.1% Triton X-100. Receptor
was labelled with rabbit polyclonal anti-FLAG and endogenous Rab8 labelled with
mouse monoclonal anti-Rab8a antibody. Colocalization studies were performed using
dual excitation (488, 543 nm) and emission (band pass 505-530 nm and long pass 560 nm
for Alexa Fluor 488 and 568, respectively) filter sets.
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3.2.9. Calcium Imaging
DIV 7-10 hippocampal neurons were transiently transfected with either empty
pEGFP (control) or GFP-Rab8 and imaged 24 hr later. Transfected cells were identified
via confocal microscopy at 488nm excitation and band pass 505-530 emission after
which cells were loaded with 10 μM fluo-4 for 30 min at room temperature and imaged
using the same parameters. Cells were stimulated with 100 μM DHPG and 1 μM
ionomycin.
3.2.10. Statistical Analysis
Densitometric data were normalized first for protein expression and the control
value was set to 100, with all other values displayed as percentage thereof. One-way
analysis of variance test (ANOVA) was performed to determine significance, followed by
a post-hoc Tukey multiple comparison test or Bonferroni’s multiple comparisons test to
determine which means were significantly different (p < 0.05) from one another.

120

3.3.

RESULTS

3.3.1. Agonist-stimulated Rab8 interaction with the mGluR1a C-tail
Previously, we demonstrated that the Rab8 effector optineurin was an mGluR1a
interacting protein by yeast two hybrid and that it played a role in antagonizing mGluR1a
G protein signalling (Anborgh et al., 2005). Therefore, in the present study, we
investigated whether Rab8 might also interact with mGluR1a. To do this, HEK 293 cells
were transiently transfected with FLAG-tagged mGluR1a or FLAG-mGluR1b and GSTtagged Rab8 and the co-immunoprecipitation of GST-Rab8 with either FLAG-mGluR1a
or FLAG-mGluR1b was assessed. We found that GST-Rab8 was co-immunoprecipitated
with FLAG-mGluR1a in the absence of agonist, but that this association was increased
two fold (92 ± 23%) in response to 30 μM quisqualate treatment (Figure 3.1A and 3.1B).
In contrast, GST-Rab8 co-immunoprecipitation with Flag-mGluR1b (which lacks an
extended intracellular C-tail) was reduced to 72 ± 7% of control FLAG-mGluR1a
immunoprecipitation (Figure 3.1A and 3.1B). Agonist treatment did not increase GSTRab8 co-immunoprecipitation with FLAG-mGluR1b (Figure 3.1A and 3.1B). Therefore,
agonist-dependent increases in Rab8 association with mGluR1a required interactions
with the extended mGluR1a C-tail.
To determine whether endogenous Rab8 colocalizes with FLAG-mGluR1a,
primary hippocampal neurons (DIV 14) were fixed and labelled for FLAG-mGluR1a and
endogenous Rab8 protein distribution and imaged using confocal microscopy.
Interestingly, while FLAG-mGluR1a and Rab8 share partial overlapping populations in
the neuronal cell body (Figure 3.2A), they show little colocalization in neuronal
projections in the absence of agonist (Figure 3.2B). However, following the treatment of
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Figure 3.1. Agonist-dependent co-immunoprecipitation of Rab8 with mGluR1a. (A)
Representative immunoblot and (B) densitometric analysis showing the coimmunoprecipitation of GST-Rab8 with the FLAG-mGluR1a and FLAG-mGluR1b in the
absence (-) and presence (+) of 30 μM quisqualate (Quis) treatment for 15 min. HEK
293 cells were transiently transfected with 1 μg of plasmid cDNA encoding either FLAGmGluR1a or FLAG-mGluR1b along with 2 μg of plasmid cDNA encoding GST-Rab8.
48 h post-transfection cells were stimulated and lysates were collected and FLAGmGluR1 was immunoprecipitated. Proteins were separated by SDS-PAGE, transferred to
nitrocellulose and immunoblotted for FLAG-mGluR1 and GST-Rab8. Data represents the
mean ± SD of 3 independent experiments. Data were normalized for both GST-Rab
protein expression levels and FLAG-mGluR immunoprecipitation and normalized to
GST-Rab protein binding to the mGluR1a in absence of agonist. *p< 0.05 compared to
GST-Rab8 co-immunoprecipitated with the mGluR1a in the absence of agonist.
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Figure 3.2. Colocalization of mGluR1 and Rab8 in primary hippocampal neurons.
(A) Representative micrographs showing localization of endogenous mGluR1 and Rab8
protein in neuronal cell body. (B) Representative micrographs showing localization of
mGluR1 and Rab8 in neuronal projections. DIV 14 neurons were treated with and
without 100 μM DHPG for 30 min, fixed and labelled for endogenous mGluR1a (red)
and Rab8 (green).

Arrows highlight colocalization. Bars represent 5 μm. Images

represent 3 independent experiments.
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hippocampal neurons with 100 μM (S)-3,5-dihydroxylphenylglycine (DHPG), both
FLAG-mGluR1a and Rab8 immunofluorescence exhibited colocalization in the spines of
these projections (Figure 3.2B). Thus, agonist treatment appeared to increase FLAGmGluR1a and endogenous Rab8 association in primary cells.
3.3.2. Rab8 antagonizes mGluR1a endocytosis to increase cell surface expression
Rab8 has been shown to differentially regulate the trafficking of the α2BAR and
β2AR and contributes to the regulation of the synaptic delivery and recycling of the
ionotropic glutamate AMPA receptor (Deretic, 1997; Gerges et al., 2004; Brown et al.,
2007; Ng and Tang, 2008; Dong et al., 2010). Therefore, we investigated whether Rab8
overexpression would affect FLAG-mGluR1a intracellular trafficking in HEK 293 cells.
Initial experiments using confocal microscopy determined whether Rab8 overexpression
resulted in an alteration of cell-surface FLAG-mGluR1a in live HEK 293 cells labelled
with Zenon 555 Alexa Fluor-labelled primary mouse FLAG monoclonal antibody.
Control cells expressing FLAG-mGluR1a alone showed steady receptor internalization
upon treatment with 30 μM quisqualate (Figure 3.3, upper panels). However, in cells
overexpressing GFP-Rab8 FLAG-mGluR1a internalization was not observed (Figure 3.3,
lower panels). To quantify the extent of FLAG-mGluR1a internalization in the absence
and presence of Rab8, we tested FLAG-mGluR1a endocytosis using a cell surface
biotyinylation assay following 5 and 15 min exposures to 30 μM quisqualate. We found
that following the 15 min exposure of FLAG-mGluR1a to agonist that FLAG-mGluR1a
internalization was significantly reduced in HEK 293 cells overexpressing Rab8, when
compared to control cells (Figure 3.4A). When we assessed the overall cell surface
expression

of

FLAG-mGluR1a,

we
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found

that

the

fraction

of

Figure 3.3. Live cell imaging of mGluR1a endocytosis in the absence and presence of
Rab8. Representative confocal micrograph showing internalization of FLAG-mGluR1a
in the presence and absence GFP-Rab8. Live HEK 293 cells transfected 1 μg of plasmid
cDNA encoding FLAG-mGluR1a either with (lower panels) or without (upper panels) 2
μg of plasmid cDNA encoding GFP-Rab8 were labelled with Zenon AlexaFluor 555 on
ice, warmed to 37°C and stimulated with 30 μM Quis for 15 min. Bars represent 5 μm.
Data representative of 3 independent experiments.
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Figure 3.4. Effect of Rab8 on mGluR1a endocytosis and cell surface
expression. (A) Representative immunoblot and densitometric analysis of
internalized biotinylation of FLAG-mGluR1a.

HEK 293 cells transiently

expressing 1 μg FLAG-mGluR1a and 2 μg either pEBG (control) or GST-Rab8
placed on ice and cell surface proteins were biotinylated. Cells were then
stimulated with 30 μM Quis for 0, 5 or 15 min to induce internalization and cell
surface biotin stripped away. Biotin-labelled proteins were collected with
neutravidin-conjugated

beads,

separated

by

SDS-PAGE,

transferred

to

nitrocellulose and immunoblotted for mGluR1a. Data were normalized for protein
expression.

Data are representative of 6 independent experiments. *p< 0.05

compared to corresponding control. (B) Representative immunoblot and
densitometric analysis of cell surface biotinylation of FLAG-mGluR1a. HEK 293
cells transiently expressing 1 μg FLAG-mGluR1a and 2 μg either pEBG (control)
or GST-Rab8 were stimulated with 30 μM Quis for 0, 5 or 15 min, placed on ice
and cell surface proteins were biotinylated. Biotin-labelled proteins were collected
with neutravidin-conjugated beads, separated by SDS-PAGE, transferred to
nitrocellulose and immunoblotted for mGluR1a. Data represent changes in cell
surface mGluR1 expression. Data were normalized for protein expression and are
representative of 6 independent experiments. *p < 0.05 compared to
corresponding control.
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FLAG-mGluR1a at the cell surface following 15 min agonist treatment was significantly
greater than in control cells (Figure 3.4B).

Therefore, Rab8 appeared to prevent

mGluR1a endocytosis and increase cell surface mGluR1a expression.
3.3.3. Rab8 antagonizes mGluR1a inositol phosphate and calcium signalling
The

Rab8

effector

molecule,

optineurin

is

known

to

contribute

to

phosphorylation-independent G protein-uncoupling and desensitization of mGluR1a
(Anborgh et al., 2005). Therefore, we assessed whether Rab8 overexpression would
result in altered FLAG-mGluR1a- and FLAG-mGluR1b-stimulated inositol phosphate
(IP) formation in HEK 293 cells. We found that the over-expression of Rab8 resulted in
a significant reduction in the maximal response for quisqualate-stimulated IP formation
in FLAG-mGluR1a expressing cells reducing the maximum response to 70 ± 7% when
compared to control FLAG-mGluR1a expressing cells (Figure 3.5A).

However, Rab8

overexpression had no effect on the maximal response for quisqualate-stimulated IP
formation in FLAG-mGluR1b expressing cells (Figure 3.5B). Thus, consistent with what
was observed for agonist-stimulated association of Rab8 with mGluR1a versus
mGluR1b, Rab8 overexpression selectively attenuated mGluR1a and not mGluR1b G
protein signalling.
To determine whether Rab8 GDP for GTP exchange was required for the
attenuation of FLAG-mGluR1a-stimulated IP formation, we assessed whether FLAGmGluR1a-stimulated IP formation would be inhibited in the presence of either dominantnegative (Rab8-S22N) or constitutively active (Rab8-Q70L) proteins. We found that the
overexpression of wild-type Rab8, Rab8-S22N and Rab8-Q70L resulted in a reduction of
FLAG-mGluR1a stimulated IP formation to a similar extent (Figure 3.6A). To determine
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Figure 3.5. Effect of Rab8 on mGluR1a- and mGluR1b-mediated inositol phosphate
(IP) formation. Inositol phosphate formation in HEK 293 cells transfected with 1 μg
plasmid cDNA encoding (A) FLAG-mGluR1a or (B) FLAG-mGluR1b with 2 μg empty
pEGFP vector or GFP-Rab8. Transfected cells were treated for 10 min with 10 mM LiCl
and stimulated with 30 μM Quis for 30 min in the presence of LiCl. Data were
normalized for protein expression and basal IP formation. Lower panels show relative
mGluR1a and mGluR1b protein expression in GFP and GFP-Rab8 transfected cells.
Data are representative of 3-5 independent experiments. *p< 0.05 compared to
corresponding control.
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Figure 3.6. Effect of Rab8 nucleotide binding mutants on mGluR1a-mediated
inositol phosphate formation. (A) Inositol phosphate (IP) formation in HEK 293 cells
transfected with 1 μg of plasmid cDNA encoding FLAG-mGluR1a with 2 μg of plasmid
cDNA encoding GFP-tagged Rab8 wild type (WT), constitutively active Rab8-Q67L
(CA), and dominant-negative Rab8-S34N (DN) mutants. Transfected cells were treated
for 10 min with 10 mM LiCl and stimulated with 30 μM quisqualate (Quis) for 30 min in
the presence of LiCl. Data were normalized for protein expression and basal IP
formation. (B) Representative immunoblot showing the co-immunoprecipitation of GFPtagged Rab8WT, Rab8CA and Rab8DN with the FLAG-mGluR1a in the absence (-) and
presence (+) of 30 μM Quis treatment for 15 min. HEK 293 cells were transiently
transfected with 1 μg of plasmid cDNA encoding FLAG-mGluR1a along with 2 μg of
plasmid cDNA encoding GFP-tagged Rab8WT, Rab8CA or Rab8DN. 48 h posttransfection cells were stimulated and lysates were collected, separated by SDS-PAGE,
transferred to nitrocellulose and immunoblotted for mGluR1a and GFP-Rab8. Data
represents 3-5 independent experiments.
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whether Rab8 associated with the receptor in a nucleotide-specific manner, we also
examined the agonist-stimulated co-immunoprecipitation of wild-type Rab8, Rab8-S22N
and Rab8-Q70L with FLAG-mGluR1a. Although FLAG-mGluR1a interactions with both
wild type Rab8 and constitutively active Rab8-Q70L were increased upon agonist
stimulation, agonist did not regulate the association of dominant-negative Rab8-S22N
with the receptor (Figure 3.6B). Thus, although Rab8 associated with mGluR1a in a
GTP-dependent manner, the Rab8-dependent attenuation of mGluR1a G protein
signalling was independent of the nucleotide-binding state of the GTPase.
Because we found that Rab8 significantly attenuated FLAG-mGluR1a-mediated
IP formation in HEK 293 cells, we investigated whether Rab8 overexpression might also
attenuate DHPG-stimulated Ca2+ release mediated by endogenous mGluR1 expressed in
primary hippocampal neurons. To assess this, primary mouse hippocampal neurons
(DIV7-10) were transiently transfected with either pEGFP (control) or GFP-Rab8.
Neurons were imaged to identify cells that were transfected with GFP protein, and GFP
protein positive cells were then subsequently loaded with the calcium indicator fluo-4
AM and the same cell imaged for DHPG-mediated for calcium release as evidence by an
increase in cellular fluorescence. The treatment of hippocampal neurons with 100 μM
DHPG resulted in an increase in Fluo-4 fluorescence in both untransfected and pEGFP
transfected neurons as expected (Figure 3.7). However, in GFP-Rab8 positive neurons
DHPG-stimulated increases in intracellular Ca2+ concentration, as measured by increased
Fluo-4 fluorescence, was attenuated (Figure 3.7). All of the cells exhibited similar
responses to challenge with ionomycin indicating that GFP-Rab8 overexpression was not
causing a generalized defect in Ca2+ regulation (Figure 3.7). In order to investigate
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Figure 3.7. Effect of Rab8 on DHPG-stimulated Ca2+-release in hippocampal
neurons. Fluorescent intensity analysis of Ca2+ release as represented by the fluorescent
calcium indicator Fluo-4. DIV7-10 primary mouse hippocampal neurons were transiently
transfected with 10 μg of plasmid cDNA encoding either pEGFP (control) or GFP-Rab8.
Twenty four hours after transfection neurons were imaged to identify transfected cells,
after which they were loaded with 5 μM of the calcium indicator Fluo-4 AM for 30 min
at room temperature and the same field of view was imaged for calcium release with the
addition of 100 μM DHPG followed by 10 μM ionomycin (iono). Data representative of
3 independent experiments.
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whether Rab8 overexpression also affected other aspects of mGluR1a signalling, we
examined FLAG-mGluR1a-stimulated ERK1/2 phosphorylation in HEK 293 cells
(Figure 3.8).

We found that agonist-stimulated FLAG-mGluR1a-mediated ERK1/2

phosphorylation was not affected by the overexpression of Rab8, but that basal ERK1/2
phosphorylation was decreased in cells expressing both FLAG-mGluR1a and Rab8
(Figure 3.8).

Therefore, Rab8 appeared to selectively regulate FLAG-mGluR1a-

stimulated IP formation in HEK 293 and Ca2+ release in response to the activation of
endogenous mGluR1 in primary mouse hippocampal neurons.
3.3.4. Rab8 decrease of mGluR1a mediated IP3 signalling is PKC-dependent
Second messenger dependent kinases, such as PKC, can contribute to the
desensitization of agonist activated group 1 mGluRs (Schoepp and Johnson, 1988;
Herrero et al., 1994; Desai et al., 1999; Francesconi and Duvoisin, 2000; Ferguson,
2001). Because we found that Rab8 expression causes a significant decrease in FLAGmGluR1a-mediated IP formation, we sought to determine whether PKC-mediated
desensitization of mGluR1a signalling might be influenced by Rab8 expression. To test
this,

HEK

293

cells

were

pretreated

with

one

of

two

PKC

inhibitors,

bisindolylmaleimide-1 (Bis-1) or chelerythrine chloride. We found that the pretreatment
of HEK 293 cells with either 1 μM Bis-1 or 5 μM chelerythrine chloride for 10 minutes
prevented the Rab8-mediated uncoupling of mGluR1a-stimulated IP formation to DMSO
control levels (Figure 3.9).

This observation suggested a role for PKC-mediated

phosphorylation in the observed Rab8-dependent attenuation of FLAG-mGluR1a IP
signalling.
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Figure 3.8. Effect of Rab8 on mGluR1a-stimulated ERK1/2 phosphorylation. Shown
is a representative immunoblot and densitometric analysis of p42/44 (ERK1/2)
phosphorylation. HEK 293 cells were transiently transfected with 1 μg of plasmid cDNA
encoding FLAG-mGluR1a along with 2 μg of plasmid cDNA encoding either pEGFP
(control) or GFP-Rab8. Cells were stimulated for 0, 1, 5 or 15 min with 30 μM Quis,
lysates were collected, separated by SDS-PAGE and transferred to nitrocellulose and
phosphorylated ERK1/2 was detected by immunoblot. Data were normalized for total
ERK expression. Data represents the mean ± SD of 3-5 independent experiments.
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Figure 3.9. PKC inhibition prevents Rab8-dependent attenuation of mGluR1amediated IP formation. HEK 293 cells were transfected with 1 μg of plasmid cDNA
encoding FLAG-mGluR1a along with 2 μg empty pEGFP vector (Control) or GFP-Rab8.
Cells were pre-incubated for 10 min with either DMSO alone or with either 1 μM
bisindolymaleimide I or 5 μM chelerythrine chloride followed by 10 mM LiCl for 10 min
and then 10 μM quisqualate for 30 min. Data were normalized for protein expression and
basal IP formation. Data are representative of 5 independent experiments. *p< 0.05
compared to control.
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3.4.

DISCUSSION
To date only a few Rab isoforms including Rab3, Rab8 and Rab23 have been

shown to be enriched in the brain and play a role in neurons (Evans et al., 2003; Geppert
et al., 1997; Ng and Tang, 2008). Rab8 is essential in several areas of polarized neuronal
transport as well as in plasma membrane trafficking in epithelial cells and Rab8 siRNA
knockdown prevents maturation of hippocampal neurons in culture (Huber et al., 1995;
van Ijzendoorn et al., 2003; Ng and Tang, 2008). Studies now link Rab8 to a variety of
different human diseases, including polycystic kidney disease, microvillus inclusion
disease and Bardet-Biedl syndrome, emphasizing the physiological importance of protein
trafficking in human disease (Nachury et al., 2007; Ng and Tang, 2008). Here we show
that Rab8 associates with mGluR1a, but not its alternatively spliced variant, mGluR1b,
which lacks an extended carboxyl-terminal tail suggesting that Rab8 binds to the
carboxyl-terminal tail of mGluR1a in an agonist-regulated manner.

Other Rabs,

including Rab4, Rab5, Rab7 and Rab11 have previously been reported to associate with
the carboxyl-terminal tail of the angiotensin II type 1 receptor and other GPCRs
(Anborgh et al., 2000; Seachrist et al., 2002; Dale et al., 2004; Hamelin et al., 2005;
Parent et al., 2009; Reid et al., 2010; Esseltine et al., 2011). Additionally, Rab8 has
recently been shown to associate with different regions of the α2BAR and β2AR carboxylterminal tails and differentially modulates their trafficking to the cell surface from the
trans-Golgi network (TGN) (Dong et al., 2010). We find that the association of Rab8
contributes to attenuated mGluR1a endocytosis, increased cell surface expression and
functions to uncouple mGluR1a from G protein signalling by a mechanism that requires
PKC activity.
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Agonist-activated mGluR1a preferentially binds Rab8 wild type and GTP bound
constitutively active mutant Rab8Q70L, but not GDP bound dominant negative mutant
Rab8-S22N. This differs from the α2BAR and β2AR, which were recently shown to
preferentially bind the GDP bound dominant negative mutant Rab8-S22N (Dong et al.,
2010). However, although this study did not investigate whether agonist activation
regulated Rab8 interactions with the α2BAR and β2AR, Rab8 knockdown resulted in
attenuated cell surface expression of the α2BAR. Rab8 also has documented roles in the
intracellular trafficking of other receptors such as the transferrin receptor, and has been
shown to drive synaptic delivery of ionotropic glutamate AMPA receptors and their
insertion into synaptic membranes (Henry and Sheff, 2008; Brown et al., 2007).
However, to date, most studies have focused on the role of Rab8 in regulating receptor
delivery to the plasma membrane from areas such as the TGN or recycling endosomes
(Deretic, 1997; Gerges et al., 2004; Gerges et al., 2005; Brown et al., 2007; Dong et al.,
2010). We present data here implicating Rab8 in the inhibition of mGluR1a
internalization. Similar to our findings, the Rab8 effector molecule optineurin is also
implicated in attenuating the internalization of transferrin receptors (Nagabhushana et al.,
2010; Park et al., 2010). Rab5 has a well documented role in facilitating endocytosis of a
number of receptors including the angiotensin II type 1 receptor and β2AR (Seachrist et
al., 2000; Seachrist et al., 2002; Dale et al., 2004). However, to our knowledge, Rab8
represents the first example of a wild-type Rab protein that contributes to the attenuation
of receptor endocytosis.
Interestingly, we find that Rab8 overexpression leads to an increase in cell surface
mGluR1a expression. This increase in cell surface expression might be explained by one
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of two mechanisms: 1) Rab8 overexpression increases cell surface expression by either
reducing constitutive mGluR1a internalization or agonist-stimulated internalization of
mGluR1a as the consequence of the release of endogenous glutamate into the media by
HEK 293 cells. 2) Rab8 overexpression facilitates the movement of receptors from the
TGN to the plasma membrane. This would be similar to what was observed for the
α2BAR, where Rab8 knockdown led to impaired TGN to plasma membrane transport of
the receptor (Dong et al., 2010). In hippocampal neurons, endogenous Rab8 along with
the mGluR1a redistribute to spine regions after agonist stimulation, suggesting that Rab8
may regulate the localization of mGluR1a to synapse. This might be similar to the
reported role of Rab8 in the neuronal trafficking and insertion of the ionotropic AMPAtype glutamate receptor at synapses (Gerges et al., 2004, Gerges et al., 2005).
Our laboratory has previously reported that the Rab8 effector molecule,
optineurin associates with mGluR1a resulting in attenuated mGluR1a-stimulated IP
formation (Anborgh et al., 2005). In the present study, we find that Rab8 also contributes
to the regulation of mGluR1a G protein signalling. We find that Rab8 overexpression
specifically contributes to the uncoupling of mGluR1a-, but not mGluR1b-stimulated IP
formation. This inability of Rab8 to regulate mGluR1b signalling is correlated with the
observations that mGluR1b lacks an extended carboxyl-terminal tail, and that Rab8 does
not effectively associate with this mGluR1 variant. Therefore, the association between
Rab8 and mGluR1a appears to be crucial for the ability of Rab8 to regulate mGluR1a
signalling. We also show that mGluR1a displays no difference in Rab8-mediated IP
signal attenuation when co-expressed with Rab8 nucleotide binding mutants, indicating
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that Rab8 nucleotide-binding status does not play a role in regulating mGluR1a
signalling.
Rab8-mediated attenuation of mGluR1a signalling is reversed by PKC inhibition,
suggesting that Rab8 modulates PKC-dependent desensitization of mGluR1a. Similar to
the decrease in IP formation found in HEK293 cells following Rab8 overexpression, we
also find that GFP-Rab8 overexpression in primary mouse hippocampal neurons
significantly reduces intracellular Ca2+ release in response to the activation of
endogenously expressed group I mGluRs with DHPG. This role for PKC in Rab8mediated attenuation of mGluR1a signalling is likely dependent upon PKC-dependent
mGluR1a phosphorylation (Hermans and Challis, 2001).
Dominant negative or depletion of Rab8 by siRNA significantly attenuates
ERK1/2 activation by the α2BAR, but not the β2AR and inhibits plasma membrane
delivery of α2BAR from the TGN (Dong et al., 2010). We find here, that although Rab8
overexpression blocks second messenger formation in response to mGluR1a, agoniststimulated ERK1/2 phosphorylation is unaltered in the presence of the GTPase.
However, we did find basal ERK1/2 phosphorylation in mGluR1a expressing cells was
significantly attenuated in cells co-expressing Rab8.

Thus, Rab8 may selectively

contribute to the regulation of agonist-stimulated G protein-signalling, as opposed to
regulating G protein-independent signalling mediated by the association of other proteins
with mGluR1a such as Pyk2 (Nicodemo et al., 2010). However, the diminished basal
ERK1/2 activity may be associated with attenuated basal mGluR1a endocytosis.
In summary, our results establish a novel role for Rab8 in the regulation of
mGluR1a endocytosis and signalling. In contrast to what has previously been shown for
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other GPCRs and Rabs, this is the first report of a Rab GTPase inhibiting GPCR
endocytosis, while simultaneously attenuating receptor signalling. This opens a new and
exciting avenue of research to improve our understanding of the molecular and
physiological consequences of Rab GTPase-mediated regulation of GPCR signalling.
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CHAPTER 4.
Naturally Occurring Pathological Mutations in Group I Metabotropic
Glutamate Receptor Alter Receptor Intracellular Localization and
Signalling1

1

A version of this chapter has been submitted for publication in Molecular Pharmacology

Contributing Authors: Jessica L. Esseltine, Melinda D. Willard, Mary E. Lajiness,
Isabella H. Wulur, Thomas D. Barber and Stephen S.G. Ferguson
Figures 4.7 and 4.8B were contributed by MDW, MEL and IHW (Eli Lilly and
Company). All other experiments were performed by JLE
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4.1.

INTRODUCTION
Metabotropic glutamate receptors mediate the actions of the excitatory

neurotransmitter, glutamate. These class C receptors are characterised by a large
extracellular amino-terminal glutamate binding region comprised of 2 globular domains,
which form a distinctive “venus fly trap” (VFT) (Conn and Pin, 1997). The specific
amino-terminal glutamate binding region has been identified as a stretch of 24 amino
acids whose mutations affect glutamate affinity (Dhami and Ferguson, 2006; O’Hara et
al., 1993). Adjacent to the VFT domain is a 70 amino acid Cysteine-rich domain required
for allosteric coupling between the VFT and the transmembrane domains (Huang et al.,
2011). This region also participates in receptor dimerization via the formation of a
Cysteine bridge between receptor pairs, the disruption of which leads to receptor loss of
function (Rondard et al., 2008; Romano et al., 2001; Romano et al., 1996).
The second intracellular loop of mGluR is involved in G protein coupling and
selectivity (Pin et al., 1994). Group 1 mGluRs (mGluR1 and mGluR5) primarily couple
through Gαq and also activate G protein-independent signal transduction pathways
including mitogen activated kinases (Gerber et al., 2007; Nicodemo et al., 2010). Group I
mGluR-mediated ERK1/2 activation can occur via PKC, β-arrestin or through the nonreceptor tyrosine kinases Src and Pyk2 (Emery et al., 2010; Nicodemo et al., 2010;
Thandi et al., 2002).
Receptor activation is quickly followed by signal desensitization, a tightly
regulated process essential to prevent aberrant signalling or chronic receptor
overstimulation (Ferguson, 2001a). Desensitization of mGluRs is complex as mGluR1
desensitization includes phosphorylation-dependent and -independent mechanisms
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(Ferguson, 2007; Dhami and Ferguson, 2006; Dhami et al., 2005, Dhami et al., 2004;
Dhami et al., 2002). GRK2-mediated mGluR desensitization is phosphorylationindependent, whereby the GRK2 RGS homology domain associates with lysine residues
691 and 692 in the receptor second intracellular loop as well as the Gαq/11 subunit of the
heterotrimeric G protein (Dale et al., 2000; Dhami et al., 2005; Dhami and Ferguson,
2006; Ferguson, 2007). Meanwhile, second messenger-dependent kinases such as PKC
mediate phosphorylation-dependent mGluR desensitization in the receptor second
intracellular loop as well as carboxyl-terminal tail (Francesconi and Duvoisin, 2000;
Ciruela et al., 1999). Threonine 695 within the second intracellular loop is a target for
PKC phosphorylation and mutation at this residue specifically disrupts PKC-mediated
receptor desensitization (Francesconi and Duvoisin, 2000; Medler and Bruch, 1999).
GPCR C-tails are responsible for association with many regulatory proteins
involved in protein scaffolding and/or transport. For example, the Homer family of
proteins is comprised of 3 family members each encoding multiple splice variants
(Shiraishi-Yamaguchi and Furuichi, 2007). Homers associate with PPxxFR motif in the
C-tails of mGluR1/5 via their amino-terminal ENA/VASP homology domains and
regulate the subcellular distribution, plasma membrane target and signalling of mGluR1/5
(Ango et al., 2002; Ciruela et al., 1999; Coutinho et al., 2001; Roche et al., 1999;
Tadokoro et al., 1999). Homer proteins link mGluR1/5 to the activation of IP3 receptors,
ERK1/2 phosphorylation and the modulation of ion channel activity (Mao et al., 2005;
Kammermeier et al., 2000; Yamamoto et al., 2005; Ango et al., 2011).
Recently, genetic screening studies of multiple tumour types has identified several
naturally occurring pathological mutations in the ligand binding and intracellular
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regulatory domains of mGluR1a (Kan et al., 2010; Parsons et al., 2008; Sjoblom et al.,
2006; Wood et al., 2007). In the present study, we have examined the effect of eight
mutations identified in lung adenocarcinoma and squamous cell cancer including:
mutations in the orthosteric glutamate binding region (D44E and A168) and Cysteinerich region of the amino-terminal domain (R375G and G396V), intracellular loop 2
(R684C, G696W and G668V) and Homer binding motif (P1148L) on mGluR1a
signalling. We find that a subset of these mutations result in altered mGluR1a-stimulated
G protein-coupling, biased ERK1/2 phosphorylation, intracellular retention in the
endoplasmic reticulum (ER), as well as lost Homer binding that are associated with
altered subcellular localization of mGluR1a
4.2.

EXPERIMENTAL PROCEDURES

4.2.1. Materials
myo-(3H)Inositol was acquired from PerkinElmer Life Sciences (Waltham, MA).
Dowex 1-X8 (formate form) resin 200–400 mesh was purchased from BioRad
(Mississauga, ON, Canada).

Normal donkey serum was purchased from Jackson

ImmunoResearch (West Grove, PA, USA). ECL Western blotting detection reagents
were purchased from GE Healthcare (Oakville, ON, Canada). Horseradish peroxidaseconjugated anti-rabbit and anti-goat IgG secondary antibody were obtained from BioRad
(Mississauga, ON, Canada) and anti-mGluR1 rabbit polyclonal antibody purchased from
Upstate (Lake Placid, NY, USA).

Rabbit polyclonal phospho-p42/44 MAP kinase

(Thr202/Tyr402), p42/44 MAP kinase antibodies were obtained from Cell Signaling
Technology (Pickering, ON, Canada). Alexa Fluor 488 donkey anti-Rabbit IgG, Alexa
Fluor 568 donkey anti-rabbit IgG and Zenon Rabbit Alexa Fluor 555 were purchased
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from Invitrogen/Molecular Probes (Burlington, ON, Canada). Rabbit anti-FLAG
antibody, M2 anti-FLAG agarose and all other biochemical reagents were purchased from
Sigma-Aldrich (Oakville, ON, Canada).
4.2.2. Cell Culture
Human embryonic kidney (HEK) 293 cells were maintained in Eagle's minimal
essential medium supplemented with 8% (v/v) heat inactivated fetal bovine serum
(Invitrogen, Burlington, ON) and 50 µg/ml gentamicin. Cells seeded in 100 mm dishes
were transfected using a modified calcium phosphate method as described previously
(Ferguson and Caron, 2004). Following transfection (18 h), the cells were incubated with
fresh medium and allowed to recover for 24 hrs for co-immunoprecipitation studies.
Otherwise, they were allowed to recover for 6-8 hrs and re-seeded into 12- well or 24well dishes and then grown an additional 18 hrs prior to experimentation.
4.2.3. ERK Activation and Immuno Blotting
HEK 293 cells were transiently transfected with the cDNAs described in the
Figure Legends. Forty-eight hours post-transfection cells were serum starved overnight in
glutamine-free DMEM and stimulated for the indicated times with 30 μM quisqualate.
The cells were then placed on ice, washed two times with ice-cold phosphate-buffered
saline (PBS) and lysed with cold-lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1%
Triton X-100) containing protease inhibitors (1 mM AEBSF, 10 μg/ml leupeptin, and 5
μg/ml aprotinin) and phosphatase inhibitors (10 mM NaF, 5 μM Na3VO4). The cells
were placed on a rocking platform for 15 min at 4°C and centrifuged at 15000 x g for 15
min at 4°C to pellet insoluble material. Cell extracts were solubilized in a 3X SDS
sample buffer containing 2-mercaptoethanol (BME). Samples were separated by SDS150

PAGE, transferred to a nitrocellulose membrane and immunoblotted to identify
phosphorylated (active) and total p42/44 (ERK1/2) (1:1000 dilution, Cell Signalling)
followed by a horseradish peroxidase-conjugated secondary anti-rabbit antibody
(1:10000, BioRad). Receptor protein expression was determined by immunoblotting 10
μg of protein from each cell lysate. Proteins were detected using chemiluminescence
with the ECL kit from GE Healthcare.
4.2.4. Co-immunoprecipitation
HEK 293 cells were transiently transfected with cDNAs as described in the
Figure Legends. Following transfection, the cells were incubated for 15 min in HEPES
balanced salt solution (HBSS) at 37°C with or without 30 μM quisqualate. The cells
were then placed on ice, washed two times with ice-cold phosphate-buffered saline (PBS)
and lysed with cold-lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1% Triton X-100)
containing protease inhibitors (1 mM AEBSF, 10 μg/ml leupeptin, and 5 μg/ml
aprotinin).

The lysates were placed on a rocking platform for 15 min at 4°C and

centrifuged at 15000 x g for 15 min at 4°C to pellet insoluble material.

Cleared

supernatant containing 250 µg protein was incubated with 25 µL of FLAG M2-affinity
beads for 1h rotating at 4°C to immunoprecipitate FLAG-mGluR1a. Following
incubation, the beads were washed twice with PBS, and proteins were solubilized in a 3X
SDS sample buffer containing 2-mercaptoethanol (BME). Samples were separated by
SDS-PAGE, transferred to a nitrocellulose membrane and immunoblotted to identify coimmunoprecipitated YFP-tagged GRK2 protein using a primary mouse anti-GFP
antibody (1:1000 dilution) followed by a horseradish peroxidase-conjugated secondary
anti-mouse antibody (1:2500 dilution). Receptor and GRK2 protein expression was
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determined by immunoblotting 10 μg of protein from each cell lysate used for
immunoprecipitation. Proteins were detected by chemiluminescence.
4.2.5. Measurement of inositol phosphate formation
HEK 293 cells were transiently transfected with cDNAs as described in the
Figure Legend. Fourty-eight hours post-transfection cells were incubated overnight in
inositol- and glutamine-free DMEM with 100 µCi/mL myo-[3H]-Inositol.

For all

experiments cells were incubated for one hour in warm HBSS (116 mM NaCl, 20 mM
HEPES, 11 mM glucose, 5 mM NaHCO3, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4,
1.2 mM KH2PO4, pH 7.4) and were then incubated with 10 mM LiCl alone for 10 min
followed by 30 μM quisqualic acid in LiCl for 30 min. Cells were placed on ice and the
reaction was stopped with 500 µL of perchloric acid and neutralized with 400 µl of 0.72
M KOH, 0.6 M KHCO3. Total cellular [3H]-inositol incorporation was determined in 50
µl of cell lysate.

Total inositol phosphate was purified by anion exchange

chromatography using Dowex 1-X8 (formate form) 200-400 mesh anion exchange resin
and [3H]-inositol phosphate formation was determined by liquid scintillation using a
Beckman LS 6500 scintillation system.
4.2.6. Confocal microscopy
Confocal microscopy was performed using a Zeiss LSM- 510 META laser
scanning confocal microscope equipped with a Zeiss 63X, 1.4 numerical aperture, oil
immersion lens (North York, ON, Canada).

For live cell imaging, HEK 293 cells

expressing FLAG-mGluR1a constructs were serum starved for 1 hr at 37°C in HBSS.
HEK 293 cells were pre-labelled with Zenon Alexa Fluor 568-conjugated with antiFLAG polyclonal rabbit antibody (Invitrogen). Cells were then either kept on ice or
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stimulated with 30 μM quisqualate for 30 min at 37°C. For fixed cell imaging, cells were
washed three times at room temperature PBS, fixed for 10 min at room temperature with
Periodate-Lysine-Paraformaldehyde (PLP) fixative (McLean and Nakone, 1974)
followed by 10 min permeablilization with 0.01% Triton X-100. Cells were blocked with
3% normal donkey serum (Jackson ImmunoResearch) and labelled with Rabbit antiFLAG polyclonal rabbit antibody followed by donkey anti-rabbit Alexa Fluor 488
antibody. Endoplasmic reticulum was labelled with red fluorescence protein (RFP)-fused
lysine-aspartate-glutamate-leucine (KDEL) ER retention sequence. Colocalization studies
were performed using dual excitation (488, 543 nm) and emission (band pass 505-530 nm
and long pass 560 nm for Alexa Fluor 488 and 568, respectively) filter sets.
4.2.7. Flow Cytometry
HEK 293 cells were transiently transfected with the cDNAs described in the
Figure Legends. Fourty-eight hours after transfection cells were placed on ice and
washed in ice-cold HBSS. Flag-tagged mGluR1a constructs were labelled with primary
rabbit anti-Flag antibody (1:500) followed by secondary goat anti-rabbit AlexaFluor-488
antibody (1:500). Cells were incubated for 10 min in 5 μM EDTA, gently removed from
dish by pipetting and fixed in 3.6% formaldehyde final concentration. Cell surface mean
fluorescence was assessed by flow cytometry.
4.2.8. Statistical Analysis
Densitometric data were normalized first for protein expression and the control
value was set to 100, with all other values displayed as percentage thereof. One-way
analysis of variance test (ANOVA) was performed to determine significance, followed by
a post-hoc Tukey multiple comparison test or Bonferroni’s multiple comparisons test to
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determine which means were significantly different (p < 0.05) from one another.
4.3.

RESULTS

4.3.1. Mutations in the cysteine-rich domain contribute to receptor dimerization
and cell surface expression
Eight naturally occurring mGluR1 mutations were previously identified in variety
of tumour types with four mutations localized to the amino-terminal domain of mGluR1 (
D44E, A168V, R375G and G396V) three mutations localized to the mGluR1 second
intracellular loop (R684C, G688V and R696W) and one mutation localized to the Homer
binding motif (P1148L) (Figure 4.1) (Kan et al., 2010; Parsons et al., 2008; Sjoblom et
al., 2006; Wood et al., 2007). Initial experiments examined whether the cell surface
expression and dimerization of FLAG-mGluR1a was affected by each of the mutations
introduced into the coding sequence for mGluR1a. Immunoblot analysis demonstrated
that FLAG-mGluR1 mutations R375G and G396V, which are localized at the border of
the glutamate binding domain and cysteine-rich regions, exhibited a reduction in dimer
formation (Figure 4.2A). Consistent with a loss of mGluR1a dimerization, cell surface
expression of FLAG-mGluR1a-R375A and -G396A exhibited reduced cell surface
expression as assessed by flow cytometry; with cell surface expression reduced to 39.7 ±
5.1% and 43.4 ± 3.2 % of wild type mGluR1a control transfected cells (Figure 4.2B). The
reduction in cell surface FLAG-mGluR1a-R375A and -G396A expression was associated
with an increased retention of both receptor mutants in the ER as demonstrated by
increased colocalization with the ER marker construct KDEL-GFP (Figure 4.3). Thus,
both the R375A and -G396A mutations result in a significant reduction of mGluR1a
expression at the cell surface as a consequence of ER retention.
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Figure 4.1. Eight naturally occurring single nucleotide polymorphisms in
mGluR1a. Eight mutations have been identified within the coding sequence for
mGluR1a including: A168V, a mutation in the orthosteric glutamate binding
region identified in lung adenocarcinoma; two mGluR1a variants in the cysteinerich region, R375G (identified in squamous cell carcinoma) and G396V
(identified in lung adenocarcinoma); three mutations in the second intracellular
loop including: the glioblastoma mutation, R684C, the squamous cell carcinoma
mutation, G688V, and the colorectal cancer G696W mutation located close to the
putative PKC phosphorylation site T695A. A colorectal cancer mutation is
located within the Homer binding region in the carboxyl-terminal mGluR1,
P1148L.
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Figure 4.2. Cell surface expression and intracellular localization of mGluR1a
variants. (A) Representative immunoblot of HEK 293 cells expressing 2 μg Flag-tagged
mGluR1 constructs highlighting the monomeric (lower) and dimeric (upper) species of
the receptor. (B) HEK 293 cells expressing 2 μg Flag-tagged mGluR1a constructs were
immunolabelled and cell surface mean fluorescence was assessed by flow cytometry.
Data were normalized for total protein expression and represent the standard error of the
mean of four independent experiments. *, p < 0.001 compared to wild type.
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Figure 4.3. mGluR1 variants localize to endoplasmic reticulum. Representative
confocal micrographs illustrating receptor intracellular localization (red) and colocalization with the endoplasmic reticulum (green). HEK293 cells expressing 2 μg Flagtagged mGluR1 constructs were fixed and immunolabelled for total cellular compliment
of receptor. Images are representative of 3 independent experiments. Bars represent 5
µm.
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4.3.2. Mutations in the amino-terminus exhibit altered basal and agonist-activated
activity
Group I mGluRs activate both IP3 and ERK signal transduction cascades and
exhibit high basal activity (Dale et al., 2000). Interestingly, three of the four aminoterminal mGluR1 variants we examined (A168V, R375G, G396V) showed significantly
reduced basal IP3 formation (in the absence of agonist) compared to wild type and
FLAG-mGLuR1a-R375G exhibited basal IP3 formation that was indistinguishable from
non-transfected cells (Figure 4.4A). Quisqualate-mediated activation of FLAGmGluR1a-A168V (a site located within the glutamate binding region) resulted in a 63 ±
17% increase in IP3 formation when compared to control FLAG-mGluR1a transfected
cells (Figure 4.4B). Quisqualate-stimulated FLAG-mGLuR1a-R375G IP3 formation was
comparable to FLAG-mGluR1a transfected cells, despite reduced cell surface expression.
However, glutamate-stimulated FLAG-mGLuR1a-R375G IP3 formation was reduced to
29 ± 4% of FLAG-mGluR1a transfected cells (Figure 4.4C). Therefore, activation of this
mutant by glutamate and quisqualate resulted in divergent signalling patterns.
4.3.3. R375G displays functional selectivity toward ERK1/2
To examine whether the mGluR1a mutations associated with various cancer cell
lines also affected other mGluR1a-activated cell signalling pathways, we examined
whether the mutations influenced the ability of mGluR1a to stimulate ERK1/2
phosphorylation in HEK293 cells. Similarly to what we found for IP3 formation, all four
amino-terminal mutations also exhibited decreased basal ERK1/2 phosphorylation, but
still displayed a statistically significant increase in ERK1/2 activation in response to
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Figure 4.4. Mutations in mGluR1 alter basal and agonist-activated inositol
phosphate formation. (A) Basal IP3 formation in HEK 293 cells transiently
transfected with 2 μg Flag-tagged mGluR1a constructs. Cells were labelled
overnight with myo-(3H)Inositol in glutamine-free DMEM, incubated for 10 min
with 10 mM LiCl followed by (B) 30 μM quisqualic acid or (C) 100 μM
glutamate for 30 min. Total cellular (3H)inositol was collected and purified by
anion exchange chromatography and [3H]-inositol phosphate formation was
determined by liquid scintillation. Data were normalized for protein expression
and represent the standard error of the mean of four independent experiments. *, p
< 0.01 compared to wild type with the same treatment.
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quisqualate treatment (Figure 4.5A). Interestingly, although FLAG-mGluR1a-R375G
demonstrated decreased basal ERK1/2 phosphorylation, quisqualate-mediated ERK1/2
phosphorylation in FLAG-mGluR1-R375G expressing cells resulted in significantly
increased ERK1/2 phosphorylation following 1, 5 and 10 min agonist stimulation when
compared to wild-type FLAG-mGluR1a (Figure 4.5B).

In contrast, ERK1/2

phosphorylation in response to the activation of either FLAG-mGluR1a-R696W or P1148L was significantly reduced when compared to wild-type FLAG-mGluR1a.
Therefore, the R375G mutant appeared to be biased towards the activation of the ERK1/2
pathway, whereas the R696W and P1148L mutations were biased for G protein-mediated
signalling.
4.3.4. GRK2 binding to mGluR1a mutants
Several of the identified mGluR1a mutations are localized to the second
intracellular loop domain of the receptor, including R684C, G688V and G696W, a
domain that is important for GRK2 binding and phosphorylation-independent
desensitization of the receptor. We find that association of GRK2 with these FLAGmGluR1a variants was unchanged compared to wild-type FLAG-mGluR1a as determined
by co-immunoprecipitation (Figure 4.6A). Additionally, these mGluR1 second
intracellular loop mutations all continue to be desensitized by GRK2 overexpression
(Figure 4.6B). Interestingly, although R696W showed no alterations in IP3 formation,
agonist-activation of this mutant failed to induce ERK1/2 phosphorylation (Figure 4.5B).
Therefore, mutation in this region does not alter GRK2 association or GRK2-mediated
IP3

desensitization,

but

showed

reduced
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receptor-mediated

ERK1/2

activity.

Figure 4.5. Changes in mGluR1-mediated ERK1/2 activation. HEK 293 cells
were transiently transfected with 2 μg FLAG-mGluR1a constructs. Forty-eight
hours post-transfection cells were serum starved overnight in glutamine-free
DMEM and stimulated for (A) 15 min or (B) 0, 1, 5 or 15 min with 30 µM
quisqualate. Cell lysates were collected, subjected to SDS-page and
immunoblotted for phosphorylated and total p42/44 (ERK1/2). Data were
normalized for protein expression and represent the standard error of the mean for
3-5 independent experiments. ns, not significant from unstimulated. *, p < 0.05
compared to wild type.
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Figure 4.6. Effect of mGluR1a mutations on GRK2 binding and receptor
desensitization. (A) HEK 293 cells were transiently transfected with 2 μg Flagtagged mGluR1 constructs along with 1 μg GFP-GRK2. Forty-eight hours after
transfection cells were lysed and FLAG-mGluR1a was immunoprecipitated.
Samples were separated by SDS-PAGE, transferred to a nitrocellulose membrane
and immunoblotted to identify co-immunoprecipitated YFP-tagged GRK2
protein.
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immunoprecipitation. (B) HEK 293 cells were transiently transfected with 2 μg
Flag-tagged mGluR1 constructs along with 1 μg empty pEGFP or GFP-GRK2.
Cells were labelled overnight with myo-(3H)inositol in glutamine-free DMEM,
incubated for 10 min with 10 mM LiCl followed by 30 μM quisqualate for 30
min. Total cellular [3H]-inositol was collected and purified by anion exchange
chromatography and (3H)inositol phosphate formation was determined by liquid
scintillation. Data were normalized for protein expression and represent the
standard error of the mean of three independent experiments.
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4.3.5. Attenuated Homer binding to FLAG-mGluR1a P1148L
The carboxyl-terminus mGluR1a encodes a Homer binding motif and the
association of Homers with mGluR1a has been show to modulate both the subcellular
localization and signalling of mGluR1a (Brakeman et al., 1997; Wood et al., 2007;
Kammermeier, 2008; Bertaso et al., 2010; Ronesi et al., 2008, 2012). The introduction of
the P1148L mutations into the C-tail of FLAG-mGluR1a did not affect IP3 formation in
response to agonist activation of the receptor (Figure 4.4), but diminished agoniststimulated ERK1/2 phosphorylation and resulted in a loss of Homer 1b binding to the
receptor (Figure 4.5B and 4.7). Co-immunoprecipitation experiments show this mutant
exhibits decreased association with Homer 1 compared to wild type mGluR1 (Figure
4.7). Moreover, the P1148L mutation resulted in altered subcellular localization of
mGluR1a to membrane ruffles, multinucleated cells and increased filopodia formation in
HEK 293 cells, an effect that was not observed for the wild-type receptor (Figure 4.8).
4.4.

DISCUSSION
In the present study, we have characterised the intracellular localization,

signalling, association with regulatory molecules and cellular morphology of eight
previously unstudied naturally occurring mGluR1 mutations (Kan et al., 2010; Parsons et
al., 2008; Sjoblom et al., 2006; Wood et al., 2007). A unique characteristic of class C
GPCRs is their constitutive dimerization at the cell surface (Kniazeff et al., 2011). Group
I mGluRs have been shown to homodimerize through covalent linkage via disulphide
bonding at cysteine 140 within the large extracellular amino-terminal domain, although
mutation of this residue is not sufficient to inhibit dimerization (Kniazeff et al., 2004;
Ray and Hauschild, 2000; Robbins et al., 1999). Here we identify two mGluR1a variants,
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Figure 4.7. mGluR1 P1148L is deficient in Homer1 binding. HEK293 cells were cotransfected with HA-Homer1 and empty vector (‘-’), or indicated FLAG-tagged mGluR1
constructs. Anti-FLAG was used to immunoprecipitate (‘IP’) mGluR1 from resultant
lysates. 48h post-transfection, co-immunoprecipitated proteins and total lysates resolved
by SDS–PAGE were immunoblotted (‘IB’) with anti-FLAG and anti-HA antibodies.
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Figure 4.8. Homer binding mutant mGluR1 P1148L promotes filopodia formation.
(A) Representative confocal micrographs illustrating receptor localization and cell
morphology. HEK293 cells expressing 2 μg Flag-tagged mGluR1 constructs were fixed
and immunolabelled for total cellular compliment of receptor. Images are representative
of 3 independent experiments. Bars represent 5 µm. (B) Graph scoring the number of
cells displaying filopodia. NIH-3T3 cells transiently expressing Flag-mGluR1 wild type
or P1148L were fixed and immunolabelled for total cellular compliment of the receptor
and number cells displaying filopodia were counted per field of view. 100 cells from
three separate experiments were counted randomly and a data represent the average
standard error of the mean of three independent experiments.
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R375G and G396V, which migrate on a western blot exclusively at the size of the
monomer (~140 kDa). The amino-terminal region of these mutations is consistent with
other studies, which report covalent linkages are not essential for dimerization of all
Group I mGluRs, suggesting that multiple interactions are involved in the dimerization of
these receptors (Sato et al., 2003; Romano et al., 2001, 1996). However, it is becoming
clear that proper receptor targeting and function of many GPCRs is dependent on dimer
formation (Milligan, 2010). For example, the GABAB receptor requires both GABAB1
and GABAB2 subunits in order to reach the plasma membrane as well as activate G
proteins (White et al., 1998; Duthey et al., 2002; Pin et al., 2004). Heterodimerization of
GABAB receptor subunits masks an ER retention sequence in the carboxyl-terminus of
GABAB (Margeta-Mitrovic et al., 2000). Additionally, heterodimerization between the
α1D- and α1B-adrenoceptors, was shown to be necessary for the proper cell-surface
expression of the α1DAR subtype (Hague et al., 2006). Dimerization is also essential for
receptor-G protein coupling. GABAB1 requires co-expression with GABAB2 in order to
couple functionally to the G protein signalling cascade (Galvez et al., 2001; MargetaMitrovic et al., 2000). This is not just due to plasma membrane localization as a mutant
form of GABAB1 that lacks its ER retention signal and can reach the cell surface on its
own still requires GABAB2 for functional activity (Margeta-Mitrovic et al., 2000). Our
data would support the concept that dimer formation may contribute to appropriate cell
surface expression of mGluR1a, as two amino-terminal mutants (R375G and G396V)
result in ER retention of mGluR1a and reduced cell surface expression. We also find that
these mGluR1a mutants, exhibit significantly reduced basal inositol phosphate formation.
However, this reduction in constitutive mGluR1a signalling may be independent of cell
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surface expression as another amino-terminal mutation (A168V), which displays the
same cell surface expression as wild type, also results in attenuated basal activity.
Group I mGluRs exhibit significant basal G protein activation (Dale et al., 2000).
However, three amino-terminal mGluR1a mutations, A168V, R375G and G396V as well
as one second intracellular loop mutant (G688V) exhibited a loss of basal activity in HEK
293 cells. The reduction in basal activity for the amino-terminal mGluR1a mutations
may be the consequence of altered affinity for glutamate that may be released from the
HEK 293 cells to feedback on the receptor. However, inconsistent with this notion is the
observation that the mGluR1a-A168V mutant exhibits increased activation of IP3
formation in response to agonist treatment. The intracellular loop mutation G688V also
resulted in decreased basal mGluR1a activity without affecting agonist-stimulated
responses. However, the rationale for the observed reduction in basal activity of the
mGluR1a-G688V variant remains to be determined.
It is well established that mGluRs activate downstream mitogenic pathways such
as the ERK1/2 signalling cascade that contributes to alterations in cell proliferation
(Rozengurt, 2007). Group I mGluRs activate ERK1/2 in both calcium-dependent and independent manners, the latter involving Gβγ and non-receptor tyrosine kinases such as
Src and Pyk2 (Nicodemo et al., 2010). We have identified three mGluR1a mutants with
altered ERK activation including mGluR1 R375G, which exhibits markedly increased
ERK1/2 phosphorylation upon quisqualate stimulation. Although this mutation does not
affect quisqualate-stimulated IP3 formation, glutamate-mediated IP3 formation is
significantly impaired for the R375G mutant. Taken together, these observations suggest
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that mutations localized to the amino-terminal domain of mGluR1a may bias receptor
signalling towards the ERK1/2 pathway.
Receptor modulation by regulatory proteins such as GRK2 represents a major
mechanism controlling the magnitude and duration of GPCR signal transduction. GRK2mediated attenuation of mGluR1a signalling occurs as the consequence of the
concomitant association of the kinase with the second intracellular loop domain of the
receptor and Gαq/11 (Dhami et al., 2004; Dhami et al., 2005; Dhami and Ferguson, 2006;
Ferguson, 2007). We investigated here, the effect of three intracellular loop 2 mutations
on the association of GRK2 with mGluR1a. We find that none of the mutations exhibits
reduced GRK2 association and that GRK2 overexpression results in normal attenuation
of G protein signalling in response to the activation of mGluR1a second intracellular loop
mutants. Interestingly, we also find that ERK1/2 activation in response to activation of
mGluR1a-R696W is lost, suggesting that this residue may contribute to the regulation of
ERK1/2 signalling by the receptor. Our previous studies have shown that Pyk2 binds to
the second intracellular loop domain of mGluR1a and may directly contribute to the
activation of ERK1/2 phosphorylation (Nicodemo et al., 2010). Future studies will be
required to assess whether this mutation affects Pyk2 binding to mGluR1a.
Of the many regulatory proteins that interact with Group I mGluRs, the Homer
family of proteins are predominantly featured as they are synaptically localized and
couple Group I mGluRs to the activation of a variety of ion channels at the synapse
(Ango et al., 2002; Ciruela et al., 1999; Coutinho et al., 2001; Roche et al., 1999;
Tadokoro et al., 1999). Here we show that the naturally occurring mGluR1 variant
(P1148L) does not associate with Homer1b, is uncoupled from the activation of ERK1/2
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phosphorylation and causes enhanced multinucleation and filopodia formation in HEK
293 cells. The loss of agonist-stimulated ERK1/2 phosphorylation by the mGluR1aP1148L mutant is consistent with recent reports that Homer 1a may contribute in part to
the coupling of mGluR1a to the activation of ERK1/2 (Mao et al., 2005; Mao et al.,
2008). The mechanism by which the P1148L mutation leads to increased multinucleation
and filopodia formation is unclear, but likely relevant to the association of this mutation
with a cancer cell line.
In this study, we characterised the signalling and intracellular localization of eight
somatic mutations in mGluR1 identified in genome-wide screens of various cancerous
tissue samples. We identified two mutations involved in dimerization and plasma
membrane targeting as well as several mutations differentially affecting IP3 formation
and MAPK signalling of this receptor. For example, we demonstrate that the R375G
mutant preferentially couples to ERK1/2 activation while exhibiting decreased basal and
glutamate-activated inositol phosphate production. Additionally, the A168V mutant
displays decreased basal and increased agonist-mediated IP3 formation. These alterations
in the mGluR1a activity may contribute, at least in part, to the phenotype of the cancer
cell lines in which they were identified. This study sheds new light on the functionality of
different regions of the receptor as well as further defining the residues involved in
mGluR1 signalling and the role of mGluR1 signalling in pathologies and may provide an
exciting opportunity for developing new mGluR1-targeted treatments.

173

4.5.

REFERENCES

Ango F, Robbe D, Tu JC, Xiao B, Worley P.F, Pin JP, Bockaert J, and Fagni L (2002)
Homer-dependent cell surface expression of metabotropic glutamate receptor type 5 in
neurons. Mol Cell Neurosci 20:323-329.
Bertaso F, Roussignol G, Worley P, Bockaert J, Fagni L, Ango F (2010) Homer1adependent crosstalk between NMDA and metabotropic glutamate receptors in mouse
neurons. PLoS One 5:e9755.
Bhattacharya M, Babwah AV, Godin C, Anborgh PH, Dale LB, Poulter MO, and
Ferguson SS (2004) Ral and phospholipase D2-dependent pathway for constitutive
metabotropic glutamate receptor endocytosis. J. Neurosci. 24:8752-8761.
Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, Huganir RL, and Worley
PF (1997) Homer: a protein that selectively binds metabotropic glutamate receptors.
Nature 386:284-288.
Ciruela F, Soloviev MM, and McIlhinney RA (1999) Co-expression of metabotropic
glutamate receptor type 1alpha with homer-1a/Vesl-1S increases the cell surface
expression of the receptor. Biochem J 341 ( Pt 3):795-803.
Conn PJ, and Pin JP (1997) Pharmacology and functions of metabotropic glutamate
receptors. Annu Rev Pharmacol Toxicol 37:205-237.
Coutinho V, Kavanagh I, Sugiyama H, Tones MA, and Henley JM (2001)
Characterization of a metabotropic glutamate receptor type 5-green fluorescent protein
chimera (mGluR5-GFP): pharmacology, surface expression, and differential effects of
Homer-1a and Homer-1c. Mol Cell Neurosci 18:296-306.
Dale LB, Babwah AV, Bhattacharya M, Kelvin DJ, and Ferguson SS (2001) Spatialtemporal patterning of metabotropic glutamate receptor-mediated inositol 1,4,5triphosphate, calcium, and protein kinase C oscillations: protein kinase C-dependent
receptor phosphorylation is not required. J Biol Chem 276:35900-35908.
Dale LB, Bhattacharya M, Anborgh PH, Murdoch B, Bhatia M, Nakanishi S, and
Ferguson SS (2000) G protein-coupled receptor kinase-mediated desensitization of
metabotropic glutamate receptor 1A protects against cell death. J Biol Chem 275:3821338220.
Dhami GK, and Ferguson SS (2006) Regulation of metabotropic glutamate receptor
signaling, desensitization and endocytosis. Pharmacol Ther 111:260-271.
Dhami GK, Babwah AV, Sterne-Marr R, and Ferguson SS (2005) Phosphorylationindependent regulation of metabotropic glutamate receptor 1 signaling requires g protein-

174

coupled receptor kinase 2 binding to the second intracellular loop. J Biol Chem
280:24420-24427.
Dhami GK, Dale LB, Anborgh PH, O'Connor-Halligan KE, Sterne-Marr R, and Ferguson
SS (2004) G Protein-coupled receptor kinase 2 regulator of G protein signaling homology
domain binds to both metabotropic glutamate receptor 1a and Galphaq to attenuate
signaling. J Biol Chem 279:16614-16620.
Dhami GK, Anborgh PH, Dale LB, Sterne-Marr R, and Ferguson SS (2002)
Phosphorylation-independent regulation of metabotropic glutamate receptor signaling by
G protein-coupled receptor kinase 2. J Biol Chem 277:25266-25272.
Dingledine R, Borges K, Bowie D, and Traynelis SF (1999) The glutamate receptor ion
channels. Pharmacol Rev 51:7-61.
Duthey B, Caudron S, Perroy J, Bettler B, Fagni L, Pin JP, and Prezeau L (2002) A single
subunit (GB2) is required for G-protein activation by the heterodimeric GABA(B)
receptor. J Biol Chem 277:3236-3241.
Emery AC, Pshenichkin S, Takoudjou GR, Grajkowska E, Wolfe BB, Wroblewski JT
(2010) The protective signaling of metabotropic glutamate receptor 1 Is mediated by
sustained, beta-arrestin-1-dependent ERK phosphorylation. J Biol Chem 285:26041-8.
Ferguson SS (2007) Phosphorylation-independent attenuation of GPCR signalling.
Trends Pharmacol Sci 28:173-179.
Ferguson SS (2001a) Evolving concepts in G protein-coupled receptor endocytosis: the
role in receptor desensitization and signaling. Pharmacol Rev 53:1-24.
Ferguson SS (2001b) Evolving concepts in G protein-coupled receptor endocytosis: the
role in receptor desensitization and signaling. Pharmacol Rev 53:1-24.
Francesconi A, Duvoisin RM (2000) Opposing effects of protein kinase C and protein
kinase A on metabotropic glutamate receptor signaling: selective desensitization of the
inositol trisphosphate/Ca2+ pathway by phosphorylation of the receptor-G proteincoupling domain. Proc Natl Acad Sci U S A 97:6185-90.
Francesconi A, and Duvoisin RM (1998) Role of the second and third intracellular loops
of metabotropic glutamate receptors in mediating dual signal transduction activation. J
Biol Chem 273:5615-5624.
Galvez T, Duthey B, Kniazeff J, Blahos J, Rovelli G, Bettler B, Prezeau L, and Pin JP
(2001) Allosteric interactions between GB1 and GB2 subunits are required for optimal
GABA(B) receptor function. EMBO J 20:2152-2159.

175

Gerber U, Gee CE, and Benquet P (2007) Metabotropic glutamate receptors: intracellular
signaling pathways. Curr Opin Pharmacol 7:56-61.
Hague C, Lee SE, Chen Z, Prinster SC, Hall RA, and Minneman KP (2006)
Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional
entity. Mol. Pharmacol. 69:45-55.
Huang S, Cao J, Jiang M, Labesse G, Liu J, Pin JP, Rondard P (2011) Interdomain
movements in metabotropic glutamate receptor activation. Proc Natl Acad Sci U S A
108:15480-5.
Kammermeier PJ (2008) Endogenous homer proteins regulate metabotropic glutamate
receptor signaling in neurons. J Neurosci 28:8560-7.
Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, Yue P, Haverty PM,
Bourgon R, Zheng J, (2010) Diverse somatic mutation patterns and pathway alterations in
human cancers. Nature 466:869-873.
Kniazeff J, Bessis AS, Maurel D, Ansanay H, Prezeau L, and Pin JP (2004) Closed state
of both binding domains of homodimeric mGlu receptors is required for full activity. Nat
Struct Mol Biol 11:706-713.
Kniazeff J, Prezeau L, Rondard P, Pin JP, and Goudet C (2011) Dimers and beyond: The
functional puzzles of class C GPCRs. Pharmacol Ther 130:9-25.
Krupnick JG, and Benovic JL (1998) The role of receptor kinases and arrestins in G
protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289-319.
Mao LM, Zhang GC, Liu XY, Fibuch EE, and Wang JQ (2008) Group I metabotropic
glutamate receptor-mediated gene expression in striatal neurons. Neurochem Res
33:1920-1924.
Mao L, Yang L, Tang Q, Samdani S, Zhang G, and Wang JQ (2005) The scaffold protein
Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated
protein kinase cascades in neurons. J Neurosci 25:2741-2752.
Margeta-Mitrovic M, Jan YN, and Jan LY (2000) A trafficking checkpoint controls
GABA(B) receptor heterodimerization. Neuron 27:97-106.
Medler KF, Bruch RC (1999) Protein kinase Cbeta and delta selectively phosphorylate
odorant and metabotropic glutamate receptors. Chem Senses 24:295-9.
Milligan G (2010) The role of dimerisation in the cellular trafficking of G-proteincoupled receptors. Curr Opin Pharmacol 10:23-9.

176

Mundell SJ, Pula G, Carswell K, Roberts PJ, and Kelly E (2003) Agonist-induced
internalization of metabotropic glutamate receptor 1A: structural determinants for protein
kinase C- and G protein-coupled receptor kinase-mediated internalization. J Neurochem
84:294-304.
Mundell SJ, Pula G, McIlhinney RA, Roberts PJ, and Kelly E (2004) Desensitization and
internalization of metabotropic glutamate receptor 1a following activation of
heterologous Gq/11-coupled receptors. Biochemistry 43:7541-7551.
Nicodemo AA, Pampillo M, Ferreira LT, Dale LB, Cregan T, Ribeiro FM, and Ferguson
SS (2010) Pyk2 uncouples metabotropic glutamate receptor G protein signaling but
facilitates ERK1/2 activation. Mol Brain 3:4.
Niswender CM, and Conn PJ (2010) Metabotropic glutamate receptors: physiology,
pharmacology, and disease. Annu Rev Pharmacol Toxicol 50:295-322.
O'Hara PJ, Sheppard PO, Thøgersen H, Venezia D, Haldeman BA, McGrane V,
Houamed KM, Thomsen C, Gilbert TL, Mulvihill ER (1993) The ligand-binding domain
in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins.
Neuron 11:41-52.
Olney JW (1994) Excitatory transmitter neurotoxicity. Neurobiol Aging 15:259-260.
Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H,
Siu IM, Gallia GL, (2008) An integrated genomic analysis of human glioblastoma
multiforme. Science 321:1807-1812.
Pin JP, Galvez T, and Prezeau L (2003) Evolution, structure, and activation mechanism
of family 3/C G-protein-coupled receptors. Pharmacol Ther 98:325-354.
Pin JP, Kniazeff J, Binet V, Liu J, Maurel D, Galvez T, Duthey B, Havlickova M, Blahos
J, Prezeau L, and Rondard P (2004) Activation mechanism of the heterodimeric
GABA(B) receptor. Biochem Pharmacol 68:1565-1572.
Ray K, and Hauschild BC (2000) Cys-140 is critical for metabotropic glutamate receptor1 dimerization. J Biol Chem 275:34245-34251.
Robbins MJ, Ciruela F, Rhodes A, and McIlhinney RA (1999) Characterization of the
dimerization of metabotropic glutamate receptors using an N-terminal truncation of
mGluR1alpha. J Neurochem 72:2539-2547.
Roche KW, Tu JC, Petralia RS, Xiao B, Wenthold RJ, and Worley PF (1999) Homer 1b
regulates the trafficking of group I metabotropic glutamate receptors. J Biol Chem
274:25953-25957.

177

Romano C, Miller JK, Hyrc K, Dikranian S, Mennerick S, Takeuchi Y, Goldberg MP,
O'Malley KL (2001) Covalent and noncovalent interactions mediate metabotropic
glutamate receptor mGlu5 dimerization. Mol Pharmacol 59:46-53.
Romano C, Yang WL, O'Malley KL (1996) Metabotropic glutamate receptor 5 is a
disulfide-linked dimer. J Biol Chem 271:28612-6.
Rondard P, Huang S, Monnier C, Tu H, Blanchard B, Oueslati N, Malhaire F, Li Y,
Trinquet E, Labesse G, Pin JP, Liu J (2008) Functioning of the dimeric GABA(B)
receptor extracellular domain revealed by glycan wedge scanning. EMBO J 27:1321-32.
Ronesi JA, Collins KA, Hays SA, Tsai NP, Guo W, Birnbaum SG, Hu JH, Worley PF,
Gibson JR, Huber KM (2012) Disrupted Homer scaffolds mediate abnormal mGluR5
function in a mouse model of fragile X syndrome. Nat Neurosci doi: 10.1038/nn.3033.
Ronesi JA, Huber KM (2008) Homer interactions are necessary for metabotropic
glutamate receptor-induced long-term depression and translational activation. J Neurosci
28:543-7.
Rozengurt E (2007) Mitogenic signaling pathways induced by G protein-coupled
receptors. J Cell Physiol 213:589-602.
Sato T, Shimada Y, Nagasawa N, Nakanishi S, Jingami H (2003) Amino acid
mutagenesis of the ligand binding site and the dimer interface of the metabotropic
glutamate receptor 1. Identification of crucial residues for setting the activated state. J
Biol Chem 278:4314-21.
Schoepp DD, and Johnson BG (1988) Selective inhibition of excitatory amino acidstimulated phosphoinositide hydrolysis in the rat hippocampus by activation of protein
kinase C. Biochem Pharmacol 37:4299-4305.
Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ,
Ptak J, Silliman N, et al. (2006) The consensus coding sequences of human breast and
colorectal cancers. Science 314:268-274.
Shiraishi-Yamaguchi Y, Furuichi T (2007) The Homer family proteins. Genome Biol
8:206.
Tadokoro S, Tachibana T, ImanakaT, Nishida W, and SobueK (1999) Involvement of
unique leucine-zipper motif of PSD-Zip45 (Homer 1c/vesl-1L) in group 1 metabotropic
glutamate receptor clustering. Proc Natl Acad Sci U S A 96:13801-13806.
Thandi S, Blank JL, Challiss RA (2002) Group-I metabotropic glutamate receptors,
mGlu1a and mGlu5a, couple to extracellular signal-regulated kinase (ERK) activation via
distinct, but overlapping, signalling pathways. J Neurochem 83:1139-53.

178

Tu JC, Xiao B, Yuan JP, Lanahan AA, Leoffert K, Li M, Linden DJ, Worley PF (1998)
Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate
receptors with IP receptors. Neuron 21:717-26.
Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA,
Roth BL, Christopoulos A, Sexton PM, et al. (2007) Functional selectivity and classical
concepts of quantitative pharmacology. J Pharmacol ExpTher 320:1-13.
Wang M, Bianchi R, ChuangSC, Zhao W, and Wong RK (2007) Group I metabotropic
glutamate receptor-dependent TRPC channel trafficking in hippocampal neurons. J
Neurochem 101:411-421.
White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P,
Foord SM, Marshall FH (1998) Heterodimerization is required for the formation of a
functional GABA(B) receptor. Nature 396:679-82.
Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber
T, Ptak J, et al. (2007) The genomic landscapes of human breast and colorectal cancers.
Science 318:1108-1113.

179

CHAPTER 5.
DISCUSSION

180

5.1.

SUMMARY
The aim of this thesis was to elucidate the role that receptor trafficking plays in

signal transduction by addressing the following three questions:
5.

Do multiple Rab proteins associate with AT1R to alter receptor desensitization or
resensitization?

6. Does Rab8 associate with mGluR1 to modulate its intracellular trafficking and
signalling?
7. What alterations do previously uncharacterized single nucleotide polymorphisms in
mGluR1 exhibit in intracellular localization and signal transduction?
The data presented in chapters 2, 3 and 4 summarize my findings aimed at
answering these important questions pertaining to the role intracellular trafficking plays
in GPCR signal transduction (Figure 5.1). In chapter 2 we learned that, in addition to the
previously published Rab5a, other Rab GTPases including Rab4, Rab7 and Rab11
associate with overlapping residues of the angiotensin II type 1 receptor C-tail and
compete with each other to regulate receptor phosphorylation, desensitization and
resensitization. Dale et al., (2004) showed that overexpression of constitutively active
Rab7 and Rab11 mutants could override Rab5a-mediated AT1AR retention in early
endosomes, and divert the receptor through Rab7 or Rab11 pathways, suggesting that
other Rabs may compete with each other for AT1AR trafficking. Here we found that
overexpression of Rab4 and Rab11 can each uncouple Rab5 from AT1R. Additionally,
Rab4 can cause Rab11 to dissociate from AT1R. However, Rab11 was unable to
uncouple Rab4 from the receptor. Additionally, Rab4, but not Rab11, facilitates the
dephosphorylation of AT1R, thus decreasing the desensitization and enhancing the
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Figure 5.1. Newly identified roles of Rab family members in GPCR endocytic
trafficking and signalling. Although Rab5 is well known to participate in clathrinmediated endocytosis, we find here that Rab8 blocks mGluR1a endocytosis. In addition
to mediating the “fast” recycling route, Rab4, but not Rab11, facilitates
dephosphorylation

of

AT1R,

thus

decreasing

resensitization.
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desensitization

and

facilitating

resensitization of the receptor. β2AR dephosphorylation and resensitization occurs as the
receptor transits between the Rab5-positive early endosome and the Rab4-positive rapid
recycling endosome while dephosphorylated CRF1α receptor colocalized with Rab4 but
not with Rab5 (Seachrist et al., 2000; Holmes et al., 2004). Moreover, it has been
reported that phosphorylated µ-opioid receptor is preferentially recycled through Rab4positive endosomes (Wang et al., 2008). The dephosphorylation of these and other
receptors within Rab4 positive recycling vesicles identifies this compartment as a key
region of GPCR resensitization. The data presented in chapter 2 support the theory that in
addition to regulating receptor trafficking, the association of different Rab GTPases may
regulate different functional outcomes for AT1R signalling.
In chapter 3 we investigated the role of the previously typified exocytic Rab8 in the
regulation of the metabotropic glutamate receptor 1 (Figure 5.2). We found that through
association with the long C-tail isoform mGluR1a, Rab8 expression resulted in decreased
internalization and attenuated IP3 signalling in HEK293 cells and Ca2+ signalling in
neurons. Multiple Rabs have been shown to be involved in both endocytic and exocytic
events. However, this is the first time a Rab has been shown to inhibit internalization. A
consequence of this Rab8-mediated internalization attenuation is increased overall cell
surface mGluR1 expression. Surprisingly, the increased cell surface expression did not
translate into increased receptor signalling, but instead resulted in a PKC-dependent
attenuation of signalling via increased phosphorylation. In chapter 3, we present a novel
role for Rab8 in attenuating mGluR1a internalization and signalling, which opens a new
and exciting avenue of research into the role of Rabs in GPCR regulation.
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Figure 5.2. Rab8 coordinates mGluR1a intracellular trafficking and signal
transduction. Rab8 associates with mGluR1a upon agonist activation and attenuates
receptor internalization, leading to increased mGluR1a plasma membrane expression.
While attenuating mGluR-mediated IP3 and calcium signalling, Rab8 has no effect on
mGluR-mediated ERK1/2 phosphorylation.
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Finally, in chapter 4 we look at the subcellular localization and signal transduction
of eight previously uncharacterised mGluR1 variants identified in various cancerous
tissues. These include four mutations within the amino-terminus, three within the second
intracellular loop and one located within the Homer binding region in the carboxylterminal tail. We find that two mutants in close proximity in the amino-terminus, R375G
and G396V do not appear to form dimers, exhibit significantly lower plasma membrane
expression compared to wild type mGluR1 and co-localize considerably within the ER
with an ER marker GFP-KDEL. We show that these mutants along with other aminoterminal mutants exhibit significantly reduced basal IP3 formation as well as decreased
basal ERK1/2 phosphorylation compared to wild type mGluR1a. Interestingly, the
mGluR1a A168VA mutant, located in the glutamate binding region, displays
significantly reduced basal signalling. However, it also displays significantly increased
agonist-induced IP3 formation. R375G, on the other hand displays biased agonism and
functional selectivity. Quisqualate-induced IP3 formation of the R375G variant shows
little difference from wild type mGluR1a, but R375G exhibits significantly attenuated
response to the natural ligand glutamate. Consequently, the activation of this receptor
variant by different ligands appears to result in divergent signalling patterns.
Additionally, mGluR1a R375G also exhibits functionally selective signal transduction in
response to quisqualate. Although quisqualate-activated mGluR1a-R375G shows no
alterations in IP3 formation compared to wild type, quisqualate treatment induces
significantly higher ERK1/2 activation. This finding is especially dramatic considering
that this mutant displays only 40% cell surface expression when compared with wild type
receptor. We also identified two mGluR1a mutations, which no longer associate with
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regulatory molecules. GRK2 remains associated with mutations in the second
intracellular loop and GRK2 overexpression continues to mediate mGluR1a
desensitization. Additionally, P1148L fails to associate with Homer 1b, is impaired in the
activation of ERK1/2 phosphorylation and appears to stimulate significant changes in
cellular morphology including increased filopodia formation and multinucleation. The
findings presented in chapter 4 opens exciting, previously undocumented roles for
mGluR1a regions involved in agonist binding and activity including biased agonism or
functional selectivity.

Taken together, our findings support the important role that

intracellular trafficking and localization plays in receptor function and signal
transduction.
5.2.

CONTRIBUTIONS TO THE FIELD OF GPCR RESEARCH
In recent years, studies from our laboratory and others have provided increasingly

convincing evidence that GPCR trafficking actively affects signal transduction and
indeed, receptor signal transduction can modulate the activity of proteins controlling the
trafficking vesicular cargo (Smythe, 2002). Thus GPCRs represent unique cargo proteins
that contribute to the regulation of their own intracellular trafficking. Our research
presented here regarding Rab-mediated GPCR alterations in signalling further supports
this idea that intracellular trafficking of GPCRs not only passively participates in receptor
signalling, but can actively alter receptor signalling.
Seachrist et al. (2002) demonstrated that AT1AR activation causes GTP loading of
Rab5a and upon agonist activation, is endocytosed in a Rab5a-dependent manner and
sequestered to large, hollow Rab5a-positive early endosomes. Dale et al. (2004) further
went to show that concurrent overexpression of either Rab7 or Rab11 overcomes this
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Rab5a-mediated AT1AR retention in early endosomes and redirects the receptor to either
Rab7-positive late endosomes or Rab11-positive recycling endosomes, respectively. This
led to the question we posed in chapter 2: do other Rab GTPases also associate with
AT1R? If so, do they compete with each other for trafficking of the receptor?
Interestingly, we found that Rab4, Rab5, Rab7 and Rab11 all associate with the same
amino acid residues of the AT1R C-tail and compete with each other for association.
Internalized AT1R usually does not readily dephosphorylate nor recycle and the Rab11
“slow” pathway has previously been shown to regulate this receptor’s recycling
(Anborgh et al., 2000; Hunyady et al., 2002; Dale et al., 2004). However, Li et al., 2008
provided evidence to suggest that in addition to Rab11, the so-called “fast” Rab4 pathway
can also regulate AT1R recycling. Therefore, we sought to determine what recycling
pathway AT1R prefers, and the consequences thereof. We found that indeed AT1R binds
more to Rab11 than Rab4. However, Rab4 can cause dissociation of Rab11 from the
receptor but Rab11 is unable to displace Rab4. Additionally, Rab4 expression results in a
significant decrease in agonist-mediated AT1R phosphorylation and thus significantly
decreased receptor desensitization, as well as enhanced receptor resensitization.
Therefore, although AT1R normally associates with the Rab11-mediated slow recycling
pathway, when presented the oppourtunity, it can alter its trafficking patterns in favour of
Rab4-mediated fast recycling, thus altering its activity.
Rab GTPases have well-documented roles in receptor endocytosis and exocytosis.
Rab5a participates in clathrin-mediated endocytosis of a number of receptors, including
AT1R, β2AR, CRF among others and Rab4, Rab11, Rab8 are known to facilitate
recycling of GPCRs, including the corticotropin releasing factor receptor 1, somatostatin-
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3 receptor, vasopressin V2 receptor, neurokinin-1 receptor, chemokine CXC receptor-2,
m4 muscarinic acetylcholine receptor and protease activated receptor, are also
differentially regulated by Rab4 and Rab11 (Innamorati et al., 2001; Kreuzer et al., 2001;
Schmidlin et al., 2001; Signoret et al., 2001; Fan et al., 2002; Volpicelli et al., 2002;
Roosterman et al., 2003; Holmes et al., 2006; Deretic, 1997; Seachrist et al., 2000;
Seachrist et al., 2002; Trischler et al., 1999). Rab8, specifically was recently shown to
differentially regulate the TGN to plasma membrane trafficking of α2AR and β2AR and
has also been shown to coordinate with Rab11 to regulate the insertion of AMPA-type
glutamate receptors into spines of hippocampal neurons (Brown et al., 2007; Dong et al.,
2010; Gerges et al., 2004). Interestingly, we uncovered a novel role for Rab8 in the
attenuation of internalization of mGluR1a resulting in an increased plasma membrane
receptor occupancy. To our knowledge, this is the first example of a Rab protein blocking
internalization of a receptor and this finding opens up the possibility of Rabs managing
yet another trafficking pathway with which to participate in receptor regulation. Contrary
to other reports, which indicate that Rab8 expression facilitates receptor signalling by
increased cell surface expression, we found that Rab8-mediated increases in mGluR1a
plasma membrane expression resulted in decreased receptor signalling both in HEK 293
cells as well as hippocampal neurons. However, our results are consistent with the role of
the Rab8 effector molecule optineurin, which was also found to contribute to mGluR1a
desensitization (Anborgh et al., 2005). This study uncovers a novel role of a Rab GTPase
in negatively regulating receptor endocytosis and intracellular signal transduction.
The signal transduction of the prototypic mGluR1a has been extensively
characterised, including mutagenesis of many putative regulatory and signalling-related
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regions of the receptor. However, recent high-throughput genetic screening studies have
identified several naturally occurring, previously uncharacterised mGluR1 mutations. In
chapter 4 we examined these naturally occurring pathological mutations of mGluR1 and
found them to play a substantial role in signal transduction and cellular localization. We
have studied three mutations in the amino terminus, which display decreased basal
signalling, a mutant in the second intracellular loop, which no longer associates with
GRK2, yet is still desensitized by it, as well as one mutation in the carboxyl-terminal tail,
which no longer associates with the regulatory protein Homer1, displays altered receptor
localization, increased filipodia formation and defective ERK1/2 activation. One
mutation in the Cysteine-rich region of the amino terminus emerged as a significant
player in intracellular trafficking as well as signalling. Specifically, mGluR1 R375G
simultaneously exhibited decreased basal IP3 formation while significantly increased
agonist-activated ERK1/2 formation. These mutations further our understanding of
mGluR1 signal transduction and intracellular localization and provide the possibility of
studying previously uncharacterised amino acid residues for the purpose of generating
novel ligands with functional selectivity.
5.3.

PHYSIOLOGICAL RELEVANCE OF TRAFFIC-DEPENDENT
SIGNALLING OF GPCRS

5.3.1. Deregulated Trafficking and Disease
The majority of pharmaceutical interventions specifically target GPCRs due to
their critical involvement in all physiological systems and the contribution of receptor
perturbations to multiple diseases and disorders such as obesity and diabetes,
hypertension, cancer and neurodegenerative diseases such as Alzheimer’s and
Huntington’s diseases among others (Ahren, 2009; Lappano and Maggiolini, 2012;
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Johnson and Liggett, 2011; Ribeiro et al., 2011; Thathiah and De Strooper, 2011).
Mutations in multiple GPCRs, which alter receptor signalling can cause or contribute to
disease progression, but it is now becoming apparent that disruption of trafficking
pathways can also contribute to deregulation of GPCR signalling and influence disease
formation. Because many GPCR ligands do not readily cross the plasma membrane,
receptor trafficking to and from the plasma membrane is crucial to cellular
responsiveness. For example, a naturally occurring loss of function mutation in the
vasopressin receptor is associated with hereditary nephrogenic diabetes insipidus (Rochdi
et al., 2010; Barak et al., 2001). This mutant is constitutively phosphorylated and
sequestered in arrestin-positive endocytic vesicles. However, disrupting the receptorarrestin complex restores plasma membrane localization and signalling. Altered
endocytosis and enhanced receptor activity has been linked to Alzheimer’s disease.
Inhibition of dynamin-dependent endocytosis has been shown to increase Aβ secretion
and a natural variant in the delta-opioid receptor containing phenylalanine at position 27
rather than Cysteine matures more efficiently and has higher stability at the plasma
membrane (Chyung and Selkoe, 2003; Sarajarvi et al., 2011). Interestingly, this variant
also enhances β and γ-secretase activity leading to amyloid precursor protein
accumulation. Therefore, in addition to rapid and effective signal desensitization, the
endocytosis and intracellular trafficking of GPCRs can spatially and temporally
determine receptor signal transduction and play a role in disease pathology.
5.3.2. Consequence of Altered Rab Protein Expression and Function
As discussed above, the role Rabs play in signal transduction is becoming more
evident, especially the direct regulation of target proteins by Rabs, including Rab190

mediated phosphorylation, ubiquitination and palmitoylation of target proteins. Rabs and
their effector proteins are often associated with diseases, including pathogen-induced as
well as inherited dysfunctions and are also associated with multiple neurodegenerative
disorders. For example, neuronal cell death in Parkinson’s disease correlates with Rab5aspecific endocytosis of α-synuclein and dominant-negative Rab5 reduces neuronal cell
death due to incomplete endocytosis of α-synuclein (Sung et al., 2001). Rab7 mutations
impair GTP hydrolysis and contribute to the hereditary neurological disorder CharcotMarie-Tooth disease type 2B (Cogli et al., 2009). As noted above, Rab8 may play a role
in the etiology of Huntington’s disease via association with mutant huntingtin (htt) and
optineurin as mutant htt prevents post-Golgi trafficking by disrupting the Rab8/optineurin
complex (del Toro et al., 2009). However, Rab11 may also contribute to the pathology of
Huntington’s disease. Rab11-dependent vesicle formation in fibroblasts is impaired in
Huntington patients and Rab11DN-expressing adult mouse brains display similar
neurodegeneration to the HD mutant mouse model (Li et al., 2009a, b). It is now apparent
that coordination of Rab proteins and their effectors can play a significant part in the
onset and development of pathologies and learning more about the role they play in
normal and diseased states may lead to better treatment options.
5.4.

FUTURE DIRECTIONS
The novel discoveries presented in this thesis highlight a number of interesting

questions to pursue in the future. Primarily, the precise details of the molecular
mechanisms involved in the crosstalk and signal transduction cascades between Rab
small G proteins and other GPCRs remain to be elucidated. Additionally, we have shown
that Rab4 influences the phosphorylation state of AT1R. How exactly does Rab4 regulate
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the phosphorylation/dephosphorylation of this receptor? Does it block kinase-mediated
phosphorylation or does it recruit phosphatases to dephosphorylate the receptor? Does
Rab4 function by itself or does it work in conjunction with an effector molecule? We also
show that different Rabs compete with each other for association with the receptor and
that some Rabs are more effective at displacing others. Therefore, a greater understanding
of how to manipulate the Rab-mediated receptor trafficking may enable us to influence
receptor signalling. Specifically, if receptors were to be found in cells or tissues
endogenously expressing higher levels of different Rabs, would their intracellular
trafficking and signalling patterns differ? It would be extremely interesting to look at
different GPCRs in endogenous tissues or cells displaying divergent Rab expression
patterns to discover whether this significantly alters signal transduction. Further, can we
alter the response of certain cells or tissues to stimulus by manipulating the complement
of Rabs? In chapter 2 we learned that Rab4, but not Rab11 alters AT1R agonist-induced
phosphorylation, thus modifying receptor desensitization and resensitization. However,
we know that as a Class B receptor, AT1R does not usually become dephosphorylated
and recycled back to the cell surface. Therefore, this raises the question of whether AT1R
activity might be manipulated in either whole tissues or whole animals by altering the
expression patterns of Rab GTPases. It would also be very exciting, for example, to
engineer a transgenic mouse expressing dominant negative Rab4 in vascular smooth
muscle cell, to determine whether these animals exhibit differences in vascular tone,
contraction both under basal conditions and after stimulation with vasoconstrictors such
as AngII. We could further study the signal transduction in isolated cells to identify any
altered or aberrant signalling in these cells compared to wild type litter mates.

192

Investigating the complement of Rabs in different tissue types or diseased tissue and the
influence on GPCR regulation would grant us greater understanding to the physiological
role Rabs play in signal transduction.
In Chapter 3 we reported how Rab8 modulates the trafficking and signalling of
mGluR1a. We need to first isolate all of the players in this regulatory pathway. For
example, we know that PKC is involved, as PKC inhibition reverses the Rab8-mediated
effect on mGluR1a signalling. However, are there other second messenger-dependent
kinases involved or does PKC exert its effect through regulation of some downstream
target? Additionally, we identified for the first time a Rab protein that blocks receptor
internalization. It is a also unclear what the specific mechanism underlying the Rab8mediated inhibition of mGluR1a signalling is and what the specific purpose of this
inhibition may achieve. The consequence of Rab8-mediated attenuation of mGluR1a
endocytosis is increased receptor localization at the plasma membrane and the concurrent
reduction in mGluR1a-mediated signalling. Our laboratory has shown that mGluR1a also
associates with the Rab8 effector molecule, optineurin (Anborgh et al., 2005) and we
have found here that Rab8 itself plays a similar role to optineurin in the desensitization of
mGluR1. Therefore, it is of interest to determine whether Rab8-mediated attenuation of
mGluR1a signalling is either independent of optineurin or works in concert with
optineurin. The glaucoma-associated optineurin E50K mutant continues to associate with
mGluR1a, however does not associate with Rab8. Presumably, if Rab8 works in concert
with optineurin, then expression of this mutant would inhibit the Rab8-mediated
mGluR1a desensitization. Conversely, if Rab8 works independently of optineurin, there
should be no effect of expressing with mutant on mGluR1a signalling. There are several
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other molecules involved in the desensitization and endocytosis of mGluR1, including
GRK2, phospholipase D2 and RalA among others (Dhami et al., 2005, 2004, 2002;
Bhattacharya et al., 2004). In the future it will be of interest to determine if any of these
molecules play a role in Rab8-modulation of mGluR1a trafficking and signal
transduction.
It would be most interesting to engineer a Rab8 conditional knockout, or
knockdown mouse (as Rab8 null mice have been reported to be lethal 3 weeks after birth,
(Sato et al., 2007) in order to determine whether these animals display altered behaviour
such as deficiencies in learning or memory, motor skills, or other behavioural
characteristics. In addition to being a Rab8 effector molecule, optineurin is also a well
known htt binding protein. Huntington's disease is a neurodegenerative disorder caused
by an abnormal polyglutamine expansion in the amino-terminus of the huntingtin protein,
leading to cell dysfunction and neuronal death (Ribeiro et al., 2011).

Optineurin

colocalizes with htt in the Golgi apparatus where it participates in post-Golgi trafficking
and Rab8 coordinates with optineurin to mediate the post-Golgi transport of proteins (del
Toro et al., 2009). Although wild-type htt does not contribute to optineurin-mediated
mGluR desensitization, mutant htt synergistically increases optineurin-mediated mGluR
desensitization in HEK 293 cells as well as in a knock-in mouse model of HD
(HdhQ111/Q111) (Anborgh et al., 2005). As was found for Rab8-mediated
desensitization of mGluR signalling, the attenuation of mGluR5 signalling observed in
HdhQ111/Q111 mice is PKC dependent (Ribeiro et al., 2010). Therefore, it would be
most interesting to further elucidate the role that Rab8 plays in the etiology of HD.
Specifically, does Rab8 complex with the receptor, optineurin and htt? Does it
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preferentially associate with wild type or mutant htt? Finally, it would be exciting to
generating a cross between our mutant HdhQ111/Q111 mice with Rab8 knock-down
mice to see if we reverse mGluR desensitization in this model and alter the Huntington
phenotype.
To our knowledge, this is the first example of a Rab protein blocking
internalization of a receptor and this finding opens up the possibility of Rabs managing
yet another aspect of receptor trafficking with which to participate in receptor regulation.
It would be of significant interest to determine whether other Rabs serve a similar
purpose, or whether Rab8 itself inhibits internalization of other receptors. Our findings
suggest that, although Rab8 expression leads to an overall increase in cell surface
receptors, phosphorylation of those receptors by second messenger-dependent kinases is
increased. Thus, Rab may either function to block mGluR1a internalization ultimately to
prevent mGluR1a dephosphorylation and resensitization or Rab8 association may block
other regulatory molecules from accessing the receptor.
In Chapter 4 we examined several previously uncharacterised naturally occurring
pathological mutations of mGluR1a, which we found played a substantial role in
modulating the signal transduction and cellular localization of mGluR1a. We first need to
delineate the regulatory molecules involved in the altered signal transduction pathways.
For example, we know that mGluR1a-G696W no longer associates with GRK2, but is
still uncoupled following GRK2 overexpression. Therefore, this begs the question as to
just how GRK2 continues to exert its effect on mGluR1a activity. The most probable
explanation is that GRK2 continues to associate with Gαq/11 through its RGS domain and
that GRK2 overexpression mediated uncoupling of mGluR1a signalling is the
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consequence of its selective interaction with Gαq/11. A good way to test this would be to
repeat the experiment with kinase-dead GRK2 mutants as well as GRK2 mutants
deficient in Gαq/11 binding. We also found that this mGluR1a mutant does not activate
ERK1/2. It would also be of value to determine whether the association of other
downstream signalling molecules, such as Pyk2 (Nicodemo et al., 2010) are also affected
by the mutation, and of course whether this affects mGluR1a signalling via these
proteins. In addition, GRK2 overexpression reverses mGluR1a-mediated cell death in
HEK 293 cells (Dale et al., 2000). Thus, it is possible that the mGluR1a-G696W mutant
may be associated with increased apoptotic cell death.
Homer proteins are post-synaptic density proteins with known functions in
receptor trafficking and calcium homeostasis. We have shown that mGluR1a-P1148L no
longer associates with Homer 1b, and although IP3 signalling is unaffected, consistent
with other reports, mGluR1a-P1148L can no longer activate ERK1/2 phosphorylation.
We also found evidence that mGluR1a-P1148L intracellular trafficking and cell
morphology is altered. What are the physiological consequences of this altered
phenotype? For example, it would be interesting to test whether the increased filopodia
formation of mGluR1a-P1178L results in an increase in cell motility.
One mutation in the Cysteine-rich region of the amino terminus emerged as a
significant player in intracellular trafficking as well as signalling. Specifically, mGluR1aR375G activation by quisqualate resulted in divergent signal transduction outcomes, the
differential activation of G protein versus ERK1/2 signalling. This “biased agonism” now
represents an important target for drug design and focuses on the development of
compounds that can stabilize different receptor conformations, thus encouraging signal
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transduction through one pathway or another. It would, therefore, be beneficial to study
the conformation that this receptor assumes in the presence and absence of different
agonist binding. Additionally, R375G simultaneously exhibited unchanged quisqualateinduced IP3 formation as well as significantly increased agonist-activated ERK1/2
formation. We should probe into the consequences of this functionally selective signal
transduction to see whether we can manipulate the signal patterns of this receptor variant.
For example, increased ERK1/2 activity of mGluR1a-R375G may lead to a change in cell
cycle regulation, apoptosis or growth.
As these mGluR1a mutants were originally isolated from human tissue, and
specifically diseased tissue, the altered signal transduction portfolios of each raise
interesting and potentially crucial questions as to the in vivo roles these mGluR1a
mutants may play in pathology. To that end, creating transgenic animal models of at least
mGluR1a-R375G and -P1148L would enable us to study the signal transduction and
intracellular trafficking of these variants in various endogenous cells and tissues as well
as to study the organism as a whole to look at development, behaviour and pathologies.
The studies that originally isolated these mutations in mGluR1a also highlighted
mutations in a number of other GPCRs, including mGluR3, α1aAR, luteinizing hormone
receptor, as well as regulatory molecules GRK1 and Homer2 and downstream effector
molecules, PLCβ, PLD2 and small G proteins such as Ral, RalGDS, Rab5c, Rab3a (Kan
et al., 2010; Parsons et al., 2008; Sjoblom et al., 2006; Wood et al., 2007). It would be
beneficial to study the mutations in these other molecules, and how they interact with
each other to determine their altered signal transduction and intracellular localization
mechanisms.
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